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SUMMARY 
 
The objective of this thesis research is to develop microelectronic acoustic 
technology towards biosensor applications. The development of a simple and robust 
resonator that employs simple microelectronic fabrication techniques for its construction 
could provide the foundation for a cost-effective sensor platform. Subsequent 
development of an appropriate surface chemistry treatment would functionalize the 
resonator as a biosensor. Implementation of this design in an array configuration allows 
for the development of ligand microarrays, which subsequently allows for multi-ligand 
recognition signatures as well as testing redundancy. The applications for such a tool 
extend to a myriad of applications, but the focus of this research is to develop this 
technology towards an early cancer detection capability. 
Specifically, I develop a solidly-mounted resonator with thin-film ZnO as my 
active piezoelectric layer. These resonators undergo an extensive development process to 
arrive at a final device design and are fully characterized throughout by X-ray diffraction 
and scattering analysis. Employing silane chemistry, these resonators are functionalized 
as immunosensors by covalently binding antibodies to the surface of the device. The 
quality of the surface chemistry is fully assessed using water contact angle, atomic force 
microscopy and confocal laser scanning microscopy. Functionalized biosensors are then 
used to quantify the concentration of known proteins marker in both a purified medium 
and a physiologically-relevant medium. 
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CHAPTER 1 
INTRODUCTION 
 
The objective of my research was to develop a biosensor technology appropriate for 
application towards the early detection of cancer. Biosensors can generally be broken 
down as follows: (shown in Figure 1.1) 
 
1. A specific molecular recognition event (generally achieved by an immobilized 
capture agent) occurs at a particular location due to exposure of the sensor to a 
sample medium 
2. This event causes a change in the operation of an adjacent or otherwise proximal 
transducer. 
3. The change in operating conditions of that transducer is detected by associated 
electronic detection equipment. 
 
 
Figure 1.1. Principles of a biosensor. 
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Given that prostate cancer represents one of the best understood at the earliest stages 
of development, I will focus on application of this sensor towards detection of prostate 
cancer relevant biomarkers. The overall goal, therefore, is to develop a microelectronic 
acoustic sensor design that will lead to point-of-care, label-free detection capability with 
the following three attributes:  
 
1. a cost-effective design that allows for simple mass production using currently 
available facilities;  
2. a sensor capable of sufficient sensitivity and selectivity to detect targets at 
pathologically relevant concentrations in physiologically relevant media; and  
3. a simple sensing protocol that accommodates little training and near real-time 
response while minimizing false negatives and false positives.  
 
There exist many problems to be solved in accomplishing such a system. For such an 
early detection system to be useful for broader clinical diagnostic applications, the sensor 
design must be highly cost effective. The microelectronics industry has made 
extraordinary progress in pushing economies of scale to reduce the price of any hardware 
produced by microelectronic fabrication. A sensor can be developed that takes advantage 
of the use of these techniques. Medical diagnostics are generally made more expensive by 
the duration and complexity of the testing protocol. The more complex the system, the 
greater the qualifications required of the technician performing the test, generally 
increasing the cost. Development of a near real-time reporting system that requires little 
training to perform would significantly mitigate these costs.  
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The applications for such a sensor technology are extensive. In the field of cancer 
treatment alone, such sensors could be used for early diagnosis, post-treatment 
monitoring, and by proteomics researchers for new marker exploration and validation. 
Beyond cancer research, such devices could be employed for everything from battlefield 
chemical weapons detection, to narcotics and explosives detection, to water quality 
monitoring [1-3].  
I will demonstrate significant progress towards realizing such a tool. Specifically, 
contributions by the author include: 
 
A. The development of a novel thickness shear mode bulk acoustic resonator 
array utilizing zinc oxide (ZnO). 
B. The novel application of an appropriate surface chemistry protocol for 
functionalization of planar ZnO with monoclonal antibodies. 
C. Combination of these two and demonstration of capability as a sensor. 
 
The first point represents an original contribution by the author that simultaneously 
addresses points 1-3 enlisted on page 2 of this dissertation. The resonator design can be 
fabricated with existing microelectronic fabrication equipment with a small footprint, 
easily implemented in a microarray configuration. The device array can easily yield as 
many as 1,000 arrays with eight devices each on a single 3-inch wafer. Further, the 
design is such that it could be fabricated on nearly any polished substrate. The second 
point is also an original contribution by the author, allowing for the application of the 
resonators developed as biosensors, as well as the functionalization of any other ZnO-
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based transducer. As neither of the first two components had ever existed before, the third 
point is obviously another original contribution by the author. The accomplishments 
listed above have led to the following peer-reviewed publications: 
 
• Christopher D Corso, Anthony Dickherber, William D. Hunt, ‘An investigation of 
antibody immobilization methods employing organosilanes on planar crystalline ZnO 
surfaces for biosensor applications,’ Biosensors & Bioelectronics 2008, Article in 
Press 
 
• Cleon Davis, Anthony Dickherber, William D. Hunt, Gary S. May, ‘In-Situ acoustic 
temperature measurement during variable frequency microwave curing,’ IEEE 
Transactions on Electronics Packaging Manufacturing, 2008, Article in Press 
 
• Anthony Dickherber, Christopher D Corso, William D. Hunt, ‘Optimization and 
characterization of a ZnO biosensor array,’ Sensors & Actuators A: Physics, 144(1) 
pg 7-12, May 28, 2008 
 
• Christopher D Corso, Anthony Dickherber (joint first author), William D. Hunt, 
‘Lateral field excitation of  thickness shear mode waves in a thin film ZnO solidly 
mounted resonator,’ Journal of Applied Physics, 101, 054514, 2007  
• Article was independently selected for publication in the Virtual Journal of 
Biological Physics Research, May 2007, indicating recognition of the potential 
impact of this research 
 
the following conference presentations: 
• Anthony Dickherber, Christopher D Corso, William D. Hunt, ‘Stability of a RF 
sputtered ZnO solidly mounted resonator sensor in varying temperature and 
conductivity environments,’ IEEE Sensors Conference, Atlanta, GA Oct 30 2007 
 
• Anthony Dickherber, Christopher D Corso, William D. Hunt, ‘Dual Mode Sensing,’ 
IEEE Engineering in Medicine and Biology Conference, NYC NY, Sept 2 2006 
 
• Anthony Dickherber, William D. Hunt, ‘Towards integration of ZnO resonator 
components with GaAs microelectronics,’ Motorola University Partnership in 
Research Program Conference, Chicago IL, Oct 2004 
 
and the following professional poster presentations: 
• Anthony Dickherber, Christopher D. Corso, John Petros, William D. Hunt, ‘A 
microelectronic bulk acoustic wave biosensor array for the detection of PSA in 
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complex solutions,’ 2008 Annual Meeting of American Association for Cancer 
Research, San Diego, CA, April 10-16, 2008 
 
• Christopher D. Corso, Anthony Dickherber, and William D. Hunt, ‘A thickness 
shear mode zinc oxide liquid sensor with off-axis excitation,’ IEEE Sensors 
Conference, Atlanta GA, Oct 29-31 2007 
 
• Anthony J. Dickherber, Christopher D. Corso, William D. Hunt, Ira Pastan, 
Mitchell Ho, Raffit Hassan, ‘Mesothelin-fc fusion protein detection using a novel 
microelectronic acoustic sensor platform,’ 2007 AACR International Conference 
on  Molecular Diagnostics in Cancer Therapeutic Development, Atlanta, GA Sept 
17-20, 2007 
 
• Anthony Dickherber, William Hunt, ‘Breaking Down Cost Barriers to Improve 
Public Health,’ The Sam Nunn Bank of America Policy Forum, Atlanta, GA 
March 27 2006 
 
• Christopher Corso, Anthony Dickherber, Payal Shah, Alexandra Migdal, Milton 
Datta, Sumana Datta, William Hunt, ‘Development of a Simple Inexpensive Bulk 
Acoustic Wave Nanosensor for Cancer Biomarkers: Detection of Secreted Sonic 
Hedgehog from Prostate Cancer Cells,’ 2006 Annual Meeting of American 
Association for Cancer Research, Washington DC, April 4, 2006 
 
• William Hunt, Christopher Corso, Anthony Dickherber, ‘Piezoelectric Bulk 
Acoustic Wave Biosensors for Real-Time Biomarker Detection in Complex 
Media,’ Moving Biosensors to Point-of-Care Cancer Diagnostics (National 
Cancer Institute Conference), Rockville, MD, June 8-9, 2005 
 
In addition, this research was supported by a pre-doctoral training award to the author of 
$67,824 from the US Army Medical Research and Materiel Command’s (USAMRMC) 
Prostate Cancer Research Program (PCRP). The USAMRMC is a research initiative of 
the Congressionally Directed Medical Research Program (CDMRP).  
I will begin with a discussion of the need for a tool that meets the criteria described at 
the beginning of this chapter and lay out the specific aims of this thesis research. In 
Chapter 2, I will explore the advantages of acoustic wave biosensors, as opposed to 
alternative transducer technologies, and discuss the principles of their operation. Chapter 
3 will include a theoretically confirmation of the proposed acoustic wave transducer (or 
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resonator) and the subsequent development of that design. In Chapter 4 I will discuss the 
challenges of developing an appropriate molecular recognition layer for the resonator 
followed by a thorough characterization of the chosen protocol. Chapter 5 will 
demonstrate the performance of the device in various sensor applications and challenges 
therein. Chapter 6 will provide a concluding discussion of the accomplishments made. 
 
Motivation  
 
President Richard Nixon launched the US war against cancer in his 1971 State of the 
Union Address, in which he pledged an extraordinary boost to the National Cancer 
Institute’s (NCI) budget and granted cancer researchers the US Army’s Fort Detrick as a 
research center [4]. Considered his most significant act was the signing of the National 
Cancer Act later that year, at which time he famously declared, “I hope in the years ahead 
we will look back on this action today as the most significant action taken during my 
Administration.” While historians are quite likely to argue that point, the question 
remains regarding how we’ve progressed on this “War on Cancer.” Since that time, 
extraordinary progress has been made in understanding the etiology of various cancers 
and in providing new lines of therapies. The need to maintain efforts regarding this 
campaign, however, are still very strong.  
Today the National Institutes of Health (NIH) estimate that more than 1,500 people 
die each day from a cancer-related cause in the U.S., accounting for one in four American 
deaths overall [5]. Perhaps more disturbing, however, is the fact that mortality rates for 
most cancers have not improved significantly over the past three decades [6]. As can be 
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seen in Figure 1.2, cancer mortality has recently surpassed heart disease mortality rates 
for individuals under the age of 85, making it the largest killer in the US for that age 
group [5]. One major component of the progress to date involves advances made through 
genomic and proteomic studies revealing the presence of serum level molecular targets, 
or biomarkers, indicative of various cancers and their proliferation [6]. Detection of these 
biomarkers in circulating blood is one of the clearest paths to achieving early detection. 
While early detection of any cancer has been identified as likely the best determinant for 
long-term survival, broadly available diagnostic tools and techniques available for 
general clinical diagnostics have not yet emerged to significantly take advantage of these 
discoveries [7, 8].  
 
 
Figure1.2. Death rates from cancer and heart disease, US 1975-2002. [5] 
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The incidence and mortality rates for the top ten cancers for both men and women in the 
US are depicted in Figure 1.3. According to the NIH’s National Cancer Institute (NCI), 
death rates decreased for 11 of the 15 most common cancers in men, but actually 
increased for prostate cancer between 1995 and 2003.[5] As demonstrated in Figure 1.3, 
it is currently estimated that prostate cancer accounts for a little less than one third of all 
new cancer cases in the US in men, with more than 218,000 new cases expected from 
2007. Figure 1.4 reveals that while mortality rates due to prostate cancer have slowed 
recently, it still represents the second largest cause of cancer-related deaths in US males. 
 
 
Figure 1.3. Ten Leading Cancer Types for the Estimated New Cancer Cases and Deaths, by Sex, US, 
2007.[5] 
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A further breakdown of the mortality rates for the top four occurring cancers is 
depicted in Figure 1.5. These four cancers represent more than half of the diagnosed 
cancers in the general population and nearly half of all mortality due to cancer. For all but 
lung cancer, diagnosis in the localized stage of development dramatically improves 5-
year and 10-year survival rates towards nearly 100%, as shown in Figure 1.5. It is widely 
believed that a winning strategy to realizing this goal involves the detection of serum- 
level biomarkers (those evident in circulating blood) that are currently being discovered 
for various cancers through genomic and proteomic investigations [6]. 
The future of cancer diagnostics will therefore likely involve ultra-sensitive screening 
tools that identify multiple markers indicative of the earliest stages of cancer 
development. These markers have been difficult to find as they exist in extremely low 
concentrations in circulating blood. In order to make use of these discoveries at a clinical 
level, ultra-sensitive biosensors exhibiting high degrees of specificity will be required to  
 
Figure 1.4. Annual-adjust cancer incidence (left) and death (right) rates from 
the U.S. among males for selected cancers [5]. 
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Figure 1.5. Relative survival (5 and 10 year) among selected cancers diagnosed with distant, regional or 
distant, or localized disease at the time of diagnosis [6]. 
 
identify these proteins in clinical samples (such as patient blood plasma or urine). A 
general review of the cancer literature regarding the use of molecular markers quickly 
reveals that there is no known single marker sufficient for positive diagnosis of any 
cancer [9-11]. A sensing technology that identifies a multi-protein signature for diagnosis 
is most likely to minimize false positives and false negatives [9]. A sensor array 
incorporating high sensitivity and high specificity could have an impact at multiple levels 
including early detection screening, post-therapy monitoring, as well as on the proteomic 
discovery process. This is discussed more thoroughly in Chapter 5. 
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The goal of this research is therefore to provide a tool for detecting multiple known 
targets in complex media at the earliest stages of neoplastic growth and proliferation. 
Prostate cancer represents an excellent test case as the early carcinogenesis and 
subsequent proliferation of this cancer are among the best understood in all of oncology. 
It is estimated that 91% of new cases of prostate cancer between 1995 and 2001 were 
diagnosed at local or regional stages of progression [5]. Not only does this indicate broad 
clinical understanding of prostate cancer, but it also indicates a wealth of tissue samples 
available for study at earlier stages of progression. 
The most commonly used techniques in clinical laboratories for detecting specific 
proteins in very low concentration in complex media (such as blood or urine) are 
immunoassays. One of the most popular is the enzyme linked immunosorbent assay 
(ELISA or EIA) test. While there are many variants to the ELISA test, conventional 
ELISA’s are considered to have a limit of detection on the order of ~ 1 ng/mL [12]. In its 
simplest form, conventional ELISA’s involve significant preparation and then application 
of various reagents, each separated by washing steps, then processing with a microplate 
reader and final analysis. The entire procedure can take anywhere between several hours 
to a couple of days to perform. Overall, ELISA’s are relatively expensive, time 
consuming and labor intensive processes requiring at least some training and a significant 
amount of practical experience to perform successfully. Desired improvements on ELISA 
capability would include label-free detection, near real-time response, greater sensitivity, 
and capacity for multiplexing. Emerging technologies such as optically-based biosensors 
[13] or marker-tagged nanoparticles [14] offer excellent alternatives for clinicians, but are 
currently expensive to produce.  
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At the outset of this research, the leading technology in label-free detection of protein 
interactions was surface plasmon resonance (SPR) based devices [15]. While many 
advancements have been made in the intervening years [13, 16, 17], including improved 
multiplexing capability, they still suffer from two significant limiting factors. The first is 
cost. SPR has gained broad use by clinical researchers of late, generating a significant 
commercial market for these sensors [16]. Significantly, however, the cost of a single 
SPR sensor is approximately $160 (Biacore’s CM5 SPR sensor chip available through 
GE Healhcare), even in this more developed market. Note, this cost is simply for the 
transducer component of the overall sensor, and still requires both the monitoring 
electronic system and the application of appropriate capture agents. For multiple sensors 
used in a multiplexed system, the commensurate price rises rapidly. Furthermore, there is 
a limitation on how many channels can be introduced for multiplexed operation, based on 
the monitoring system being used. It is not feasible that these sensors could be utilized by 
the broader public for routine testing of multiple targets on a massive scale. The second 
limiting factor of the SPR system is that the sensitivity range is narrow and fixed by the 
precision of the detection mechanism. 
The sensors I have proposed take advantage of advances made in the microelectronics 
industry allowing for fabrication of piezoelectric resonator-based sensors in an array 
package to provide multiplexed sensors at a much lower cost. A microelectronic mass-
production facility could quite easily produce these sensor arrays and significantly take 
advantage of economies of scale and drive down the price as the market size increased. 
Another advantage of this approach comes from the fact that the detection limit of 
acoustic sensors is a function of their resonant frequency, which can be controlled by 
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physical parameters of the resonator. As fabrication technology and capabilities continue 
to improve, the detection capabilities of these sensors should improve correspondingly. 
The specific aims of this thesis research are therefore as follows: 
 
1. To develop a bulk acoustic resonator device appropriate for application as a 
highly sensitive biosensor. 
2. To develop an appropriate biosensor preparation procedure by immobilization of 
appropriate capture agents. 
3. Demonstrate the functionality of these biosensors towards known cancer 
biomarkers. 
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CHAPTER 2 
BACKGROUND & SIGNIFICANCE 
 
To make clear what I am attempting to do, it is necessary to clearly explain the 
principles that I will be employing towards developing the proposed sensor and also 
describe how this work fits into the broader body of research regarding biosensor design 
and development. First, I will describe the principles of acoustic-based sensors, as 
opposed to electrochemical or optical transduction devices. As part of this discussion, I 
will include a discussion of how my work fits within the field of acoustic sensor device 
technology. Second, I will describe how acoustic wave devices can be employed toward 
biosensor applications and the potential advantages of using such a platform over 
alternative label-free detection methods. Finally, I will argue for importance of 
multiplexing and the development of a biomarker micro-array. 
 
Principles of acoustic resonators 
 
Acoustic wave resonators function by the excitation of the piezoelectric class of 
crystals due to an alternating electric field. That is to say, piezoelectric crystals have the 
capacity to launch and support a mechanical acoustic wave as the result of transducing 
energy from an excitatory RF electric field [18]. All crystals are classified into one of 
seven categories, based on their degrees of symmetry. The seven systems are in turn sub-
divided into point groups, or classes, according to their symmetry with respect to a point. 
This yields thirty-two classes of crystal in total. Twenty-one of the thirty-two existing 
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crystal classes exhibit a lack of centro-symmetry, or an inversion asymmetry. Of these 
twenty-one, all but one exhibit non-zero piezoelectric constants [19]. This piezoelectric 
crystal family of twenty is characterized by this inversion center, which form electrically 
neutral dipoles in their natural state. The crystal of interest for this research is zinc oxide 
(ZnO), which is a hexagonal 6mm class crystal, and belongs to this piezoelectric family. 
When an external stress is applied to a piezoelectric crystal, the symmetry is disturbed 
causing a charge asymmetry, resulting in an electric displacement across the material. 
This is the direct piezoelectric effect. The inverse piezoelectric effect, as the name 
implies, describes the strain of the material under an electric field due to the realignment 
of unit crystal dipoles in response to that field. Thus, an acoustic wave can be launched 
through the bulk of the material by exposing the crystals to an oscillating electric field. 
By matching the oscillation of the electric field to the physical parameters of the crystal 
that bounds the mechano-acoustic wave, a resonance condition is achieved in which the 
maximum amount of energy is being transduced into mechanical energy due to the 
favorable conditions. 
The fundamental equations that describe the relationship between the electric dipole 
and external forces is described by the following constitutive relations: 
EeScT :: −=     (2.1) 
SeED :: += ε     (2.2) 
Note that equation (2.1) is an extension of Hooke’s law in three dimensions, where T is 
stress, S is strain, c is the stiffness tensor. The second term in (2.1) represents the effect of 
piezoelectric stiffening under an electric field where E is the electric field and e is the 
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piezoelectric coupling tensor. Equation (2.2) is Maxwell’s definition for electric 
displacement, D, where ε is the permittivity tensor of the material and E is again the 
apparent electric field. Equation (2.2) is modified by the inverse piezoelectric strain 
component of the electric displacement formed by the product of the piezoelectric tensor, 
e, and the external strain, S. A more extensive treatment of the generation and 
propagation of acoustic waves in crystals can be found in Rosenbaum [20].  
Propagation of an acoustic wave in a solid can take several forms, or modes. In 
general, these waves can be either longitudinal (particle displacement in parallel with the 
propagation direction), shear (particle displacement perpendicular to the wave 
propagation direction) or a combination of the two. For the purpose of developing a 
biosensor application, any resonator device used must employ an acoustic mode that 
exhibits particle displacement parallel to the surface of the device. This is necessary as 
any particle displacement not parallel to the surface would be readily absorbed by either 
the viscoelastic surface coating comprising the capture molecules necessary to 
functionalize the sensor, or by the liquid test media itself as compression waves.  
Acoustic wave devices are broadly categorized by those that travel within the crystal 
bulk, known as bulk acoustic waves (BAW), or those that travel along the crystal surface, 
known as surface acoustic waves (SAW). This research will not investigate the shear-
horizontal surface acoustic wave (SH-SAW) family of devices which have been applied 
in numerous studies towards sensing in a liquid phase environment [21-24]. The 
sensitivity of shear-mode resonator-based biosensors has been characterized by many, 
including Sauerbrey [25], Kanazawa [26, 27], and more recently Hunt [28], (and will be 
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discussed in greater detail later in this chapter) but all agree that the sensitivity of these 
devices is proportional to a power of the fundamental resonant frequency, fo.  
The resonance frequency of a SAW device is controlled by a surface parameter of the 
electrode fabrication. SAW devices are created by depositing an electrode configuration 
called ‘interdigitated trandsducers’ (IDTs) onto the surface of an appropriately aligned 
polished crystal surface, as seen in Figure 2.1.  The smaller the distance between 
“fingers” of the IDT exciting the surface acoustic wave, the higher the resonant 
frequency, as the transducer spacing defines the wavelength of the acoustic wave. 
For bulk acoustic devices, the resonant frequency is a function of the thickness of the 
film. Piezoelectric crystal films can be deposited with extremely small thicknesses 
through a variety of liquid and vapor film deposition techniques [29]. In order to achieve 
ultra-high frequencies (e.g. GHz) of operation in a SAW device, extremely high 
resolution photolithography equipment is required, which is neither cheap nor widely  
 
 
Figure 2.1. IDT electrode configuration commonly employed for fabrication of a SAW transducer.  
[Taken from www.sp.phy.cam.ac.uk] 
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available. For this reason, it is much simpler to achieve higher fundamental resonant 
frequencies in BAW devices than in SAW devices. For this reason, this research will 
focus on a BAW design. 
 
Resonator Design 
 
Piezoelectric ZnO thin films have most often been used in the past as high frequency 
filters for a multitude of telecommunications applications [30, 31]. Typically these 
devices are operated in the thickness-excited (TE) longitudinal mode in which the 
frequency can be tuned simply by varying the thickness of the ZnO thin film. Methods of 
excitation will be discussed in greater detail later in this chapter. When operated with an 
adjacent liquid medium, the longitudinal mode energy is dissipated, as described earlier, 
into the liquid as compression waves for devices utilizing waves that propagate at a 
velocity higher than the sound velocity in the liquid. This results in a highly reduced 
quality factor, Q, and poor mass resolution in a sensor application. Q is a common 
parameter used to characterize the strength of a resonator. Resonator Q is broadly defined 
as: 
    
There exist many methods of estimating Q, which receives discussion by Rosenbaum 
[20]. As previously mentioned, acoustic waves can travel in a variety of modes. The 
thickness shear mode (TSM) is better suited for liquid sensing applications due to the 
shear particle displacement of the acoustic wave in the piezoelectric film. Since the 
Energy Conserved per cycle 
Energy Dissipated per cycle
Q = 2π⋅ 
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adjacent liquid medium cannot effectively support a shear wave, very little energy is 
transferred into the liquid resulting in minimal damping of the acoustic wave.  
The term ‘TSM resonator’ is often used interchangeably with quartz crystal 
microbalance (QCM). That is because the QCM is by far the most widely used resonator 
in commercial applications that operates in the TSM mode. QCMs are fabricated by 
taking thin slices at the appropriate angle from a single crystal bulk, as shown in Figure 
2.2. Application of TSM resonators in biosensor applications are described in greater 
depth later in this chapter.  
The sensitivity of acoustic waves in AT-cut quartz plates has been widely exploited 
with QCMs as gravimetric sensors in both vapor phase and in liquid phase sensing [32-
35] which uses TE to excite the wave. It has been shown, however, that lateral field 
excitation (LFE) can also be used to excite the TSM wave in QCMs [36-39] and that the 
resulting device may be more sensitive to surface perturbations than the standard TE 
QCM for liquid-phase sensing applications [40-42]. The LFE configuration is 
demonstrated in Figure 2.3 below, in comparison to the TE configuration. The 
 
 
Figure 2.2.  A quartz plate is cut at an angle of 35˚10' with respect to the optical axis to form AT-cut quartz 
suitable for QCM applications. A deviation of only 5' from this angle leads to a significant change in the 
temperature coefficient.[43] 
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advantages of LFE over TE liquid-phase applications are mainly attributed to the fact that 
in LFE, the electrodes that generate the electric field are not directly in the path of the 
acoustic wave, as in TE. Since the metal material that forms the electrode is a source of 
acoustic wave scattering and damping, its removal from the acoustic path results in 
higher Q values. Other advantages include increased stability at a given harmonic, and 
reduced aging of the crystal since the electrode is absent from the area of greatest 
vibrational motion [44]. For biosensor applications, removing the electrode from the 
acoustic path also means that biological molecules can be immobilized directly onto the 
region of highest particle displacement which should result in greater sensitivity of the 
sensor.  
There are numerous disadvantages to using QCMs as biosensors, however. QCMs 
typically operate in the frequency range between 5-35 MHz. In AT-cut quartz plates, it is 
difficult to further increase the fundamental operating frequency because of its 
 
 
Figure 2.3. Lateral field excitation resonator configuration as compared with the more common thickness 
excitation configuration. 
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vs 
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E 
Piezoelectric thin film 
Piezoelectric thin film 
Electrodes 
Electrodes 
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dependence on the thickness of the quartz plate. At very low thicknesses, the quartz plate 
becomes extremely fragile and is too difficult to handle. It is possible to achieve higher 
frequencies with the QCM by monitoring harmonic modes beyond the fundamental, but 
these become progressively diminished with increasing harmonic number [45, 46]. 
It is therefore necessary to develop a TSM resonator that can be easily fabricated in a 
robust design that can achieve higher frequencies of operation than the QCM. The first 
aim of this research is therefore to develop a thin film ZnO bulk resonator operating a 
TSM, which requires two fundamental criteria to be met. First is excitation of the TSM 
itself. One method of achieving this is LFE of c-axis oriented ZnO and involves an 
electrode configuration similar to the one seen in Figure 2.3. LFE of ZnO will be 
discussed in greater detail in Chapter 3. Second, a resonator requires that the acoustic 
wave be maintained in the crystal. A fundamental rule of mechanics is that acoustic 
energy has a preference to propagate through a denser media, with particles free to move 
and carry the wave. For that reason, it is often asserted that acoustic waves prefer to 
travel in media with a slower acoustic velocity. The acoustic velocity of a crystal film is 
described by  
n
n
a
cv ρ=
     (2.3) 
where ρn is the film density and cn is the appropriate stiffness parameter. A second 
fundamental rule is that high acoustic impedance mismatches between adjacent media 
encourage a high reflection response of an incident acoustic wave. Acoustic impedance 
can be described by [47] 
 22
nnn cZ ρ=      (2.4) 
As air has very low stiffness and density compared to piezoelectric crystals, its effective 
acoustic impedance is zero. That is why a common technique for fabricating thin film 
bulk acoustic resonators (FBARs) requires the etching of an air barrier beneath the 
piezoelectric film. In this configuration, the vast majority of acoustic energy is reflected 
at each surface and remains within the piezoelectric crystal film. 
This etching step is both difficult to achieve and requires an additional and expensive 
fabrication step. Furthermore, the films of ZnO necessary to produce the very high 
frequencies desirable for higher orders of sensitivity would cause these devices to be 
extremely delicate. The solution to this problem is to deposit the piezoelectric film onto a 
solid structure that mimics the acoustic impedance of air, which is referred to as a solidly 
mounted resonator (SMR). Newell first described the concept of SMRs in 1965 [48], in 
which an acoustic mirror (analogous to an optical Bragg reflector) is deposited beneath 
the piezoelectric crystal film, as shown in Figure 2.4. I employ this configuration in order 
to develop a design that is both robust and easy to fabricate.  
Excitation of shear mode bulk waves in thin film ZnO have been reported as early as 
1974 [49]. More recent success has been reported by Krishnaswamy, et al., who 
attempted the growth of inclined c-axis oriented films coupled with an electrode pattern 
in which the electrodes are situated on opposing surfaces of the thin film to produce an 
electric field through the thickness [50]. The incline of the ZnO axis would thereby allow 
for excitation of the crystal orthogonal to the c-axis and stimulate a shear mode acoustic  
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Figure 2.4. The solidly mounted resonator configuration (SMR) consisting of alternating layers of ¼-λ low 
and high acoustic impedance films. 
 
wave. Wang and Lakin took a similar approach and had excellent success in fabricating 
oriented films with the c-axis of the hexagonal crystal oriented 40° to the substrate 
normal [51]. While their resonator quality factor, Q, and electro-mechanical coupling, K2, 
were high, the operating frequency attempted was low (~293 MHz) and the fabrication 
procedure required bulk etching of the Si wafer to produce air-backed ZnO membrane 
resonators. More recently, Link et al. have revived the inclined ZnO growth research with 
the intent of developing ZnO TSM resonators for liquid phase sensing [52, 53]. Their 
device design is demonstrated in Figure 2.5. A shortcoming of the inclined ZnO growth 
method, in general, is that the thickness excitation requires that the electrodes be in the 
path of the acoustic wave. While it offers the benefit of a higher operating frequency than 
the QCM for sensing, it still suffers from the same pitfalls as the QCM because the 
electrodes are located in the area of highest sensitivity.  
In a study by Woo Wai et al. focusing on non-inclined c-axis oriented ZnO, the TSM 
was excited through LFE [54]. The devices were fabricated through the use of a self-  
Piezoelectric 
Crystal Film 
ZL 
ZL 
ZH 
ZH 
Substrate 
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Figure 2.5. a) Schematic cross section and b) scanning electron microscopy of solidly mounted resonators. 
The upper ZnO film is c-axis inclined [53]. 
 
aligning process that involved ZnO liftoff and a spiral electrode structure spanning 2 mm 
in diameter. Operating close to 4.1 GHz, the devices illustrated the ability for ZnO 
FBARs to be operated at high frequencies with relative ease. An acoustic mirror was not 
implemented in the design, however, and the resonator Q was very low (roughly 35). 
Acoustic velocity calculations made from the numbers given in the study yield 
~3,280 m/s. Given that the acoustic velocity, va, of a resonator is defined by Equation 
(2.3), a theoretical estimation of ~2,841 m/s is calculated using single-crystal bulk 
stiffness properties of ZnO available in Auld [55]. This value is reasonable considering 
the polycrystalline variations in depositions of thin film ZnO. 
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Acoustic Biosensors 
 
Acoustic resonators were first recognized as an appropriate platform for highly 
sensitive sensors in the 1950’s. The mechanism for detection relies on the stable 
resonance of an acoustic wave in a fixed space. The physics of an acoustic wave 
propagating through a crystal, oscillating between opposing boundaries, is well 
understood and has been thoroughly characterized by Auld [55]. For sensor applications 
of acoustic resonators, the acoustic wave acts as a probe that indirectly queries the 
surfaces for changes in the boundary conditions. Perturbations of those boundary 
conditions results in a measurable frequency shift. 
Sauerbrey was the first to observe that the resonance condition of a piezoelectric 
resonator was impacted by the loading of one surface. He worked to characterize the 
sensitivity of acoustic sensors using the QCM as part of his dissertation research in the 
late 1950’s. One publication in particular is often cited in the literature in regard to 
acoustic sensors, in which Sauerbrey observes that the resonant frequency of the QCM 
shifts in accordance with the following [25]:  
qq
o
A
mf
f µρ
∆−=∆
22
     (2.5) 
where fo is the unloaded resonant frequency of the sensor, A is the acoustically active 
surface area, ρq is the crystal density, µq is the crystal stiffness, and m is the mass loading 
at the surface of the crystal. As can be seen from Equation (2.5), the shift in resonant 
frequency of the sensor is proportional to the change in mass at the surface boundary via 
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a coefficient scaled by the square of the unloaded resonance frequency. The higher fo, the 
more sensitive the resonator is to a corresponding mass loading at the surface.  
The derivation of this equation requires assumptions that are not valid, however, for 
operation in a liquid environment or for loading of biological materials at the surface. 
One assumption, for example, is that the loaded mass must be a rigid film. As noted 
earlier, the acoustic waves have a propensity to travel in materials of higher acoustic 
impedance. For the case of a liquid film, there exists a decay length in which the shear 
acoustic wave propagates into the liquid film. This decay length, δ, is defined as  
L
L ωρηδ 2=
     (2.6) 
where ηL is the viscosity of the liquid, and ρL the liquid density. For the case of a 5 MHz 
QCM resonator, the acoustic wave would travel 250 nm into water.  
Kanazawa and Gordon were the first to address an appropriate description for 
acoustic resonators operating in a liquid, deriving the following relationship [26]: 
qq
LL
off µπρ
ρη23−=∆
.     (2.7) 
William Hunt, alternatively, approaches the entire relationship afresh, seeking “to go 
beyond the static Sauerbrey equation to a more dynamic equation” to more precisely 
define the change in boundary conditions as a description of the molecular recognition 
event [28]. Beginning with the complex reciprocity relation described by Auld [55], Hunt 
employs time-dependent perturbation theory to derive the following relation for 
frequency shifts experienced by the QCM in a biosensor application: 
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where ωu is the unperturbed frequency (in radians), t is time, hf is the height of the film, 
∆ρ and ∆µ are the density and stiffness of the film, and VS represents the acoustic shear 
wave velocity. If ∆ρ and ∆µ were known, it would then be possible to solve (2.8) using 
the integrating factor method, which would yield: 
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It must be noted that Hunt assumes a stress-free boundary in which no acoustic 
energy transfers into the adjacent liquid/air space beyond the biofilm. That is to say, 
0=⋅ nT ) . He acknowledges that this is not accurate, of course, but the assumption is 
required to simplify the derivation. Proceeding with this assumption and assuming that ω, 
ρ and µ do not vary with time, Equation (2.8) becomes 

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Note that Equation (2.10) has a striking similarity to the Sauerbrey Equation (2.5) with 
the exception that the frequency shift is now a function of both a change of mass loading 
at the surface as well as a change in the mechanical stiffness of the film. This has 
significance when the film consists of biological molecules that are known to undergo a 
conformational change upon binding a target. This provides both the opportunity that 
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TSM resonators could have an enhanced detection capability and the cautionary note 
towards interpreting the meaning of collected data. 
The work of Sauerbrey established the potential for acoustic wave devices as a viable 
sensor platform. QCMs became widely used because they demonstrated exceptional 
conservation of energy as a resonator, characterized by Q values of up to 70,000 and 
excellent frequency stability between 0-50˚C [47]. Breakthroughs in oscillator technology 
allowed Nomura and Okuhara in 1982 to demonstrate that these sensors could be 
employed in a bioanalytic capacity by operating them in liquids [56]. Since then, they 
have been employed quite extensively as biosensors [47], with several commercial QCM 
systems available today [45]. As mentioned earlier, QCMs are limited by the fact that 
films thin enough to reach the GHz range of operation are far too fragile to handle if cut 
from a single-crystal bulk and cannot be deposited onto a support substrate with the 
crystal texture required.  
 
Sensor Arrays 
 
As mentioned earlier, it is generally agreed that there is little chance that a single 
biomarker will be able to provide definitive evidence of cancer proliferation [57]. One of 
the most successful and widely used marker screening tests involves the diagnosis of 
prostate cancer (PCa) by measuring the serum concentration of prostate specific antigen 
(PSA) in conjunction with a digital rectal exam, describing an examination performed 
with the examiner’s finger. There exists significant controversy over the use of PSA 
testing as a means of diagnosing PCa, predominantly due to the high false positive rate 
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[58-62]. Extensive long-term studies (including such studies as the Prostate, Lung, 
Colorectal and Ovarian Screening Trial ff to be completed in 2015) begun in the 1990s 
have yet to provide conclusive evidence of the efficacy of the PSA screening test for 
those under 75. For individuals over 75, however, the US Preventive Services Task Force 
has already issued a recommendation against the regular practice of PSA screening. 
Given the average lifespan of males and taking into consideration the generally slow 
progression rate of PCa, this recommendation was made because the cancer itself tends to 
not have a significant impact on these individuals overall survival or quality of life. 
Taken together with high false positive rate of the PSA test itself, the negative 
psychological impacts of a positive diagnosis, and the trauma associated with available 
treatments, the negative impacts are considered to outweigh the benefits of screening 
[63]. This recommendation has understandably been met with some contention from 
clinicians, and as a result is likely to be considered as a suggestion rather than as a rule, 
by most. Obviously, a more definitive screening mechanism is required in general, that 
will allow for the quantification of multiple molecular targets. 
It is further desirable to minimize false negatives and false positives. Sensor arrays 
allow for implementing redundancy in the system by preparing multiple sensors in the 
same array for the same target and thereby delivering enough data to employ statistical 
analysis of the results. For this reason, sensor arrays that can test for multiple targets 
simultaneously offer the most useful tool for an early detection system for cancer. A 
cursory search of the literature quickly reveals that many researchers are already pursuing 
sensor array systems rather than single sensor systems [31, 48, 55-63]. These array 
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systems often include, however, delicate designs that are difficult and expensive to 
fabricate.  
A recognition of the importance of this approach is exemplified by one of the primary 
initiatives of the NCI’s Early Detection Cancer Network (EDRN), whose mission is “to 
make molecular diagnostics a reality [allowing for] individualized treatment for cancer 
patients.” The initiative of interest is the identification of proteomic technologies that 
allow for rapid identification of cancer proliferation signatures. That is to say, the 
proliferation of a particular cancer is revealed by the quantification of multiple targets in 
a patient’s sample. Their efforts have converged upon various protein and nucleic acid 
microarray technologies that allow for rapid screening and subsequent validation of new 
circulating biomarkers. Some of the technologies highlighted in their latest annual report 
include the LUMINEX Corporation’s xMAP system and the nucleic acid programmable 
protein array (NAPPA) system from Harvard Medical School [64]. 
Acoustic biosensor research in the past has largely focused on the application of 
QCM devices [65, 66]. As is the case for most biosensors, these sensors are comprised of 
two fundamental components (described in Figure 1.1). The first being the base 
transducer device, or resonator, that excites and maintains a resonating acoustic wave in 
the piezoelectric crystal. The second component is the immobilization of appropriate 
capture agents at the surface of the crystal, thereby functionalizing the resonator as a 
biosensor. When a target molecules from the test medium interact or bind with the 
capture molecules, the boundary conditions are altered which in turn changes the 
resonance conditions for the acoustic wave. This is measured as a resonant frequency 
shift. 
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Theoretically, the sensitivity of an acoustic biosensor is directly related to the value of 
that resonant frequency, as discussed previously in this chapter.  While QCM technology 
offers excellent detection capabilities, it is limited in several ways with respect to 
biosensor applications. The most significant limitations include the relatively low 
frequency of operation, as mentioned in Chapter 2, but also the relative difficulty in 
multiplexing the sensors due to their large size. Cost is also a drawback to QCM 
technology as the sensors are comprised of quartz plates which can be expensive to 
manufacture to the required specifications. SAW devices have provided several 
advantages in addressing many of the aforementioned criteria [65, 66], but mass 
fabrication tools still limit commercially available SAW devices to the sub-gigahertz 
(GHz) range of operation. 
This research proposes an acoustic-based solution that meets all of the requirements 
proposed by Erickson, et al [57]. In summary, those requirements include sensitivity and 
specificity, multiplexing capability, and a reduction in measurement complexity and cost. 
The simple design is compatible with existing microelectronic fabrication processes that 
allow for cost-effective mass production, and has a very small footprint (< 5 mm2). As 
mentioned earlier, with moderate spatial arrangement, one could easily fit as many as 
1,000 arrays, each consisting of eight devices, onto a single 3-inch wafer. The design will 
also allow for expandable array configurations. The sensing mechanism involved is 
entirely electronic and occurs as the capture molecules bind their target. The sensors 
thereby provide a means of label-free, near real-time reporting with minimal electronic 
hardware. 
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CHAPTER 3 
RESONATOR DESIGN & IMPLEMENTATION 
 
The development of a novel microelectronic resonator requires two fundamental 
problems be solved. Primary is the identification of an appropriate material with the 
proper crystal orientation that will support the acoustic mode of interest. As identified in 
the previous chapter, the TSM is the mode of interest for the purpose of biosensor 
application. Further, a robust and low-cost design is desired, which will be achieved by 
pursuing a solidly mounted ZnO resonator configuration. This encompasses the second 
problem, which is the development of an appropriate acoustic mirror to reflect the 
acoustic energy back into the piezoelectric crystal. I will begin this chapter with a 
theoretical confirmation that c-axis oriented ZnO can support the desired TSM wave. I 
will then discuss the chosen resonator package design and derive a theoretical model for 
the desired acoustic mirror and subsequent implementation of the solidly mounted TSM 
thin film ZnO resonator. Finally, I will discuss efforts to improve the device design for 
the purpose of biosensor applications.  
 
Thickness Shear Mode in ZnO 
 
Propagation of an acoustic wave via piezoelectric excitation in a crystal bulk is 
described by the Christoffel equation: 
ijij vvk
22 ρω=Γ     (3.1) 
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where k is the wave number defined as ω / va (or frequency/acoustic velocity), ρ is the 
density of the material, vi and vj are the particle polarization direction vectors, and Γij is 
the piezoelectrically stiffened Christoffel matrix. Γij is defined as, 
( )( )
Ij
j
S
iji
iLijKjE
KLiKij lEE
eEEe
cl 


 +=Γ ε    (3.2) 
where En is the three dimensional electric field vector and the liK matrix describes the 
divergence of the acoustic wave propagation, taking the following form: 
liK = 
0 0 0
0 0 0
0 0 0
x z y
y z x
z y x
l l l
l l l
l l l
     
 .   (3.3) 
In (3.3), the nonzero terms come from the propagation vector  
ˆ ˆˆ ˆ
x y zl l l= + +l i j k .     (3.4) 
The lIj matrix is simply the transpose of liK, and EKLc  is the material stiffness tensor at a 
constant electric field rotated by the appropriate Euler angles. As mentioned above, the 
crystal orientation was confirmed by X-ray diffraction to be a highly c-axis aligned 6mm 
hexagonal ZnO crystal, so no Euler angle rotations need be applied. Further assuming 
wave propagation in the direction of the thickness of the film and also aligned with the 
substrate surface normal, the terms lx and ly go to zero and lz can be assumed to be unity.  
In order to generate a TSM wave in normally aligned c-axis oriented ZnO, it is 
necessary to use LFE of the ZnO bulk. As demonstrated in Figure 2.3, LFE involves co-
planar electrodes generating an electric field parallel to the film surface, or laterally. 
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Given that the electric field has been maximized in the x-y plane, it can be assumed that 
Ez goes to zero (i.e. the electric field in the z direction) and the electric field parameters 
can be described as Ex2 + Ey2 = 1. 
The standard stiffness tensor for the 6mm class of hexagonal crystals is defined as 
c =
11 12 13
12 11 13
13 13 33
44
44
66
0 0 0
0 0 0
0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
c c c
c c c
c c c
c
c
c
          
    (3.5) 
where the subscripts exhibit the abbreviated Einstein summation notation [20] that allows 
the true 9 x 9 stiffness tensor to be reduced via symmetry to the 6 x 6 in (3.5). The 
corresponding piezoelectric coupling tensor takes the form 
e =
15
15
31 31 33
0 0 0 0 0
0 0 0 0 0
0 0 0
e
e
e e e
     
.    (3.6) 
By defining the electric field E as 
T
iy
x
j EE
E
E =








=
0
,     (3.7) 
it is now possible to solve for (3.2) symbolically, yielding the following solution to the 
Christoffel matrix: 
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Substituting (3.8) into (3.1), we find that the Christoffel equation is a simple eigenvalue 
problem, where the corresponding eigenvalues and respective eigenvectors solutions are 
4411 ,
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Each of the three solutions, xn, describes the particle displacement associated with an 
acoustic wave mode. The associated eigenvalues describe that mode’s acoustic velocity, 
va, and direction. As can be seen, the only term that exhibits piezoelectric stiffening is the 
x2 term, which indicates particle direction only in the x-y plane. The associated 
eigenvector, λ2, describes shear wave propagation due to piezoelectric transduction in the 
z-direction through the c44 term. The acoustic velocity of this wave can thus be described 
by 
2
15
44
11
a
ec
v ερ
+
= .     (3.10) 
ZnO single-crystal bulk values taken from Auld [55] can be used for the terms in 
(3.10) in order to determine a theoretical velocity. This yields a shear wave velocity 
traveling in the thickness direction of 2,841 m/s in hexagonal 6mm ZnO. It is important to 
stress that this value is ideal based on bulk single crystal values. Most ZnO thin films, 
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including the films used for this research, are both polycrystalline and involve dopants 
that mitigate the conductive properties of pure ZnO. For these reasons, it is reasonable to 
assume that shear values will vary from the ideal velocity calculated above. Indeed, other 
investigators that have demonstrated TSM ZnO resonators have empirically determined 
values of 3,280 m/s [19], and 3,370 m/s [54]. It is worth noting that applying the 
appropriate stiffness values from Auld, a longitudinal wave traveling in the thickness 
direction should travel at 6,100 m/s, by comparison. This has been verified by numerous 
implementations of longitudinal wave FBAR devices [67-69], as well as those achieved 
in the very same lab in which this thesis research was accomplished [70, 71]. 
Thus I have demonstrated that the TSM is possible in c-axis oriented ZnO. It remains, 
therefore, to determine a device design that allows for growth of c-axis oriented ZnO 
films in a configuration that is both a robust and low cost implementation. 
 
Solidly Mounted Resonator 
 
Traditionally, FBARs are fabricated by etching the support layer upon which the 
piezoelectric film was deposited in order to create an air boundary on both the top and 
bottom of the piezoelectric film. Recall from Chapter 2 that acoustic energy prefers to 
travel in a medium where it travels slower, which is characterized by the mode acoustic 
velocity. More critical, however, is the magnitude of the impedance mismatch regarding 
the medium on either side of a boundary. As for electromagnetic waves, if the perceived 
acoustic impedance across a boundary is matched, the wave would pass through the 
boundary with practically no reflection. If a substantial impedance difference is 
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perceived, however, then a substantial amount of the acoustic energy would be reflected. 
Theoretical estimation of the characteristic acoustic impedance of a material, Za, is often 
determined using the relation described in Equation (2.4). Using bulk properties for ZnO 
given by Auld [55], one can estimate the shear mode acoustic impedance of ZnO to be 
15.53 kg/m2s. Given the extremely low density and stiffness properties of air, one can 
reasonably assume that air has an effective acoustic impedance of zero. As described in 
Chapter 2, this low impedance boundary is necessary for containing the acoustic energy 
within the piezoelectric film. As I also explained in Chapter 2, the etching process 
required to accomplish this configuration is both often difficult to achieve (especially 
when ZnO is the piezoelectric film of interest) and does not accommodate the goal of 
producing a simple and cheap fabrication process.  
For this reason, a solidly mounted resonator (SMR) configuration was chosen, as 
described in Figure 3.1. The SMR configuration was introduced by Newell [48], in which 
he describes the fabrication of an acoustic mirror below the piezoelectric film. The theory 
behind this configuration is similar to that of a Bragg reflector for reflecting optical 
waves, in which alternating materials of high and low impedance at ¼-wavelength 
thickness can mimic a zero acoustic impedance boundary at the piezoelectric layer. 
The theory has been modeled by several using transmission line theory [72-74]. 
Ballato presents a networked transmission line model for piezoelectric acoustic wave 
excitation and propagation employing networked electromagnetic models of electro-
elastic activity as perfect analogs of mechano-acoustic activity, both within the bulk at 
any point and also at the boundaries. According to Ballato, appropriate analogs from the 
electrical input impedance of multiple transmission lines in series (representing multiple 
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material films adjacently layered on top of each other) are identical to the effective 
acoustic impedance of the overall structure and substrate. Ballato’s electric circuit model 
is actually designed to model the coupling of electrical inputs to mechanical wave 
propagation through a piezoelectric bulk via transformers, but is entirely appropriate for 
modeling the propagation of mechanical waves in the non-piezoelectric films that make 
up the acoustic mirror. This model can be represented as the one shown in Figure 3.1.b. 
Ballato’s model will be revisited later when discussing the resonator design. 
From transmission line theory, we know that the characteristic electrical input 
impedance, Zin, at a junction is given by [75] 
( )
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Figure 3.1. Schematic of a) the SMR configuration and b) the transmission line representation. 
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where k is the wave number, l is the length of the transmission line, Zo is its characteristic 
impedance of the incident material, and ZL is the apparent load impedance of the material 
beyond the boundary. In order to calculate the apparent acoustic impedance seen at the 
bottom boundary of the piezoelectric layer, shown in Figure 3.1 as Zin, Equation (3.11) 
can be rewritten to estimate the effective impedance of the acoustic mirror and substrate 
as follows [76] 
( )
( )



+
+=
kdjZZ
kdjZZ
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eq
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tan
1,4
41,
4    (3.12) 
where d is the film thickness, Z4 is the acoustic impedance of layer 4 and Zeq,1 is 
calculated by 
( )
( )



−
+=
kdjZZ
kdjZZ
ZZ
eq
eq
eq tan
tan
2,3
32,
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This recursion is continued until all layers have been defined through to the substrate. 
This calculation is easily accomplished through the MATLAB script I created, which is 
presented in Appendix A.  
Having implemented a script to model the mirror response, it was therefore easy to 
consider multiple material options for the mirror layers. Recall from Chapter 2 that 
alternating materials of high and low acoustic impedance yield a stronger reflection 
response. With that in mind, the materials considered are enlisted in Table 3.1, in which 
the acoustic impedances and shear velocities were calculated using Equations (2.3) and 
(2.4), respectively, and bulk values from Auld [55]. Note that the shear velocity is 
obviously required to determine the ¼-wavelength film thickness. 
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Table 3.1. Material options for use in the acoustic mirror. *Material properties for Ta2O5 were obtained 
from [77]. All others from Auld [55]. 
 
It is desirable to choose the material immediately adjacent to the piezoelectric ZnO to 
have a lower acoustic impedance, rather than a high one, as explained by Lakin, et al 
[31]. Multiple mirror pairings were considered and modeled using a center frequency of 
2.0 GHz and 6 layers of alternating mirror materials, with the results demonstrated in 
Figure 3.2. As expected, the material pairing exhibiting the strongest degree of 
impedance mismatching demonstrated the most significant mirror response, though the 
responses shown in Figure 3.2 suggest that most of these mirror configurations should 
respond adequately when 6 layers are implemented. 
Since Ta2O5 was on hand and demonstrated efficacy for previous designs for 
longitudinal devices [76], it was thought that this would work sufficiently for ZnO TSM 
devices. As is true for reflector gratings for SAW devices, the greater the number of 
gratings, the more efficient the reflector. Simulations were executed for various numbers 
of layers for alternating ¼-wavelength layers of fused silica (SiO2) and Ta2O5. As can be 
Material 
Vertical Shear 
Stiffness, c44 
(1010 N/m2) 
Density (kg/m3) Velocity (m/s) Impedance (kg/m2s) 
ZnO 4.247 5680 2841 15.53 x 106 
Fused SiO2 3.12 2200 5132 11.3 x 106 
Ta2O5* 5.69 8200 2634 21.6 x 106 
LiTaO3 9.4 7450 3552 26.5 x 106 
Al2O3 14.5 3986 6031 24.0 x 106 
W 15.2 19200 2814 54.0 x 106 
Si 7.956 2332 5841 13.62 x 106 
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Figure 3.2. Modeled mirror reflection response from 0 to 4 GHz for multiple 6-layer mirror configurations. 
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Figure 3.3. Modeled response of acoustic mirror using Ta2O5 and fused silica with 4, 6, 8 and 10 
alternating layers at 1/4 wavelength thickness. 
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seen in Figure 3.3, significant improvement is demonstrated from 4 layers to 6 layers, 
with only slight improvement in efficiency from 6 layers to 8 layers (and practically no 
benefit extending to 10 layers). An important result of these simulations is broadband 
response of these mirror simulations. The reason this is advantageous is due to a 
significant shortcoming of RF sputtering thin films onto a substrate, which is the 
tendency for significant variation in film thickness. The parallel resonance frequency of a 
TSM BAW resonator is determined by 
d
v
f ap ⋅= 2     (3.14) 
where d is the film thickness and va is the acoustic velocity. Significant variation in the 
film thickness will cause a commensurate variation in resonance frequency. The Unifilm 
PVD-300 sputtering system uses a patented deposition process that allows it to achieve 
99.7% thickness uniformity across a three inch wafer. Even with this quality, a variation 
of 1% for a device intended to operate at 2 GHz would result in ± 215 MHz across the 
wafer. Therefore the broadband response of the mirror is desirable as it would 
accommodate these variations. 
Simulations were also implemented with an odd number of mirror layers. The results 
of these simulations are shown in Figure 3.4. As can be seen, a notch feature appears at 
the center frequency where the desired resonance activity should be. This is expected due 
to the alternating nature of the low to high impedance clamped boundary versus the high 
to low impedance free boundary of the mirror [31]. Therefore odd layer implementations 
were not attempted. 
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Figure 3.4. Modeled response of acoustic mirror using Ta2O5 and fused silica with 5, 7 and 9 alternating 
layers at ¼-wavelength thickness. 
 
Deposition of c-Axis Oriented Thin Film ZnO 
 
It is well known that ZnO can be deposited as a thin film through various methods, 
including chemical vapor deposition (CVD) [78, 79], metal-organic CVD [80-82],  
molecular beam epitaxy [83-85], electron beam (E-beam) evaporation [86], pulsed laser 
ablation [87], and the sol-gel method [88] to name but a few. Highly c-axis oriented films 
are consistently deposited, however, by means of RF magnetron sputtering [89-93]. RF 
magnetron sputtering involves the bombardment and energetic release of atoms, or 
sputtering, of a target material by an ion plasma beam. Magnetron sputtering is generally 
desired for slower deposition at lower vacuum levels which yields relatively well ordered 
crystal films with high uniformity. This method will be employed in this research for this 
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reason and because of the compatibility of the method with existing low-cost commercial 
fabrication. The c-axis orientation is important for the implementation of the desired 
thickness shear mode, as I shall demonstrate later in this chapter. 
Multiple investigations testing one or more parameters for optimizing RF magnetron 
sputtering of ZnO have been performed including RF power (stepped and constant) [93, 
94], oxygen:argon ratio and pressure [90, 92, 95], surface roughness [91], 
substrate/electrode material [96], and substrate temperature [97]. Interestingly, in nearly 
all studies, researchers concluded that the parameter (or parameters) under investigation 
was the most important variable for the high c-axis orientation of sputtered ZnO. 
Gardeniers et al, report one of the more thorough examinations by testing a variety of 
factors, including substrate material, substrate temperature, RF power, and distance 
between the target and the substrate [89]. Indicative of the findings broadly in the 
literature, they conclude that all parameters have a significant impact on the quality of the 
ZnO film. 
For the purpose of this research, a protocol for high quality c-axis oriented ZnO has been 
employed by a former member of the lab, Dr. Shawn Pinkett, in collaboration with Dr. 
Jerry Siebert. Dr. Pinkett achieves high c-axis oriented ZnO using the parameters outlined 
in Table 3.2, the derivation of which are fully treated in [76]. All films were sputtered 
using the Unifilm PVD-300 RF/DC sputtering system, which employs a moving platform 
for the substrate wafer, both spinning the wafer and moving it periodically beneath the 
plasma beam in an effort to achieve a highly uniform coating across the wafer.  
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Table 3.2. Sputtering parameters used for deposition of highly c-axis oriented ZnO using the Unifilm PVD-
300 sputtering system. 
 
 
 
 
X-ray Diffraction Characterization 
The crystallinity of thin films is often gauged by making X-ray diffraction (XRD) 
measurements of the film. Crystallinity describes the condition under which atoms are 
arranged in a regular pattern. Single-crystal films require that there is a smallest volume 
element that by repetition in three dimensions sufficiently describes the crystal.  This is 
extremely difficult to achieve through conventional synthetic thin-film deposition 
methods, of course, so it is necessary to gauge the degree of ‘poly-crystallinity’ of a thin 
film in order to assess its quality. The measurements most often used for assessing thin 
films are the full width at half maximum (FWHM) of the θ−2θ scan and of the 2θ-ω 
rocking curve scan, in which Figure 3.5 describes the terms used. θ  describes the angle 
of incidence from the target platform supporting the wafer while 2θ represents the angle 
from that incidence vector to the receiver device. ω  is the term used to describe any tilt 
applied to the support platform. The θ−2θ scan varies the θ and 2θ angles and gives the 
diffraction angle peak revealing the predominant crystal orientation. The FWHM is a 
measure of the span of the reflection peak at half-maximum and the θ−2θ FWHM in 
particular is the parameter most often described in the literature to characterize the crystal  
Parameter Value 
Temperature 325ºC 
Deposition Pressure 5.02 x 10-3 Torr 
Argon:Oxygen ratio 97.5 : 2.5 
RF Power 135 W 
Distance from target to substrate 6.9” 
Substrate material <0 0 1> Silicon, mechanical grade 
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Figure 3.5.  XRD for assesmment of thin film crystallinity. 
 
uniformity of a thin film. The 2θ-ω rocking curve scan is generally considered a better 
assessment of the quality of the film [98] and involves varying ω at a fixed 2θ angle, 
which reveals a detailed structure of the peak being analyzed. Due to the prevalence of 
θ−2θ scans demonstrated in the literature, these were used for the purpose of this film 
characterization. 
The films were characterized using a Philips X’Pert Materials Research 
Diffractometer using a hybrid mirror/monochromator incident optics and a ¼-degree 
receiving slit in the diffracted optics beam path. Considering that high c-axis orientation 
is a principle component of achieving the desired TSM resonator, it was decided that 
ZnO should be deposited on multiple substrates to find out how much of an impact the 
underlying substrate crystal structure would have on the epitaxial growth of ZnO. ZnO 
was deposited on DC sputtered W, RF sputtered Ta2O5, RF sputtered SiO2, polished (1 0 
0) silicon, polished (1 0 0) gallium arsenide (GaAs), and polished (0 0 1) sapphire 
(Al2O3). The first 3 surfaces were chosen due to their potential as components of the 
 Detector 
θ
Incident 
beam Reflected 
beam 
n ^ 
2θ Thin film ω 
ϕ
ψ
 47
acoustic mirror, and the final three for general comparison purposes. The polished 
sapphire was of particular interest, as it is considered lattice matched to c-axis oriented 
ZnO and should yield the highest degree of orientation [89, 96]. By contrast, the polished 
GaAs is not lattice matched and should therefore yield a relatively lower degree of 
crystallinity. The results of these depositions are demonstrated in Figure 3.6 below. Note  
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Figure 3.6. θ−2θ XRD scans of ZnO RF sputtered onto a) Sapphire, b) GaAs, c) Silicon, d) W, e) Ta2O5 
and f) fused silica. 
 48
that results indicate that there was little variation in the quality of the ZnO film due to the 
substrate crystal. This gave me confidence that ZnO deposited using the protocol 
described in Table 3.2, would yield high crystallinity regardless of the substrate material. 
That is to say, the mirror surface material would not impact the ability of the ZnO film to 
support the desired TSM. The 2θ FWHM measurements for all substrate materials are 
summarized in Table 3.3. Incidentally, these results indicate c-axis oriented crystallinity 
on par with that reported by others referenced in this document [89, 90, 92-97].  
 
Table 3.3. 2θ FWHM from XRD scan results of ZnO RF sputtered onto various surfaces. 
 
 
 
 
From ZnO to Ta2O5 
 
Figure B.1 demonstrates the initial SMR design for achieving the base transducer for 
my biosensor application. Many wafers were fabricated with multiple electrode 
configurations and mirror thicknesses attempted over a period of nearly 2 years before I 
finally discovered a resonance response using the parameters shown in Table 3.4. The 
majority of this time was spent on alternate electrode configurations and broad 
approaches to achieving the LFE design. The electrode configurations attempted over this 
time period are demonstrated in Appendix B. Note that the configuration that finally 
Base Layer 2θ  FWHM 
Sapphire 0.20º 
GaAs 0.25º 
Si (1 0 0) 0.23º 
W 0.24º 
Ta2O5 0.20º 
Fused Silica (SiO2) 0.26º 
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worked utilized an 8-layer mirror, consisting of SiO2 as the low acoustic impedance 
material and Ta2O5 as the high acoustic impedance material, and ZnO as the piezoelectric 
crystal. Each layer was deposited via RF sputtering using the parameters described in 
Table 3.4. The electrodes were deposited by electron beam evaporation at a thickness of 
1200 Å of Al with a 300 Å adhesion layer of Cr. Layer thicknesses were chosen to yield 
the 8-layer mirror response reflected in Figure 3.7. A SEM image of the profile of the 
fabricated device is shown in Figure 3.8, confirming the fabrication result was as 
intended. 
 
Figure 3.7. Initial ZnO SMR design. 
 
Table 3.4. Deposition parameters for original device design. 
Parameter ZnO Ta2O5 Fused Silica (SiO2)
Layer Thickness 750 nm 450 nm 850 nm 
Temperature 325ºC Ambient Ambient 
Deposition 
Pressure 5.03 x 10
-3 Torr 5.02 x 10-3 Torr 5.02 x 10-3 Torr 
Argon:Oxygen 
ratio 97.5 : 2.5 97.5 : 2.5 98 : 2 
Power 135 W @ 98 V 115 W @ 121 V 281 W @ ~58 V 
Deposition Rate 400 Å/min 600 Å/min 300 Å/min 
Distance from 
target to substrate 6.9” 6” 6” 
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Figure 3.8. SEM image of profile of fabricated device, confirming output of fabrication to meet the design 
specifications. 
 
Resonator performance was assessed using a Cascade Microtech 9000 probe station 
and Cascade Microtech ACP40/GSG-150 probes. Results were recorded with a HP8753C 
Network Analyzer equipped with an 85047A S-Parameter Test Set. The resonator is a 
one port device, so the measurements made are referred to as the reflection scattering 
parameters, or S11 response. The S11 response is a ratio of the reflected signal over the 
incident signal over a given frequency range. From the S11 data, it is in turn possible to 
obtain the impedance response of the resonator through the following transformation: 
( ) ( )( )fS
fSZfZ oin
11
11
1
1
−
+=     (3.15) 
where Zo is the load impedance (generally 50Ω). One-port S11 responses of each device 
are the first tests I perform on any fabricated resonator and give the best information 
regarding the resonance quality. Due to the parallel electrode configuration required for 
LFE and the semiconductor nature of ZnO, the scattering response should look like a 
simple capacitor, in which a relatively constant reflection of the incident signal is 
observed. As the frequency range is swept, there is a range in which the physical 
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parameters of the thin film and the transduction properties of the piezoelectric crystal 
absorb the incident signal, transforming it into a mechano-acoustic wave that propagates 
through the bulk. At the resonance condition, a standing wave is achieved and a 
maximum transduction of electrical into mechanical energy is established. The narrower 
the frequency range, or band, of that transduction and the greater the overall absorption of 
the incident electromagnetic energy, the stronger the performance of the resonator. This 
is reflected in higher resonance quality factor, Q. 
A typical S11 response for these initial resonators is shown in Figure 3.9.A below. As 
can be seen, the device exhibits a characteristic resonator reflection scattering response, 
albeit a relatively poor one, at around 1 GHz. These resonance conditions are deemed 
weak as the response band is very wide and the overall energy absorbance is relatively 
small. Figure 3.9.B and 3.9.C shows the conversion of the S11 response into the 
corresponding magnitude of the input impedance response, accomplished through the 
relationship described in Equation (3.15), and the Smith Chart of the complex reactance, 
respectively. It must be noted, however, that as this was the first resonance observed after 
nearly 2 years of experimentation with various configurations, I was still relatively 
excited about the breakthrough. I was surprised by the response, however, as the 
resonance observed would have meant the TSM wave launched in ZnO was resonating 
with an acoustic velocity of 1,980 m/s, much lower than the expected 2,840 m/s (see 
Chapter 2). I hypothesized that several possibilities existed at this point. These included 
the possibility that the dopants in the ZnO target material used for sputtering were 
substantially affecting either the density or stiffness of the sputtered film or that the 
physical properties of the mirror itself was not focused properly on the resulting acoustic 
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Figure 3.9. A) S11 response, B) |Zin| response, and C) Smith Chart showing typical responses for 8-layer 
mirror resonators with ZnO on top. 
 
wave and may be scattering the energy. 
My initial excitement at finding a resonance was substantially diminished when I 
fabricated a subsequent wafer with a substantially thinner layer of ZnO. Upon probing 
this next series of resonators with the probe station, I observed the exact same response as 
with the previous fabrication. Recall from Equation (3.14) that the resonance frequency 
of a bulk acoustic wave resonator device is determined directly by the thickness of the 
piezoelectric film. This led to yet another fabrication in which I fabricated electrodes 
directly onto the 8-layer mirror, in which fused silica was the top layer, and no ZnO was 
present. This wafer yielded the results shown in Figure 3.10 below. As can be seen, these  
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Figure 3.10. A) S11 response, B) |Zin| response, and C) Smith Chart showing typical responses for 8-layer 
mirror resonators without ZnO on top. 
 
responses are remarkably similar to those shown in Figure 3.9, meaning the resonance 
had nothing to do with ZnO. At this point, it was thought that perhaps Ta2O5 could be 
piezoelectric and led to the investigation described in the following section. 
 
The Case for Piezoelectric Ta2O5  
 
Piezoelectric Ta2O5 have been employed for SAW devices [99-103]. Thin x-axis 
oriented monoclinic crystalline Ta2O5 films deposited by DC diode sputtering on fused 
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quartz with y-directed SAW propagation has been successfully demonstrated [104, 105]. 
In another application, Ta2O5 films have been deposited as a loading layer on top of ST-
cut quartz in an effort to optimize SH-SAW performance. At an optimal thickness, this 
layer was shown to improve K2 and reduce insertion loss over devices without the film 
[106]. 
Despite the characterization of Ta2O5 for SAW applications, there has not been much 
investigation into bulk acoustic modes for piezoelectric Ta2O5 to date. I therefore decided 
to investigate the bulk acoustic properties of Ta2O5 in a thin film Ta2O5/SiO2 stack 
deposited by RF magnetron sputtering. The motivation for this was to generate a 
resonator which exhibits the TSM of operation through LFE. For a surface-only mounted 
electrode configuration, the separation of the Ta2O5 layers by a SiO2 layer might help to 
focus the electric field in a horizontal orientation through the Ta2O5 layer. For lateral 
field excitation applications, it was believed that this would help to improve the electrical 
coupling to a TSM mode.  
A thin film 3-layer stack of alternating SiO2 and Ta2O5 was deposited by RF 
magnetron sputtering using the Unifilm PVD-300 sputtering system. The layers were 
alternating fused silica (SiO2) and Ta2O5, in which Ta2O5 was the first layer deposited 
onto a mechanical-grade Si (1 0 0) wafer. Electrodes were fabricated on top of the stack 
in the configuration shown in Figure 3.11. The sputtering parameters for the 3-layer 
alternating stack are provided in Table 3.4. The SiO2 layer was determined to be 
approximately 750 nm thick while the Ta2O5 layers were approximately 450 nm thick. 
The final thicknesses of each layer were verified using SEM imaging, and can be seen in 
Figure 3.12 from a cross-sectional view. The SEM images were taken using a LEO 1530 
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Thermally-Assisted Field Emission Scanning Electron Microscope system. The 
electrodes were 150 nm of aluminum deposited on top of a seeding layer of 30 nm 
chromium using a CVC E-beam evaporator and standard photolithography process, 
outlined in Appendix C. 
 
 
Figure 3.11. Device design for LFE of a piezoelectric Ta2O5 TSM resonator. 
 
 
Figure 3.12. SEM image of profile of fabricated resonator. 
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The electrodes were designed such that the electric field created upon excitation 
would be perpendicular to the wafer surface normal. This laterally-oriented electric field 
was already found to excite the resonance shown in Figures 3.9 and 3.10. It was further 
believed at this point that this electrode configuration was exciting the TSM acoustic 
wave in the Ta2O5 (i.e. through LFE). It was therefore required to demonstrate that this 
was even theoretically possible. 
X-ray Diffraction Characterization of Ta2O5 
XRD data were taken on a Philips X’Pert Materials Research Diffractometer using a 
hybrid mirror/monochromator incident optics and a ¼-degree receiving slit in the 
diffracted optics beam path. Previous investigations with DC diode sputtering have found 
a significant variety in the growth of Ta2O5 crystals by altering the deposition parameters. 
A 2θ-ω scan of the film indicated a weak polycrystalline peak at ~26.4°, indicating an (11 
0 1) orthorhombic 2mm crystal orientation shown in Figure 3.13. The peak was found 
only after applying a 10º offset on ω to the wafer upon running the 2θ-ω scan, however, 
indicating the crystal must have grown offset from the normal of the substrate by that 
angle. The pole plot depicted in Figure 3.14 is a 2.5-D plot of the 4-pole symmetry about 
the φ axis with a 90۫ rotation on ψ for the radial axis. Three of the peaks in the pole plot 
are readily apparent. The fourth, however, while well above the noise floor, is a much 
smaller peak than the three other peaks. Other samples sputtered under the same 
condition required a tilt of ~12.3º for the [11 0 1] peak to be observed. This was found to 
be repeatable under the sputtering conditions given in Table 3.4. Using a reciprocal space 
diagram and powder diffraction X-ray tables, it was determined that if one assumes that  
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Figure 3.13. 2θ-ω scan of 10º tilted Ta2O5 
 
Figure 3.14. 2.5-D pole plot, or φ scan, of 4-pole symmetry. [Prepared by Dr. Walter Henderson, Georgia 
Institute of Technology] 
 
the [17 0 1] axis is aligned parallel to the Si [1 0 0] axis, then the [11 01] axis is tilted 
approximately 10 degrees to the low angle side as was observed.  If one assumes that the 
[19 0 1] is aligned to the Si, the tilt is ~12.3 degrees, which is the offset that was seen in 
some of the samples.  Initially, these alignments do not seem to make much sense from 
an epitaxial alignment point of view, but after examining at the lattice constants, there 
may be a viable explanation.  The orientation with the [17 0 1] ([19 0 1]) axis parallel to 
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the Si [1 0 0] axis has an in-plane periodicity of 6.728 (6.628) Å.  The ratio of this 
distance for the [17 0 1] ([19 0 1]) orientation to the Si [1 0 0] lattice constant, 5.43095 Å 
at room temp, is thus 5:4 (11:9 close to 6:5) within about 1%.   
Compared to the values in the cases where the [1 0 0], [0 1 0], and [0 0 1] Ta2O5 
directions are parallel to the Si [1 0 0] – 81:10, 7:5 and 7:8, respectively – it is likely that 
the proposed orientations are the most energetically favorable way for the Ta2O5 to 
achieve a harmonic or periodic lattice match on Si.  In particular the elevation of the 
Ta2O5 [1 0 0] axis out of the interface plane seems to be strongly preferred.  That axis 
with its large lattice constant is a difficult match to the underlying silicon, and the 
substrate therefore is a poor template for that potential orientation.  The scans show that 
there is clearly an amorphous component as evidenced by the broad slowly, trailing hump 
at lower 2Ө angles, shown in Figure 3.13.  However, the φ scans strongly suggests the 
presence of oriented, crystalline (likely polycrystalline) Ta2O5. 
Thickness Shear Mode in Piezoelectric Ta2O5 
Once the crystal orientation is known, it is possible to solve the Christoffel equation 
described in Equation (3.1) to find the modes of propagation in the bulk given a defined 
electrical excitation direction. We begin by considering the non-piezoelectric Christoffel 
equation, as provided in Equation (3.1) and (3.2). It is estimated that the oriented Ta2O5 
films belong to a class of 2mm. The orthorhombic system class 2mm tensors are used in 
the calculations here because of the XRD results discussed above. All solutions to the 
Christoffel equation were implemented in MATLAB, using the code presented in 
Appendix E. 
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If the direction of propagation is chosen to be in the z direction, then lx and ly go to 
zero, and lz becomes 1. The Euler angles are chosen such that the rotated system 
corresponds to the z-axis in the direction normal to the (17 0 1) plane and the x-axis can 
be chosen to be oriented in the plane parallel to (17 0 1) and in line with the electric field. 
Since there are different manners of describing Euler angles, I have chosen the one most 
familiar to us. In that system, φ corresponds to a counterclockwise rotation about the z-
axis, θ corresponds to a counterclockwise rotation about the new y’-axis, and ϕ  
corresponds to a counterclockwise rotation about the new z’’-axis. Under this convention, 
the Euler angles to describe a system in which the z-axis is normal to the (17 0 1) plane 
are φ = 0, θ =86.633º and ϕ = X where X is the angle corresponding to the direction of 
the electric field. Since our electrodes are fabricated on top of sputtered Ta2O5, X is 
arbitrary because the exact orientation of the electrodes in the x-y plane with respect to 
the crystal lattice is unknown. For simplicity, I will set ϕ = 0. 
For the Ta2O5 stack structure described in Figure 3.11, the electric excitation is 
orthogonal to the wave propagation direction. Therefore, if the wave propagation is in the 
direction of the z-axis, the electric field is in the x-y plane. From the general solutions, it 
is possible to determine that the exact orientation of the electric field with respect to the 
crystal lattice is not as important here because it yields similar results.  
Here I will describe the coupling and acoustic wave propagation for the purely x-axis 
oriented case since symbolically the solutions are much simpler than those for the odd-
angle rotated case and will then attempt to explain how the (17 0 1) normal relates to this. 
First, the orthorhombic 2mm tensors, obtained from Nakagawa, et al [20], were 
transformed such that the z-axis is normal to the (1 0 0) surface of Ta2O5. Then, the wave 
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propagation is specified to be in the z direction of the transformed axes and the electric 
field in the direction of the x-axis. The symbolically solved Christoffel matrix comes out 
to be: 
55
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The eigenvalues of this matrix correspond to terms that can be used to solve for the 
acoustic velocity for each of the three wave propagation modes. Upon inspection, it is 
possible to see that only the y-directed particle displacement is piezoelectrically stiffened. 
This means that for an electric field in the horizontal plane, parallel to the surface, a shear 
wave will be generated with a propagation direction normal to the surface. No other 
component of the Christoffel matrix contains a stiffened term. Similarly, if I solve for the 
Christoffel matrix with an electric field designated along the y-axis of the crystal, the 
Christoffel matrix becomes 
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which shows that this time, the particle displacement is parallel to the surface, but normal 
to the electric field. The coefficients involved in the stiffness have changed, but this is as 
expected for an orthorhombic crystal. Therefore, one can imagine that an electric field 
oriented at some angle between the x and y axes of the transformed system would provide 
a particle displacement normal to the field in the x-y plane with a wave propagation 
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direction oriented toward that of the z-axis. Indeed it does, but the symbolic eigenvectors 
of the solved Christoffel matrix are too complicated to show here, even in the simplest 
case of a 45° offset. 
The above situation has been solved assuming strong crystal orientation toward (1 0 
0). It has already been shown, however, that the deposited film exhibits a highly 
polycrystalline mix with a predominant orientation along (17 0 1). To accurately predict 
any resulting piezoelectric activity, one must rotate the tensors according to the 
appropriate Euler angles described above and then solve and interpret the resulting 
Christoffel matrix. For the case of an x-directed electric field, it can be demonstrated that 
the particle displacement for the longitudinal case and for the shear cases are not directly 
aligned with the z and x axes respectively. They also show no piezoelectric stiffening just 
as in the (1 0 0) case discussed above. Coupling is reflected, however, in the y-direction 
and the particle displacement is directly aligned with the y-axis, as expected. For the case 
of a y-directed electric field, on the other hand, no coupling for the y-directed particle 
displacement shear mode is seen because of the angle difference between the (17 0 1) and 
(1 0 0) faces. Piezoelectric coupling due to the y-directed field does occur, however, for 
the longitudinal and x-directed shear modes. Therefore, we can conjecture that most 
likely, the lateral excitation of the Ta2O5 consists of multiple directions of particle 
displacement and will depend upon the exact angle of the electric field with respect to the 
crystal orientation. I have shown, however, that a thickness directed shear wave 
theoretically can be excited in both (17 0 1) and (1 0 0) oriented Ta2O5 thin films. 
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Finite Element Modeling of Ta2O5 LFE SMR 
In addition to the Christoffel matrix calculations, electrostatics finite element 
modeling of the system was carried out using the software package Comsol 
Multiphysics™. The motivation behind this was two-fold. First, it helped to clarify the 
orientation of the electric field in the Ta2O5 stack as generated from the electrodes. It 
must be confirmed that an electric field parallel to the surface does emerge in the regions 
of interest in order to verify the lateral excitation of the device. Secondly, by modeling 
the system, it is possible to look at the relative levels of electrical energy density within 
the stack layers. Figure 3.15, prepared by Dr. Corso, shows the electric field through the 
layered stack. The first and third layers are Ta2O5 sandwiching a layer of SiO2. Below the 
stack is the (1 0 0) mechanical-grade silicon substrate wafer that the entire structure was 
fabricated upon.  
The resulting simulation shows that the electric field is much denser in the Ta2O5 
layers than in the SiO2 and is fairly horizontal in the active area of interest in between the 
electrodes (indicated by the box). It appears that the electric field in the top Ta2O5 layer is  
 
Figure 3.15. FEM plot of the electric field line orientation in active area (indicated by box).  
[Prepared by Dr. Christopher Corso, Georgia Institute of Technology] 
y-axis (m) 
x-axis (m) 
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relatively parallel to the surface. The permittivity of the SiO2 is such that it draws the E-
field more directly through to the subsequent layer. The permittivity of Ta2O5 then 
redirects the E-field in a manner parallel to the surface, which provides lateral excitation 
of the film. Figure 3.16 is an arrow plot where the size and direction of the arrow 
demonstrates the relative strength and orientation of the field in the stack. In the top 
Ta2O5 layer, the arrows within the active region are very well aligned. The electric field 
in the SiO2 layer appears to have a more vertical component, especially towards the edge 
of the active area. The results from these simulations offer an independent confirmation 
that a lateral electrical excitation field exists in the Ta2O5 which substantiates the 
calculations made in the previous section. The finite element results also demonstrate the 
usefulness of the thin-film stack structure for electric field manipulation with regards to 
the piezoelectric films. 
In order to calculate the energy density in the stack layers, finite element modeling 
was again utilized. The finite element simulation results in 2-D were extracted with each 
 
Figure 3.16. FEM arrow visualization of electric field orientation and relative strength.  
[Prepared by Dr. Christopher Corso] 
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point paired with a finite energy density. For each layer, the energy density values of all 
the points falling within the active area of interest of the layer were summed and divided 
by the total number of points to give the average energy density at a location within the 
active area. The totals were found and the ratio of the average energy density in the layer 
to the lowest average energy density in the stack was computed for each layer. The 
results are summarized in Table 3.5. From the data, it is apparent that the average energy 
density each Ta2O5 layer is greater than the corresponding average energy density of the 
SiO2 layer directly above it. Clearly, there is some propensity for the electrical energy to 
migrate towards the Ta2O5 layers. This can be explained by the large relative dielectric 
permittivity of Ta2O5 which is approximately 19.5 in the y-axis direction [107] as 
compared to 3.8 for fused quartz [108]. Figure 3.17 shows a visualization of the energy 
density for the active area of the stack in between the electrodes. The lighter color 
corresponds to a higher energy density whereas the darker color corresponds to a lower 
energy density. It is clear from the image that the greatest energy density exists just at the 
edges of the electrodes in the top Ta2O5 layer. The layer contains a large amount of 
electrical energy density within the active region. This is important because the larger 
energy density allows for a better opportunity for coupling electrical energy into a 
mechanical wave. In the following layers a greater amount of energy density is contained 
in the Ta2O5 layer than in the SiO2 layer which is desirable for the excitation of an 
acoustic wave in the Ta2O5.  
Table 3.5. Average energy density for each layer.  [Prepared by Dr. Christopher Corso] 
Layer Average Energy Density Ratio 
Ta2O5 Layer 3 81.27:1 
SiO2 Layer 2 1.00:1 
Ta2O5 Layer 1 1.82:1 
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Figure 3.17.Visualization of electric energy density. [Prepared by Dr. Christopher Corso] 
 
Ta2O5 Resonator Results 
 
It was determined that the strongest resonance responses came from device arrays 
with the electrode configuration shown in Figure 3.18. RF probing of individual devices 
(i.e. those not fabricated as part of an array) yielded weaker resonance. Several regions of 
resonance regions were observed for each device around 450 MHz with the sharpest peak 
generally in the area of 525 MHz.  As can be seen from a representative Smith Chart 
shown in Figure 3.19, multiple clear loop patterns emerge, indicative of resonance, are 
present.  This response is typical of the response observed in a vast majority of the 
devices tested. The multiple peaks may be attributed to either the multiple layers of or the 
polycrystalline nature of the Ta2O5. From a sampling of 10 “good” devices, an average 
unloaded Q of these resonators is approximately 1,500, which is quite high 
y-axis (m) 
x-axis (m) 
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Figure 3.18. Electrode configuration used for results of Ta2O5 resonator tests. 
 
Without the appropriate stiffness tensor quantities for the bulk material, it is difficult 
to derive the phase velocity value and thus the resonant frequency of a thickness shear 
wave for comparison with our results.  However, in an attempt to further establish the 
existence of a thickness shear mode, a simple water test could be applied since water 
cannot support a shear wave but can support a longitudinal wave.  If the acoustic activity  
 
 
Figure 3.19. Smith Chart of Ta2O5 resonator array. 
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were longitudinal, application of de-ionized water at the surface would devastate the 
acoustic resonance observed in the device.  Figure 3.20 below shows the response before 
(squares) and after (triangles) application of water to the surface.  As can be seen, the 
water had no deleterious affects on the S11 suppression and a negative frequency shift 
occurred after water was observed of approximately 167 MHz.  According to Sauerbrey 
[109], this response is to be expected from a TSM device, roughly described by Equation 
(2.5). It is reasonable to assume that the observed frequency shift could indicate a mass 
loading effect of the surface of the device by the de-ionized water. This further confirms 
the prediction made by analysis of the Christoffel solution that the resonance is a TSM 
wave.  The response to the water test was shown to be repeatable across different device 
configurations in various locations about the wafer. 
 
 
Figure 3.20. Frequency response representation of the S11 resonator response before and after water 
loading. 
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Not All Resonances are Acoustic 
 
The next step, which should have been attempted before launching into the 
investigation described in the last section, involved an experiment in which the devices 
described in the previous section were repeated, but with films deposited at half the 
thickness. The results of these experiments again revealed results nearly identical to the 
previous results, in both quality and in frequency of response. As is described by 
Equation (3.14), acoustic resonance is directly determined by the film thickness. So this 
latest discovery confirms that not only does the resonance activity have nothing to do 
with piezoelectric ZnO, but that the resonance has nothing to do with piezoelectricity at 
all. In other words, the resonance observed through one-port S11 analysis was not acoustic 
in nature. Additional experiments in which the electrode traces were modified or cut in 
various locations revealed that the resonance was, in fact, purely electromagnetic in 
nature. 
It was obvious at this point that these devices had limited, if any, usefulness as a 
biosensor. The lessons learned from this detour allowed for a more robust vetting of the 
resonators that were eventually developed for biosensor applications, however. These 
include a confirmation that the resonance observed from S11 responses are piezoelectric in 
nature and that the mode of propagation is assessed properly. It is not an entirely 
uncommon experience to review the published literature and come across reports in 
which thorough vetting of the observed phenomena were not performed. 
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From Ta2O5 back to ZnO 
 
Given that piezoelectric Ta2O5 was not effective, it was decided that the original 
strategy of implementing a ZnO TSM SMR should be renewed. This time, however, the 
Ta2O5/SiO2 mirror would not be used as it was thought to be insufficiently capable of 
reflecting the TSM wave. It was then determined that tungsten (W) and fused silica 
(SiO2) might form an appropriate mirror for TSM acoustic waves resonating in a ZnO 
film, given the mirror predictions shown in Figure 3.2. W could also be deposited using 
the Unifilm PVD-300 Sputterer. A schematic of the new resonator design is shown in 
Figure 3.21. 
 
 
Figure 3.21. Design of ZnO SMR with alternating low acoustic impedance (SiO2) 
and high acoustic impedance (W) layers form a Bragg reflector. 
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Device Fabrication 
 
As indicated above, all layers of the SMR were deposited using the Unifilm PVD-300 
sputtering system. The deposition parameters for W and SiO2 are outlined in Table 3.6. 
Recall that the deposition parameters for ZnO are described in Table 3.2. The thickness 
of each deposited layer was confirmed using a Leo 1530 thermally-assisted field emission 
(TFE) scanning electron microscope (SEM), shown in Figure 3.22. Layers 
understandably varied slightly across the 3” wafer, but were relatively uniform (<10% 
variation across the wafer). Layer thicknesses are described in Table 3.7, below. Given 
the material thicknesses measured, the acoustic mirror response was modeled using the 
model described in Figure 3.1. As can be seen from Figure 3.23, while not as smooth as I 
would prefer, the mirror should adequately reflect a TSM acoustic wave designed to 
resonate at 2.0 GHz.  
Electrodes were deposited using a CVC E-beam evaporator onto the surface of the 
ZnO in various configurations consisting of a 30 nm layer of chromium (as a seeding/ 
adhesion layer) followed by 120 nm of aluminum. The electrodes were formed using a 
standard photolithography lift-off recipe, described in Appendix C. The various electrode 
configurations fabricated are shown in Figure 3.24, in which the ‘straight-finger’ 
geometries that yielded the best results are highlighted. Note that several dimensions of 
each electrode configuration were implemented in the mask design. Worth noting at this 
juncture is that very little difference was observed for operation of the TSM with respect 
to changes in the electrode width or gap spacing between electrodes. Some 
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Table 3.6. Unifilm PVD-300 sputtering parameters for the deposition of W and fused silica to form the 
acoustic mirror. 
Parameter Tungsten (W) Fused Silica (SiO2) 
Temperature Ambient Ambient 
Deposition Pressure 5.00 x 10-3 Torr 5.02 x 10-3 Torr 
Argon:Oxygen ratio 100 : 0 98 : 2 
Power 121 A @ 135V 270 W @ ~40V 
Distance from target 
to substrate 6” 7.1” 
Substrate material <0 0 1> Si - lyr 1 fused silica - all others Sputtered <1 1 0> W 
 
 
                 Table 3.7. Material layer thickness as 
assessed by SEM 
      
Measured 
Thickness (nm)
710
1220
596
1206
596
1141
596
220Cr/Al Electrode
SiO2 (L2)
SiO2 (L4)
W (L3)
SiO2 (L6)
W (L5)
ZnO
W (L1)
Material
 
Figure 3.22. SEM image showing profile of fabricated SMR.         
 
 
Figure 3.23. Model of mirror response given measured thickness values obtained by SEM for a 6 layer 
mirror consisting of W and SiO2. 
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Figure 3.24. a) Electrode geometries fabricated in an effort to achieve LFE of TSM in ZnO with the 
enlarged image b) showing the ‘straight-finger’ geometries used to demonstrate high Q TSM devices. 
[Note: W15 – electrode width = 15µm, G3 – electrode gap 3µm, L150-electrode length=150µm] 
 
a) 
b) 
Active area 
Device 
description 
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differences were observed with later experiments with respect to the different geometries, 
a discussion of which is provided later in this chapter. 
Figure 3.25 below demonstrates both a typical impedance response S11 response via a 
Smith chart and the corresponding magnitude of the impedance response converted using 
Equation (3.15). As described by Rosenbaum with regards to LFE devices, generally the 
admittance response, Yin, rather than the impedance response, Zin, is considered which 
takes the form [20] 
( )




−⋅=
2
2tan1 20 kd
kd
KCjYin ω    (3.15) 
where C0 is the clamped capacitance of the parallel electrode configuration, K2 is the 
piezoelectric coupling coefficient, k is the wave number described in (3.1), and d is the 
thickness of the piezoelectric film. This relation led to the development of the 
Butterworth-Van Dyke (BVD) equivalent circuit model, which is often used to represent  
 
Figure 3.25. Typical magnitude of input impedance (left) and Smith chart of S11 response (right) of 
straight-finger LFE devices. Responses are typical of several thousand resonators fabricated and tested. 
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the resonance condition at and near resonance. The Ballato equivalent circuit model, 
briefly discussed earlier in this chapter, provides accuracy outside of the immediate 
region of resonance, but is a much more complicated circuit with analogs that are not as 
clearly drawn as with the BVD model. The BVD model, shown in Figure 3.26 [20], is 
slightly more useful for describing the physical phenomena of piezoelectric resonance 
and for simple modeling purposes. 
From the impedance response described in Figure 3.25(right), note that there are two 
peaks of interest. The local maximum of the response represents the frequency at which 
the contributing capacitive and inductive impedances from the BVD model are 
maximally constructive, and is referred to as the parallel resonance, fp. Alternatively, the 
local minimum of the impedance response represents the frequency at which the 
contributing capacitive and inductive impedances are maximally destructive, and the 
impedance approaches being purely resistive. This condition is called the series 
resonance, or fs. Oscillator circuits can be designed to drive a crystal resonator at either of 
 
 
Figure 3.26. Butterworth-Van Dyke equivalent circuit model for piezoelectric resonance. The ‘Motional 
Arm’ represents the effective acoustic impedance near the resonance condition. 
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these conditions, but the parallel resonance is the most common, and is the one that I will 
focus on for this research. 
It should be noted at this juncture that Q and K2 are common metrics for assessing 
resonator performance. It is possible to estimate theoretical values for Q from material 
properties using the following formulae: [20] 
ηω
ρ
r
avQ
2
=
     (3.17) 
where ωr is the resonance frequency, and η is the relevant material viscosity, or 
sometimes as [55] 
ηωr
cQ =  .    (3.18) 
It is similarly possible to estimate K2 by [20] 
SEc
eK ε
2
2 =     (3.19) 
Obtaining single-crystal bulk values for ZnO from Auld [55], it is thereby theoretically 
possible to obtain K2 values as high as 7%. Due to the fact that the viscosity tensor for 
ZnO has not been determined, it is not possible to obtain a theoretical Q value for these 
resonators at this juncture.  
A summary of the S11 results for the ‘straight-finger’ devices, depicted in Figure 
3.24.b, are provided in Table 3.7. The average unloaded Q of the parallel resonance, Qp, 
was approximately 340 with a K2 of approximately 0.4% (n = 30). The calculations used 
to assess Q and K2 empirically from the S11 response are as follows: [20] 
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where fp is the parallel resonance frequency and ∠Z is the phase of the impedance 
response of the resonator. Note that the Qs of the series resonance can be similarly 
calculated replacing fp with fs in Equation (3.20). Note that Q is also commonly estimated 
by taking a FWHM measurement from the relevant peak from the magnitude of the 
impedance response, as is done by the HP8753C Network Analyzer. 
Immediately noticeable from the results summarized in Table 3.7 is the relatively low 
K2 value, given the potential of 7% calculated earlier. From Equation (3.21), we find that 
K2 is approximated by the frequency separation of the series resonance and the parallel 
resonance peaks from the magnitude of the input impedance response. Given the 
relationship described, the greater the frequency separation between fs and fp, the greater 
K2. Without a corresponding increase in the magnitude of the fp peak, however, then there 
must be a decrease in resonator Q due to the expansion of the width of the peak at half-
maximum caused by the wider frequency spread. 
 
Table 3.8. Summary of LFE of TSM in ZnO SMR using first successful device design (Figure 3.10). 
[n=30] 
Parameter Average [Std Err] Maximum 
fp 2.213 GHz [± 1.8 MHz] 2.227 GHz 
Qp 342 [± 19.9] 553 
K2 0.44 % [± 0.03 %] 0.88 % 
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As a comparison, the QCM is widely attributed with having extremely high resonator 
Q (>60,000 at 10 MHz [109]), yet only exhibits kt2 of 0.5%. Note that for TE devices the 
coupling coefficient is represented as kt2, whereas LFE devices are described using K2, as 
discussed by Rosenbaum. The two are related by [20] 
12
2
2
+= K
Kkt .    (3.21) 
Given that the operation of an acoustic biosensor involves the ability to resolve shifts 
in the resonance condition in response to a perturbation of the boundary conditions at one 
surface, it is felt that particular focus must be concentrated on optimization of resonator 
Q at the expense of K2 in order to develop the most effective device for biosensor 
applications. Anecdotal evidence of superiority of Q as a key parameter for sensor 
application is the extensive and successful use of the QCMs which, as stated, exhibits 
high Q and very low kt2. 
 
Confirmation of TSM 
 
Before optimization of the device design can be undertaken, two central points must 
be confirmed regarding the device operation. As demonstrated by the investigation of 
Ta2O5, it is easy to misinterpret the collected results and make erroneous conclusions 
about the observed phenomena. In order to confirm that the devices were in fact 
operating the TSM acoustic wave in the ZnO film, a series of experiments were 
performed.  
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The first issue to be resolved is that the device exhibits changes in frequency in 
response to changing piezoelectric film thickness, confirming the resonance as an 
acoustic phenomenon. Further that the extracted acoustic wave velocity corresponds with 
the predicted theoretical values derived for single-crystal bulk ZnO described previously. 
Films were deposited in three different thicknesses onto the same mirror, of 660 nm, 710 
nm, and 790 nm. The thicknesses were confirmed using the Leo 1530 TFE-SEM and the 
results are summarized in Table 3.8. As the data confirms, the observed resonance is 
indeed an acoustic wave and the wave velocity is very close to the predicted value of 
2,841 m/s. Furthermore, the acoustic velocities extracted agree closely with the results of 
comparable studies [19, 51-53]. 
The second issue that must be confirmed is that the wave demonstrates shear particle 
displacement to the surface. Without access to a tool for physically imaging this 
parameter, a simple water drop test was implemented to demonstrate this. If the acoustic 
wave consisted of any longitudinal component, this should readily be transferred into the 
liquid medium as a compression wave. While the shear wave does exhibit some 
penetration into the liquid medium, as described by Kanazawa and Gordon [27], the 
majority of the acoustic energy should reflect back into the piezoelectric crystal. Figure 
3.27 represents a typical result of depositing 20 µL of deionized water (DI H2O) onto the  
 
Table 3.9. Summary of observations of TSM resonance due to different ZnO film thicknesses deposited 
onto the same acoustic mirror. 
Measured ZnO Thickness 
(nm) 
fo 
(GHz) 
Extracted Acoustic Velocity 
(m/s) 
790 2.0 3,160 
710 2.2  3,130 
660 2.35 3,100 
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device surface, as observed through the S11 response. Some deterioration of the resonance 
was observed resulting in lowering of the Q factor, which is due to the slight energy 
absorption into the liquid described above. Worth noting is that a more dramatic effect is 
observed when DI H2O is deposited onto the surface of a QCM. Figure 3.28 provides a 
demonstration of that effect for comparison purposes. Note that both resonators exhibit a 
negative frequency shift upon introduction of water in addition to the spreading and loss 
of some of the acoustic energy. The frequency shift represents a mass-loading event at 
the surface. With significantly larger surface area and more water deposited on the 
surface, the QCM (fp = ~10 MHz) only reflected a 2.5 kHz frequency shift, while the 
ZnO SMR (fp = ~2.0 GHz) shifted by 11.3 MHz. This is consistent with the argument 
made in Chapter 2 claiming the sensitivity of the sensor to be directly proportional to a 
power of the resonant frequency. 
 
 
Figure 3.27. Frequency shift observed in S11 measurement in response to loading the ZnO SMR surface 
with deionized H2O.  
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Figure 3.28. Frequency shift observed in S11 measurement in response to loading the QCM surface with 
deionized H2O 
 
It must be mentioned that several resonance peaks were observed from the broader 
band S11 responses. Two of the stronger resonance peaks were observed at~6,000 m/s and 
also at ~4,800 m/s. The 4,800 m/s peak was of particular interest as it dampened very 
little upon presentation of DI H2O at the device surface. The peak was of significant 
interest because of its higher Q, yielding high potential for biosensor applications. It is 
strongly suggested that this resonance be further investigated for such an application. 
Table 3.7 summarizes the observations of this resonance activity. 
 
Table 3.10. Summary of LFE of 4,800 m/s resonance in ZnO SMR using device design shown in Figure 
3.10. [n=29] 
Parameter Average [Std Err] Maximum 
fp 3.424 GHz [± 6.1 MHz] 3.467 GHz 
Qp 562[± 30.55] 744 
K2 0.23 % [± 0.05 %] 0.27 % 
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Resonator Testing 
 
Due to the difficulty of fabrication and various issues regarding spurious resonance 
activity, it was decided that a new electrode configuration was required that balanced the 
electromagnetic field incident on the piezoelectric film. There was also reason to believe 
that a superior resonator could be achieved by fabricating a device in which the gap size 
between electrodes was significantly larger than the piezoelectric film thickness, as 
described by Rosenbaum as preferable for LFE [20]. The new design was accomplished 
by implementing a more symmetric electrode design that surrounded the signal electrode 
with ground electrodes, rather than establishing the ground on a single side as seen in 
Figure 3.24. The two electrode geometries were then implemented with various electrode 
widths and gap sizes for each configuration.  
A total of eight different electrode configurations were tested using the two electrode 
shapes depicted in Figure 3.29. Devices were evaluated based on quality factor, Q, and 
coupling coefficient, K2, as calculated from the S11 response of each device. Results 
obtained from ANOVA demonstrate that a statistically significant gap (p < 0.01) emerges 
between the performance of the circular shaped devices (Figure 3.28, left) and the 
straight electrode devices (Figure 3.28, right) when analyzing their K2 and Q results. It is 
evident that the average Q is higher for the straight electrode configuration while the 
effective K2 is lower. One possible explanation for this is that the circular electrode 
configuration has a larger surface area over which excitation of the crystal occurs.  
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Figure 3.29. New electrode design exhibiting greater symmetry and larger electode gap widths. [Note: 
W20 - electrode width = 20mm; GF0 - electrode gap = 40 mm] 
 
Therefore, the coupling of the electric field to the crystal over grain boundaries and 
crystal non-uniformities is more efficient overall while the added mass of the larger 
electrodes acts to reduce the Q. These results are summarized in Table 3.8 and Figure 
3.30.  
As indicated by the strong correlation between devices G & H, it is readily apparent 
from the data that the electrode widths fabricated had no statistically significant impact 
on the device performance as assessed by Q and K2. One would hypothesize that greater 
distribution of the electric field from a constant power source to the piezoelectric crystal 
would result in a more distributed and efficient coupling of electrical energy into acoustic 
wave energy. Since Q is a ratio of energy conserved to energy dissipated per cycle, it 
would seem that the Q factor should improve as a reflection of this. It was surprising that 
the size of the gap between electrodes had no clear functional relationship with the device 
performance. Gap size does have some impact, however, as can be seen from device D in 
Table 3.8. Compared with the other straight electrode configurations, the 10 µm gap 
exhibits a significantly lower Q and higher K2, on average. It appears that beyond a 
particular threshold between 10 µm and 20 µm between straight electrodes, there was a 
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Table 3.11. Assessment of device performance of tested resonators from analysis of collected S11 
parameters. 
Device Shape Electrode 
width (µm) 
Electrode 
Gap (µm) 
# Tested Average Q Average 
K2 
A Circular 20 10 92 198 0.86% 
B Circular 20 20 72 195 0.87% 
C Circular 20 40 70 192 0.86% 
D Straight 20 10 69 198 0.84% 
E Straight 35 20 74 217 0.78% 
F Straight 35 40 98 206 0.77% 
G Straight 20 50 25 220 0.74% 
H Straight 35 50 44 221 0.73% 
 
 
Figure 3.30. Comparison of various electrode configurations using Q and K2. Note, results 
represent the assessment of over 500 devices fabricated and tested. 
 
notable improvement in Q. No clear pattern emerges beyond this, however, for the ranges 
tested.  
Having determined that the straight electrode configuration yielded higher Q devices, 
which has been identified as the desired parameter, 8-element arrays of these devices 
were fabricated in order to verify that the resonator design displayed in Figure 3.28 (left) 
performed as well in the array configuration as individual devices. That is to say, to 
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confirm that the array structure did not bear any beneficial nor detrimental effects on the 
resonator’s performance. Sampling more than 150 arrayed devices similar to those seen 
in Figure 3.31 showed that there in fact was a statistically significant difference in device 
performance. Note that tests were performed on both arrayed circular electrodes as well 
as straight finger electrodes. As in the isolated individual devices, the Q of the straight 
finger devices outperformed the circular devices. There was a significant deterioration in 
performance, however, from incorporation into array configurations. All of these arrays 
are demonstrated in Appendix B, and are similar to the array demonstrated in Figure 
3.31, below. Results are summarized in Table 3.9. A 30% decrease in Q and a 15% 
decrease in K2 was observed for straight finger devices with a 20 µm gap fabricated in the 
array configuration versus the isolated configuration. For devices fabricated into 8-
element arrays with a 50 µm gap, again a decrease of 28% was observed in Q but only a 
8% decrease in K2. Note that the trade-off between Q and K2 is still evident in these 
devices. One explanation for the decrease in performance is the addition of a significant 
amount of metal surrounding the active devices for bonding pads and ground-bus 
connections. The added mass from the electrodes provide a lossy material at the surface 
boundary which can act to scatter the acoustic energy. In addition, the different electrode 
configuration itself is likely to have altered the electric field from the isolated 
configuration, contributing to a change in the resonator performance. I felt that the results  
 
Table 3.12. Assessment of arrayed device performance of tested resonators from analysis of S11 response. 
Array Electrode 
Shape 
Electrode 
width (µm) 
Electrode 
Gap (µm) 
# Tested Average 
Q 
Average 
K2 
1 Circular 20 10 46 133 0.83% 
2 Circular 20 40 32 121 0.83% 
3 Straight 35 20 63 150 0.66% 
4 Straight 35 50 23 159 0.67% 
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were still good enough to proceed, however, with sensor testing. 
 
 Biosensor Compatibility 
 
As this is a novel resonator design implementation, it is important to characterize the 
general stability of the TSM acoustic wave in the thin film ZnO SMR. First, it was 
important to confirm that the resonance itself is stable and does not vary over time. An 
experiment was conducted holding the resonator fixed at 25ºC while constantly driving 
the resonator at 1 mW using a HP 8753C Network Analyzer. Devices were probed using 
Cascade Microtech ACP40 GSG-150 probes. It was found that the resonator was more 
than suitably stable, exhibiting a 0.01% shift (32 kHz) after 3 hours of constant 
resonance. The results are depicted in Figure 3.32.  
 
Figure 3.31. Digital image of fabricated 8-device array. Device is designed for probing with Cascade 
Microtech ACP40 probes and with pads large enough for subsequent wire bonding.  
(occupies 2.0 mm x 2.4 mm space) 
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A second parameter commonly investigated relates to the resonators susceptibility to 
varying temperatures. The parameter often investigated regarding this susceptibility is the  
temperature coefficient of resonant frequency (TCF), which is defined as  
( )
RTx
x
x fdT
dffTC
,
1⋅=     (3.22) 
where T is the temperature, fx is the relevant resonant frequency and RT represents room 
temperature (25°C). The temperature was varied from 25°C up to 175°C in increments of 
25°C and the resonant frequency was measured after the system was allowed to stabilize 
at each temperature point for at least 10 minutes. The results yielded an empirically 
derived TCF for the series and parallel resonance of +24.6 ppm/°C and +25.6 ppm/°C, 
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Figure 3.32. Parallel resonance frequency plotted against time demonstrating stability of resonance over a 
three hour time period, at a constant 25ºC. 
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respectively. Note that these are considered relatively low TCF values, suggesting these 
devices are appropriate for sensor applications. These results are demonstrated in Figure 
3.33. This experiment was conducted 3 times with identical results. 
The susceptibility of device Q and K2 was also investigated to confirm no degradation 
in the quality of the resonance itself with increasing temperature. It was found that the K2 
remained very stable over the temperature range tested, varying by only 0.1% over the 
155°C range. The Q drift of the resonator was slightly more significant, varying by 
roughly 42% over the 155°C temperature range. For application in a bench-top biosensor 
application in which testing is likely to occur at or near room temperature, the Q 
remained stable enough to consider negligible exhibiting an average shift of 0.28/°C 
 
 
Figure 3.33. Frequency drift of parallel and series resonance frequencies with increasing 
temperature. 
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 (<0.2% per degree). The results for the temperature stability of Q and K2 are summarized 
in Figure 3.34 and 3.35, respectively. 
When designing sensors for use with physiological samples, it is important to assess 
the sensor’s performance under varying sample conductivity conditions. Hu et al. 
characterized the effects of sample conductivity on QCMs employing LFE rather than the 
typical TE for biosensor applications [110]. I determined that a similar investigation of 
the characteristics of the TSM in ZnO was sufficient to investigate this.  
Considering the goal of employing these resonators in biosensor applications with 
biological fluid samples, the resonators were tested over a range of sample conductivities. 
Biological fluids are filled with electrolytes, which imbue the fluid they are in with 
conductive properties. It is common in the literature to see 0.9% NaCl in DI H2O 
described as an equivalent salinity to blood. Therefore, I loaded the surface with 0.0% to 
0.9% wt/vol of NaCl in DI H2O. Saline solutions were prepared using 99.5% NaCl 
(Sigma) and HPLC-grade deionized H2O (Burdick & Jackson) and mixed for at least 30 
seconds on a mini vortexer (VWR Scientific Products). The devices were tested using the 
equipment described earlier in this chapter. In addition, a laptop computer running a 
custom LABVIEW program for tracking the resonance frequency of the device under test 
was employed [111]. The device arrays were exposed to the saline solutions by hand 
pipetting ~1 µl directly onto the resonator array surface while being probed.  
Results indicate that the magnitude of resonator frequency shift varied little in 
relation to loading with pure water alone, as indicated in Figure 3.36. As can be seen, the 
percentage of frequency shift with increasing sample conductivity was less significant 
than the increasing noise level. These devices are not ultra high Q, as QCM devices are, 
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Figure 3.34. Susceptibility of resonator Q to changes in operating temperature from 25°C to 175°C. 
 
 
Figure 3.35. Susceptibility of resonator K2 to changes in operating temperature from 25°C to 175°C 
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so the resonance peak is still slightly broad. Incidental high-frequency fluctuations in the 
reflection parameters will cause the parallel resonance monitor to register a shift if 
frequency, though the broad peak does not actually shift. The error bars in Figure 3.36 
indicate the measured variance due to these incidental fluctuations. A further indicator of 
this can be seen in Figure 3.37, which demonstrates the results of a typical experiment 
when a 0.9% saline sample is deposited on the device surface then subsequently washed 
with DI H2O.  Figure 3.38 is provided as a comparison of the relatively lower levels of 
noise observed with DI H2O alone. 
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Figure 3.36. Typical experiment demonstrating change in parallel resonance frequency with increasing 
saline concentration on the surface of the resonator. 
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Figure 3.37. Demonstration of a typical conductivity experiment with 0.9% NaCl in DI H2O. 
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Figure 3.38. Demonstration of a typical conductivity experiment with 0.0% NaCl in DI H2O. 
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CHAPTER 4 
SENSOR FUNCTIONALIZATION 
 
In order to functionalize the resonators developed through Chapter 3 for biosensor 
applications, it is necessary to create conditions at the surface of the piezoelectric layer 
that execute a molecular recognition capability for a specific target. This often requires a 
surface chemistry protocol involving the immobilization of an appropriate capture agent 
at the surface of the device that in turn has a high degree of specificity for a single target 
molecule. In this chapter I will discuss the selection of appropriate capture agents and the 
development of an appropriate protocol for immobilization of those capture molecules on 
the surface of my resonators. The use of a reference sensor as a control is absolutely 
critical for this protocol. Reference sensors functionalized with capture molecules 
specific to a target absent from the test media help guarantee that any frequency shift of 
the test sensor is due to binding of the intended target and not to non-specific binding or 
other changes in the surface. This argument can be made because both the test sensor and 
the reference sensor have received identical functionalization treatments with similar 
capture molecules and exposed to the same test medium. Any difference in behavior 
observed in the two sensors can be attributed to binding of the test sensor to target 
molecules in the liquid sample under test. 
Recall that acoustic wave biosensors function by detecting changes in the path over 
which the propagating wave travels (see Chapter 3). As with most types of biosensors, 
the ability to obtain repeatable results from an acoustic sensor, especially one with 
potential for extremely high sensitivity, is related to the repeatability of the prepared 
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surface layer, or biolayer, which executes the function of molecular recognition. A 
requirement for any high precision biosensor is that the output signal, or device response, 
be repeatable given multiple identical samples and on different sensor elements prepared 
in the same manner. Therefore controlled, reproducible immobilization of appropriate 
capture molecules to functionalize the device is necessary to preclude device to device 
signal variations. In assessing the quality of the various biolayer protocols attempted in 
this research, therefore, it is critical to qualify both the uniformity and repeatability of the 
biolayer. 
 
Capture Molecule Selection 
 
There are a myriad of capture agents that have been employed to functionalize 
transducers of various types into biosensors since the first biosensor was developed by 
Updike and Hicks in 1967 [112]. These include oligonucleotides, receptor proteins, 
enzymes, antibodies, synthesized polypeptides and lectins [113]. For the purposes of our 
specific applications, recall that we desire keeping interactions close to the surface so as 
to maximize the device sensitivity. For that reason, there is no need to consider capture 
agents larger than these. With the exception of glucose sensors, the most commonly 
employed capture agents are antibodies (Ab) [113]. To an increasing degree, however, 
biosensor developers are looking more towards oligonucleotide structures for a number 
of reasons, which are discussed later in this chapter. Recalling the goals of this biosensor 
research, it is a high priority to establish a biosensor with high specificity and selectivity. 
Of the capture agents reviewed for this research, antibodies and aptamers top the list for 
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high affinity for their target analytes. A secondary priority is the ease of fabrication and 
potentially low cost of production. Given these criteria, I will consider both options and 
how well they would work for our application. 
Antibodies 
As mentioned, antibodies are one of the most commonly employed capture agents for 
biosensor applications. Ab’s, or immunoglobulins (Ig’s), are produced by all vertebrates 
as an essential component of their immune system. These molecules exhibit specific 
molecular recognition capability, determined through a complex evolutionary refinement 
process [12]. They are produced by the B cells of all placental animals in five isoforms, 
including the pentamer IgM, the dimer IgA, and the monomers IgD, IgE, and IgG. 
Among these, the IgG molecule is most widely used because it is by far the most 
abundantly produced and exhibits the greatest stability (generally lives 4 to 10 times 
longer than the other isoforms in plasma) [12]. 
The IgG molecule is a 150 kDa protein made up of two “heavy chain” segments (446 
amino acids in length) and two “light chain” segments (214 amino acids in length) and 
comes in four subclasses. The four subclasses are categorized based on minor structural 
differences of the heavy chain, mostly accounting for the location of Cystine residues. 
The general monomer structure is demonstrated in Figure 4.1 below. The binding domain 
is located at the two amino-terminals of the structure and exhibit excellent specificity and 
affinity for their targets. The binding mechanism is controlled by both the variable amino 
acid residues that make up the binding pocket and the ‘hinging’ action of the di-sulfide 
bonds holding the heavy and light chains together. Taken together, IgG1 molecules (the 
most abundant IgG subclass) have reported extraordinary affinity (Ka > 1010 M-1) [114]. 
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Figure 4.1. Secondary structure of the IgG monomer with individual regions identified [115].  
 
 
Another attractive component of using IgG antibodies is the wide array of surface 
chemistry protocols for immobilizing the molecules in a functional manner on various 
surfaces. Recall the binding domain is located at the amino-terminals of the protein as 
indicated in Figure 4.1. For use as a capture agent attached to the surface of a transducer, 
the molecule must therefore be immobilized nearer the carboxyl-terminal (the region 
described as the Fc portion of the Ab, or crystallizable fragment) in order to maintain 
functionality as a capture agent. It is further desirable to achieve a covalent (or stronger) 
bond between the antibody and the device surface, so as to achieve a more generally 
stable sensor configuration. All protocols that I have encountered to date achieve this 
with the IgG molecule by covalent binding of an acid head group to an available amine 
terminated residue on the antibody. The Fc portion of the antibody exhibits a relatively 
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rich population of available lysine residues, as indicated by the highlighted regions in 
Figure 4.2 below [116]. There are 18 Lysine residues and 5 Arginine residues in each of 
the two 220 amino acid length segments of the heavy chain within the Fc portion of the 
antibody. 
Most of the work regarding covalently binding IgG molecules to oxide surfaces in an 
effort to functionalize them has focused on the use of quartz (SiO2). Hydroxyl groups at 
the surface of an oxide provide sites for reaction with cross-linking molecules to form 
covalent bonds [117]. One of the more common methods for functionalizing SiO2 
surfaces involves the use of organosilanes. Success with immobilizing antibodies on SiO2  
 
 
Figure 4.2. IgG molecule with approximate location of Lysine residue highlighted. 
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surfaces has been shown using amine- and thiol-terminal silanes such as 3-
mercaptopropyl-trimethoxy-silane (MTS) with a variety of heterobifunctional 
crosslinkers, such as N-γ- maleimido-butyryloxy succinimide ester (GMBS) [117, 118]. 
Other work in modifying SiO2 surfaces has focused on forming self-assembled 
monolayers (SAMs) using epoxysilanes [119, 120]. The great advantage of using an 
epoxysilane such as (3-glycidoxypropyl) trimethoxy-silane (GPS) for forming SAMs on 
oxide surfaces is that it eliminates the need for a secondary crosslinker between the silane 
molecule and target antibodies. The exposed epoxy groups react readily with amine 
groups. Given that hydroxyl groups are also available at the surface of planar ZnO, it is 
thought that some of these techniques may be employed. 
Despite the amount of research that has been performed on various oxides, including 
SiO2, there have actually been relatively few studies involving the functionalization of 
planar ZnO surfaces. One study reports the use of 3-aminopropyl-triethoxy-silane (APS), 
which is an amine-terminated silane, to covalently bind Interleukin-6 to the surface of 
device-quality ZnO films [121]. APS is used as the primary crosslinker, followed by 
glutaraldehyde as a secondary homobifunctional crosslinker to bind the protein, 
Interleukin-6. A major drawback with the use of glutaraldehyde, however, is that it binds 
to other gluteraldehyde and is known to form large polymer conglomerates which may 
bind many residues and form large multiprotein complexes [117]. My own early attempts 
at functionalizing planar ZnO using APS and glutaraldehyde yielded surfaces that 
indicated this was in fact occurring in my own preliminary trials. This study does 
demonstrate, however, that silane chemistries can be applied to the surface of ZnO. 
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There are many disadvantages to using antibodies for capture agent applications, of 
course. For one, the production of monoclonal antibodies for sensor and immunoassay 
applications is generally achieved through the Hybridoma Technique. This protocol 
involves the generation of lymphocytes due to the immune response of an infected 
vertebrate and isolation and extraction of these cells. The cells are then fused with 
myeloma cells, thereby forming hybridoma cells, that are then allowed to produce 
monoclonal antibodies (mAb’s) indefinitely in cell culture. The protocol is demonstrated 
in Figure 4.3 below. Hybridomas are both laborious and expensive to produce and can  
 
 
 
Figure 4.3. The Hybridoma Technique is the predominant method for generating monoclonal antibodies for 
commercial and laboratory applications. [Taken 10/28/2008 from http://www.antibodystation.com ] 
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often prove restrictive. It is obviously difficult to create Ab’s using this process for toxins 
or for targets which do not elicit an immune response. Additionally, mAb’s tend to vary 
from batch to batch [122]. It is also impossible to generate mAb’s for targets under non-
physiological conditions. These proteins are also sensitive to temperature and pH 
changes, and denaturation of the molecule is irreversible. Finally, Ab’s are relatively 
large (150 kDa) and difficult to immobilize on various surfaces in such a way that 
ensures its binding capacity for its target. 
Aptamers 
As previously mentioned, aptamers are oligonucleotide sequences that can 
selectively, and with high affinity, bind a target ligand. Both RNA and DNA strands can 
fold into a plethora of well-defined secondary and tertiary conformations for a given 
sequence, which is the basis for using them as binding agents for a wide variety of 
molecular targets. Aptamer have been found to undergo significant conformational 
changes upon binding with its target ligand, generally yielding a new complex in which 
the aptamer becomes imbedded in the tertiary structure of the target ligand [123]. 
Selection of the appropriate oligonucleotide sequence represents the crux of determining 
appropriate aptamers for different target ligand.  
The first in vitro selection of RNA was accomplished in 1974 by Sol Spiegelman 
[124].  It was only after the development of polymerase chain reaction (PCR), however, 
that it became reasonable to more generally search for appropriate aptamer species for 
known target ligands [125]. So ripe was the field for such a breakthrough, that three 
separate groups (two within the same month) developed a similar process, exclusive of 
one another, for aptamer selection [126-128]. The process developed for aptamer 
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selection is now referred to as the Systematic Evolution of Ligands by EXponential 
enrichment (SELEX) process. This process is described in Figure 4.4 below. The SELEX 
process is essentially a technique for reviewing extraordinarily large combinatorial 
libraries (most systems start with a DNA library containing 1014 to 1015 individual and 
distinct molecules) through an iterative process allowing for in vitro selection and 
subsequent amplification of selected oligonucleotides. The process is repeated as many 
times as necessary to determine the best oligonucleotide for a given target, for degree of 
specificity (rejecting candidates that bind structural analogs), and for maintained activity 
in desired environmental conditions. Early implementation of the SELEX process would 
take as long as two days to accomplish a single round. Given that between 8 to 15 rounds 
are necessary to yield an acceptable aptamer candidate, the overall process would take the 
better part of 2-3 months of constant refinement [122]. Vast improvements in 
instrumentation automation and understanding of individual step sensitivities has 
shortened the time of each round to less than 2 hours, yielding final candidates in less 
than 2 days [129]. 
The use of aptamers as capture agents in biosensor applications has the following 
advantages [122]: 
• Large number of thermodynamically stable structural variants vs. peptides of 
equal length 
• No known structure for which aptamers cannot be made to bind to 
• Specificity and affinity to match and, in some cases, surpass antibodies 
• Can use DNA microarray spotting technology to immobilize defined densities 
in precise locations on a large scale 
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Figure 4.4.  Systematic evolution of ligands by exponential enrichment (SELEX) process. 
 
• Selected species can easily be modified to improve affinity and specificity 
(unlike Ab’s) as well as to improve robustness in various environments 
• Aptamers are much lighter and smaller, thereby capable of forming denser 
layers and being closer to the “sensing” surface  
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• Generation and selection is performed in vitro 
– Can function in non-physiological conditions 
– Selection conditions can be manipulated, allowing kinetic parameters to 
likewise change on demand 
• Can be used for toxins or other targets that do not elicit an immune response 
• Little to no batch-to-batch variation 
• Reporter molecules (eg. radio-labeling) and other modifications can be 
arbitrarily bound at precise locations, increasing capability and variability 
• Denaturation is reversible 
• Long shelf-life under adverse conditions 
• Can bind target proteins irreversibly, if desired 
• Rapid automated selection process for aptamer isolation 
• Oligonucleotide clones are cheap and easy to mass produce 
The Decision to Use Antibodies 
With regards to applications specific to this research, there are two attributes in 
particular that make aptamers especially attractive. First, it becomes possible to fabricate 
sensors with re-usable surfaces. Aptamers can be made to release their target upon 
exposure to extreme heat, salt, or chelating agents [130-132]. Second, aptamers are easily 
immobilized on nearly any surface with controllable densities [132]. Given the limited 
investigation of covalently binding capture molecules to the surface of planar ZnO, this 
becomes an obvious advantage.  
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There are disadvantages, as well, to using aptamers. First of all, they are generally not 
commercially available for many targets. In order to obtain aptamers for any particular 
target, one would most likely have to partner with a laboratory that has the time and 
inclination to collaborate. Georgia Tech does not have such a laboratory, so any 
collaboration would likely need to be conducted remotely. Secondly, nucleic acids are 
notoriously difficult to deal with and would likely require significant expertise in 
biochemistry in order to manipulate for a novel application. While I have a confident 
grasp of the fundamentals of biochemistry, a parallel doctoral-level pursuit in the field 
would be neither feasible nor appropriate. Finally, the application itself of a new aptamer 
species to a previously un-investigated planar surface is entirely novel, and would require 
a greater investment in time and resources than pursuit of a more conventional approach. 
Given the already significant challenges of the goals of this thesis research, it is 
unlikely that this would be the more expeditious solution to the dilemma of 
functionalizing the surface of my biosensor. Suffice it to say that there is extraordinary 
potential in the use of aptamer technology as the capture mechanism for biosensor 
applications. It is strongly felt by this researcher that due to advantages such as size, 
overall stability, and the potential for reuse of each sensor, that aptamers will likely play 
a significant role in the ultimate development of this and other biosensor technologies. 
I have therefore determined that because of the prevalence of existing immobilization 
techniques and relative ease of procurement, Ab’s should be used as the appropriate 
capture agent for functionalization of these biosensors. It must be repeated that this 
approach still has drawbacks, such as being relatively costly for mass production, slow 
development times, and the relatively large size of each molecule, to name a few. This 
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approach still accomplishes the proof of concept for this sensor technology. In the future, 
it will likely be more interesting to pursue aptamers and other molecules that offer means 
of skirting these drawbacks. Given our capture agent selection and device function, we 
can therefore identify the biosensor being developed as a label-free immunosensor array.  
 
Surface Preparation Protocol 
 
As mentioned above, a critical aspect for the development of label-free 
immunosensors is the employment of highly uniform and repeatable antibody 
immobilization techniques. As previously discussed, silane chemistries offer a strong 
possibility for successfully immobilizing Ab’s on the surface of our ZnO in a covalent 
manner. A review of the literature identifies two different molecules appropriate for such 
a purpose. They are (3-glycidyloxypropyl) trimethoxysilane (GPS), and (3-
mercaptopropyl) trimethoxysilane (MTS) for the immobilization of IgG Ab’s. In order to 
assess the chemical modification of the ZnO surface, I employed water contact angle 
measurements, atomic force microscopy (AFM), and fluorescence microscopy.  
To provide visual confirmation of the density and uniformity of antibody 
immobilization, fluorescently labeled IgG antibodies are employed for each protocol. 
Over the course of the investigation, I found fluorescence microscopy to yield the most 
relevant information for assessing the surface coating uniformity and repeatability. The 
ultimate test of functionality is assessed by using the prepared devices in a basic sensor 
experiment. Publication of these findings can be found in [133]. 
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ZnO Preparation 
ZnO samples were prepared by depositing 500 nm of ZnO onto 3” (1 0 0) silicon 
wafers (University Wafer) by RF magnetron sputtering using the Unifilm PVD-300 
sputtering system. The wafers were diced into 1 cm × 1 cm squares for the surface 
functionalization experiments. Prior to surface functionalization, the ZnO samples were 
sonicated in acetone for 5 minutes in an ultrasonic bath before being cleaned using an ion 
beam mill. The samples were milled in a 20% oxygen / 80% argon atmosphere for 5 
minutes with a beam current of 9 mA at 50 VDC. This was done to remove any adsorbed 
chemical species from the surface and to provide a reactive surface for the silane to bind. 
It is important to note that the milling procedure was found to be absolutely critical to 
preparing highly repeatable and highly uniform surfaces. Without this step, all protocols 
attempted yielded relatively poor results. 
Surface Modification 
The silane solutions for treating the ZnO samples were prepared under a nitrogen 
atmosphere. The solutions prepared were a 4% solution by volume of MTS (Fluka) in dry 
toluene (Sigma) and a 4% solution of GPS (Sigma) in dry toluene. Immediately following 
the ion milling procedure to clean the ZnO surface, samples were placed in vials 
containing 2 mL of the silane, sealed in a centrifuge tube (VWR), and placed in a 
nitrogen environment for 24 hours. The samples were then removed from the vials and 
rinsed with ethanol followed by sonication for 5 minutes in ethanol (95%, Sigma). The 
samples were then dried with a stream of N2 gas. Samples treated with the 4% MTS were 
then placed in vials containing 2 mL of 2 mM GMBS (Fluka) in ethanol and sealed for 24 
hours. Following sonication in ethanol, GPS coated samples were immediately treated 
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with the protocol described in the next section. The MTS+GMBS coated samples were 
removed from the GMBS solution and sonicated in ethanol for 5 minutes. With the 
crosslinkers attached, the surfaces are now considered activated. 
Covalent Antibody Attachment 
The activated surfaces were treated with 548 nm Alexa-Fluor labeled Goat anti-rabbit 
IgG antibodies (Invitrogen). 25 µL of a 200 µg/mL solution of the fluorescently labeled 
antibodies in PBS buffer (pH 7.4) was pipetted onto the surface of the samples. The 
antibody solution was incubated for 2 hours in an opaque GelPak™ container (Fisher) in 
a nitrogen environment at room temperature. After incubation with the Ab solution, each 
substrate was rinsed with aliquots of PBS buffer followed by rinsing with a light stream 
of ultra-pure water (Burdick & Jackson) to remove any unbound antibodies from the 
surface. Control samples for testing simple antibody adsorption directly to the ZnO 
surface were also prepared by incubating ion etched ZnO samples with the antibody 
solution for 2 hours.  
Based on previously described mechanisms [117, 121, 134], a summary of the 
reactions for covalently attaching antibodies to the ZnO surface is shown in Figure 4.5.  
Deposition of the silanes is achieved through reaction of the head groups with hydroxyl 
groups at the ZnO surface. The thiol group on the MTS molecules react with the 
maleimide region of the secondary crosslinker GMBS in organic solvent. This reaction 
leaves the succinimide residue of the GMBS available for antibody attachment. The 
succinimide residue then binds to an available amino group of the antibody to form a 
covalent bond between the antibody and the ZnO surface. It has been shown that 
antibodies immobilized using this approach still maintain a significant amount of activity,  
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Figure 4.5. The proposed immobilization scheme for covalent attachment of IgG antibodies to the surface 
of sputtered ZnO using a) GPS and b) MTS + GMBS as silane-based crosslinkers. 
 
albeit less than with oriented immobilization techniques such as those that target the 
carbohydrate group on the Fc region of the IgG antibody [118]. However, the ease and 
simplicity of the immobilization protocols studied here make them more suitable for  
biosensor applications than oriented immobilization techniques which often require 
numerous steps, harsh experimental conditions, and high antibody losses prior to 
immobilization.  
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Surface Protocol Results 
Water Contact Angle Measurements 
Water contact angle measurements were performed using an SEO Phoenix 150 
Contact Angle Analyzer. The contact angles for each of the surface treatments were 
evaluated by averaging the contact angles from at least five separate measurements for 
each surface treatment, in which at least two surfaces for each protocol, following 
reaction with the silane. The silanized samples were measured and compared to a control 
sample consisting of ZnO with no surface treatments other than ion etching to clean the 
surface of any adsorbed species and sonication in ethanol to simulate the rinse process.  
The results from the water contact angle (WCA) measurements after the samples 
were coated with the silanes indicate that the average WCA for each of the crosslinkers 
were greater than the WCA of the control, indicating an increase in surface 
hydrophobicity. The results are summarized in Table 4.1 below. Samples coated with 
MTS had an average water contact angle of 77° which were statistically different than the 
untreated ZnO (control) case which exhibited a water contact angle of 72°. The contact 
angle results for surfaces coated with MTS seem to agree well with previous WCA 
investigations of dithiol self-assembled monolayers on gold which were reported to be 
approximately 83.5° on average [135]. The WCA measurements performed with the 4% 
GPS solutions also suggest that the surface is being chemically modified. These samples 
yielded a significant increase in average WCA to 80º. An interesting phenomenon was 
observed for samples coated with GPS, however. Immediately after the water droplet is 
placed onto the sample surface, it was observed that the WCA is much higher than the 
control case indicating that the surface is hydrophobic. However, the WCA changes as a 
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function of time in a manner that seems to be unrelated to evaporation phenomena. The 
WCA value of 80º was averaged from measurements taken immediately after the drop 
was placed on the surface. After a period of 20 to 30 seconds, the WCA drops by about 5-
7 degrees and then stabilizes. One possible explanation for this phenomenon is that the 
water droplets react with the exposed epoxy groups, hydrolyzing the ring to form surface 
hydroxyl groups which would result in increased hydrophillicity.  
 
Table 4.1. Water contact angle measurements for surface treatments applied. (n = 10 for each case) 
Surface Treatment Avg. WCA (degrees) 
Untreated ZnO 72 ± 2 
GPS 80 ± 5 
MTS 77 ± 1 
 
Atomic Force Microscopy Measurements  
AFM was used for monitoring the morphological changes at the surface that result 
from coating the surface with the crosslinkers and subsequent immobilization of 
antibodies. AFM was considered an appropriate instrument for assessing morphological 
changes at the surface as it is capable of measuring features with extremely high 
resolution (on the order or a few nanometers) and can do so at atmospheric pressure. This 
is important as the surface will contain antibodies, which would denature at the pressure 
and temperature required for vacuum systems such as SEM. Further, the measurement 
mechanism is roughly passive, when operated in tapping mode, as opposed to the 
significantly invasive (and potentially destructive) mechanisms that employ X-ray or 
electron beam modalities. Figure 4.6 shows typical stepwise AFM scans for each surface 
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after treatment with the crosslinkers and antibody solution, with surface roughness 
measurements summarized in Table 4.2. 
A Digital Instruments (DI) 3000 AFM was used in tapping mode to measure the 
following: bare ZnO samples; samples after treatment with MTS+GMBS and GPS, 
respectively; and finally, samples after treatment with the crosslinkers + antibody 
solution. AFM probe tips were obtained from Veeco Instruments (FESP). Multiple scans 
 
 
Figure 4.6. AFM topographical scans of a) the untreated ZnO surface and samples treated with b) GPS, c) 
GPS + Ab, d) MTS + GMBS, and e) MTS + GMBS + Ab. Scans are 1 µm x 1 µm with a vertical scale 
maximum of 65.0 nm. 
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Table 4.2. AFM surface analysis for each stage of both surface treatments [bounds are standard deviation]. 
Surface Treatment Roughness (nm) 
Avg. Particle Height 
(nm) 
Avg. Particle 
Diameter (nm) 
Untreated ZnO 2.8 ± 0.4 3.0 ± 0.5 24.7 ± 7.8 
GPS 1.2 ± 0.3 2.3 ± 0.6 20.5 ± 11.3 
GPS + Ab 2.0 ± 0.1 3.3 ± 0.8 24.1 ± 10.4 
MTS 2.4 ± 0.1 3.4 ± 0.4 22.9 ± 5.8 
MTS + GMBS 3.7 ± 0.8 6.8 ± 0.7 26.9 ± 8.4 
MTS + GMBS + Ab 7.0 ± 1.5 13.7 ± 0.3 33.2 ± 6.9 
 
 
of each sample were taken to across each 1 cm × 1 cm sample and scans were taken on 
multiple samples. The scans were evaluated for surface roughness and overall average 
particle height and diameter using the DI Nanoscope software.  
Note Figure 4.6.a demonstrates the characteristic cobblestone appearance of the 
surface of the untreated control ZnO sample, with round grains that have fairly well 
defined boundaries. For the bare ZnO case, the mean surface roughness is approximately 
2.8 (± 0.4) nm while the particle height is 3.05 (± 0.5) nm. The characteristic AFM scan 
of the surface after silanization with GPS in Figure 4.6.b shows a surface that is 
morphologically different from that of the controlled case. The average surface roughness 
decreases on average by 42% to 1.2 (± 0.3) nm. This implies an overall smoothening of 
the surface which is similarly suggested by the appearance of the scan. One possible 
explanation is that the GPS molecules have been deposited into the gaps in-between the 
grains to fill some of the grain boundaries. The results were observed at many locations 
across any single chip, and from chip to chip. After incubation with the antibody solution, 
the GPS+Ab treated surface has an increased surface roughness on average to 2.0 (± 0.1) 
nm with an average particle height of 3.3 (± 0.8) nm which indicates that the surface is 
being modified, statistically after treatment with the antibody solution.  A typical scan is 
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shown in Figure 4.6.c. These results offer strong evidence that either antibodies were 
successfully immobilized on the surface due to this protocol or that the exposure of the 
GPS coated surface was morphologically altered upon exposure to the antibody solution. 
The AFM scans of the samples treated with MTS+GMBS in Figure 4.6.d show 
significant differences in the surface morphology as compared to the GPS. Rather than a 
decrease in surface roughness, we see an increase in surface roughness to 3.7 (± 0.7) after 
treatment with MTS+GMBS. The average particle height for the MTS+GMBS treated 
samples was increased to 6.8 (± 0.4) nm indicating an increase in particle size due to 
deposition of the MTS+GMBS. Figure 3.2.e clearly shows the subsequent treatment with 
the antibody solution yields particles on the surface that have a significantly larger 
average height 13.7 (± 0.3) nm which is indicative of the immobilization of the antibodies 
to the surface. The data from these scans along with the WCA measurements provide 
confidence that the surface is being chemically modified and that the surfaces are 
morphologically modified after treatment with the antibody solution.  
Confocal Microscopy 
While the AFM scans offered significant evidence suggesting that the surfaces were 
being altered morphologically, they did not offer conclusive evidence that antibodies 
were immobilized on the surface. These scans were also unable to demonstrate uniform 
distribution of immobilized antibodies. I decided that an additional analysis was required 
in order to confirm the presence of antibodies and assess the degree of density and 
uniformity of any antibody immobilization. The antibody conjugation reaction was 
executed using both GPS and MTS+GMBS onto ZnO samples similar to those prepared 
for the AFM scans. The devices were then dried with a stream of N2 gas and fixed to a 
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glass slide in preparation for confocal microscopy analysis. A Zeiss Laser Scanning 
Microscope 510 equipped with a HeNe laser (543 nm excitation) was used to visualize 
the distribution and intensity of the fluorescently labeled antibodies. Each sample was 
viewed at 10× and 40× magnification and images were taken at random locations 
throughout the area of antibody deposition. Control samples were prepared and analyzed 
for comparison between fluorescence due to antibody coverage and fluorescence to due 
background noise. Rather than incubation with the 200 µg/mL antibody in PBS, the 
control samples were treated with the full crosslinking protocol then incubated with 25 
uL of 5 mM azide in PBS to replicate the solution containing the Alexa-Fluor labeled 
antibodies. Therefore, the only difference between the control and target samples is the 
presence of antibodies. To quantify the fluorescence for each surface treatment, the 
detector gain was fixed at a constant value and images were taken for all of the samples. 
The RGB luminance intensity signal was collected for each pixel in 0.03 mm2 areas 
across the samples. The average fluorescence intensity was calculated by taking the mean 
pixel luminance intensity for each 0.03 mm2 area and averaging the values over at least 
25 measurements.  
While the AFM scans clearly indicate that the surfaces are being modified with the 
surface treatment, fluorescence microscopy was employed to provide more information 
about antibody surface coverage density and uniformity. Prior studies characterizing 
antibody immobilization techniques have generated a variety of methods for analyzing 
the amount of antibodies bound to the surface of a material [117, 118, 134]. As acoustic 
biosensors become increasingly more compact, the antibody immobilization surface 
coverage becomes increasingly more important. It is necessary to compare the surface 
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treatments quantitatively, which is most effectively demonstrated in this study through an 
analysis of the fluorescence images due to fluorophor-labeled IgG molecules. Example 
images of typical responses for each surface treatment are demonstrated in Figure 4.7. 
Figure 4.8 shows a comparison of the average fluorescence intensity (luminescence) 
for the two silane immobilization methods versus the untreated bare ZnO sample. Each 
scan includes the average fluorescent intensities accounted for by the control samples, 
which serve as an estimation of the combined background fluorescence from the ZnO, the 
crosslinker molecules (for the GPS and MTS+GMBS treated chips), and the PBS buffer. 
The average intensity was found to be highest overall for the MTS+GMBS+Ab samples 
as compared to the GPS+Ab and the bare ZnO. The fluorescence evident from the bare  
 
MTS+GMBS+AbMTS+GMBS+Buffer
0.030 mm2
ZnO Control
GPS+AbGPS+Buffer  
Figure 4.7. Typical confocal laser scanning microscope images upon HeNe excitation for different surface 
chemistry protocols. 
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ZnO sample treated with antibodies above the control can be attributed to a small amount 
of antibody adsorption to the surface of the ZnO in the absence of crosslinking 
molecules.  
Statistically, the fluorescence of the samples treated with the MTS+GMBS+Ab were 
on average about 21% higher than the samples treated with GPS+Ab. Since variation of 
the fluorescence within a region of constant size can be attributed to the amount of 
fluorophor present, these results indicate a highly repeatable increased antibody surface 
coverage with the MTS over the GPS. The MTS fluorescence as compared to the 
untreated ZnO case indicates roughly a three-fold increase of average fluorescent 
intensity. The uniformity of the fluorescence is quite high as is illustrated by a relatively 
low standard deviation over 25 separate measurements across the sample. I also found 
ZnO GPS MTS
A
vg
. F
lu
or
es
ce
nc
e 
In
te
ns
ity
0
20
40
60
80
100
120
Control
w/ Ab
 
Figure 4.8. Average fluorescence intensity for each surface treatment after incubation with antibodies 
versus incubation with buffer [Error bars = Std. Error]. [n = 25 for each of the 6 cases shown] 
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the results to be repeatable from sample to sample which also indicates robustness in the 
protocol with each of these surface treatments. 
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CHAPTER 5 
BIOSENSOR IMPLEMENTATION AND TESTING 
 
The foundational components of my novel acoustic wave, label-free, immunosensor 
microarray have now been developed. It is therefore appropriate to apply these sensors 
towards cancer-relevant biomarker detection. The testing was broken up into two 
approaches. First, in assessing the potential sensitivity of the sensors, a dose response 
curve was generated for increasing concentrations of recombinant mesothelin-Fc protein 
in buffer. Positive indications from these experiments allowed me to pursue the 
application of these devices towards targets in more physiologically relevant media. The 
immunosensor microarrays were therefore prepared for detection of PSA in conditioned 
medium from a LNCaP prostate cancer cell line. The eight-device sensor arrays described 
in Chapter 3, designed to operate at ~2 GHz, were used for these experiments. In this 
chapter, I will describe specific needs for cancer detection in general and the relevancy of 
the two markers chosen. I will then describe the outcomes of both experimental goals. 
 
Designing a Sensor for Early Cancer Detection 
 
Advances in the understanding of carcinogenesis and tumor development are moving 
slowly towards developing a complete understanding of the etiology of various 
carcinogenic mechanisms. One extraordinary byproduct of this broad investigation is the 
discovery of new potential molecular targets, or biomarkers, for identifying malignancies 
at the earliest stages of development. It is often remarked that what is required to 
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accelerate this discovery process is a tool for high content screening of complex tissue 
samples [48, 123]. An ideal biomarker would obviously be a target that could be 
measured at detectable levels in peripheral blood, can clearly separate benign conditions 
from malignant disease, and whose levels would provide information for disease 
proliferation, or staging. Since it is very unlikely that such a marker exists for any 
condition, it is further necessary to develop a system that can efficiently screen for 
multiple targets. As discussed in Chapter 2 of this manuscript, a biosensor array is an 
appropriate way to approach high content screening capability and make use of these 
discoveries.  
As indicated in Chapter 2, it is entirely unlikely that quantification of a single marker 
from patient tissue will satisfy the criteria for making diagnostic decisions with high-
confidence. Some of the difficulties with using PSA for such a decision making tool has 
already been discussed, and will be covered further later in this chapter. It is already 
common therapeutic practice, however, to employ tools such as nomograms for making 
decisions regarding the treatment of cancer patients. Nomograms provide risk 
assessments for patients considering various therapeutic options based on a number of 
critical measurements specific to that individual compared with the outcomes of hundreds 
(if not thousands) of past patients that presented with similar conditions. The Body Mass 
Index (BMI) is one of the most commonly known nomograms. For prostate cancer 
patients, two nomograms in particular are widely used for assessing treatment options: 
the Partin Tables (developed at Johns Hopkins Hospital) and the Kattan Tables 
(developed at the Memorial Sloan-Kettering Cancer Center) [124-127]. Both nomograms 
require information such as Gleason score, PSA-related activity, and tumor staging.  
 119
Any tool developed for achieving HCS is likely to be applicable for post-therapeutic 
monitoring as well as clinical diagnosis and early detection. Since clinicians are already 
familiar and comfortable with the use of nomograms, information resulting from HCS 
tests can quickly be incorporated into the nomogram’s algorithm. It is conceivable that 
extensive use of HCS biosensors coupled with significant elucidation of the proteome of 
various cancer proliferations could be entirely sufficient for early detection, tumor 
staging, treatment selection and appropriate continuous monitoring. 
As mentioned in Chapter 2, a broad effort to develop biosensors that provide label-
free detection of clinically relevant biomarkers is underway. Recent approaches in the 
development of biosensor array systems have made use of various optical [136-138], 
electrical [139, 140], and piezoelectric [57, 141, 142] transduction mechanisms, to name 
a few. Some of the efforts regarding the challenges associated with an acoustics-based 
tool for such a sensor array have been discussed in Chapter 2.  
This research presents an acoustic-based solution that meets all of the requirements 
proposed by Erickson, et al [57], which includes significant sensitivity and specificity, 
multiplexing capacity, and reduced complexity and cost of fabrication. Here, I engage in 
a preliminary investigation of the potential of these devices as biosensors towards the 
following clinically relevant cancer biomarkers: human recombinant mesothelin-Fc 
fusion protein and prostate specific antigen (PSA).  
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Selected Cancer Biomarkers 
Mesothelin 
Mesothelin is a 40 kDa cell-bound surface glycoprotein found abundantly on normal 
mesothelial cells of the pleura, pericardium and peritoneum [143]. Mesothelial cells are 
flat in shape and are responsible for regulating the transport of cells and molecules into 
and out of the peritoneal cavity. Translation of the gene encoding mesothelin first yields a 
71 kDa pre-cursor protein, which is subsequently split into a 31 kDa protein called 
megakaryocyte potentiating factor (MPF) and the 40 kDa mesothelin protein. Early 
investigations suggested that mesothelin played a role in cell adhesion[144], though 
subsequent work has called that into question [145]. Over-expression of mesothelin has 
been associated with several cancers including ovarian, lung, pancreatic, mesotheliomas, 
and squamous cell carcinomas [143, 144, 146-149]. The function of mesothelin remains 
largely unknown, but with regards to carcinogenesis, mesothelin is credited as playing a 
tumor differentiation function [150]. It has been shown that mesothelin should remain 
below 9 ng/mL in serum for healthy individuals and above 25 ng/mL for patients with 
advanced stage mesothelioma [151]. 
Prostate Specific Antigen 
PSA is a 31 kDa glycoprotein, initially thought to be exclusively produced by the 
prostate gland [152]. Ironically, prostate specific antigen has since been found not to be 
specific to the prostate and has been discovered in low concentrations in the 
endometrium, normal breast tissue, breast tumors, breast milk, female serum, adrenal 
neoplasms and renal cell carcinomas [153]. PSA is a kallikrein-related serine protease 
responsible for the liquefaction of the seminal coagulum during ejaculation to aid in 
 121
semen motility [152]. The protein proved to be an appropriate forensic semen marker for 
rape cases and other criminal investigations in the late 1970’s [152].  
PSA has been employed as a key biomarker for prostate cancer diagnosis since the 
mid 1980’s and is one of the only U.S. Food and Drug Administration (USFDA) 
approved markers for the diagnosis of cancer [154]. PSA testing coupled with the digital 
rectal exam (DRE) has an extensive history as the standard practice for diagnosis of 
prostate cancer in the U.S. [155]. PSA replaced prostatic acid phosphatase (PAP) as a 
marker for PCa diagnosis because of improved sensitivity [154]. 90% of apparently 
healthy men maintain a serum PSA level below 2.0 ng/mL and the generally accepted 
lower cut-off for a positive diagnosis is 4.0 ng/mL. That being said, malignant cases of 
PCa are certainly found among a small population of men with PSA levels below 2.0 
ng/mL and there are also men with benign conditions with PSA levels above 4.0 ng/mL 
[154]. 
As indicated in Chapter 2, diagnosis of PCa from serum concentration of PSA has 
generated a significant amount of controversy that has persisted for more than a decade 
[58-60]. For men with PSA levels between 2.5 to 4.0 ng/mL, it is difficult to discern PCa 
from benign prostatic hyperplasia (BPH), and often leads to many unnecessary biopsies 
[156]. BPH is a relatively common condition experienced by roughly half of all men over 
50 years of age [157], which similarly results in increased concentrations of serum-level 
PSA. As a result of this range of low specificity, a significant amount of work has been 
done to investigate alternate means of interpreting the results of PSA screening. Several 
practices have developed including measuring PSA velocity [158-160], the ratio of free 
to complexed PSA [152, 153], age-adjusted PSA [161], PSA density [162, 163] and 
 122
several others. The use of PSA velocity has emerged as more commonly used in clinical 
practice and refers to the time it takes to double ones serum concentration of PSA. PSA 
velocity is described as offering reasonably improved sensitivity for patients whose PSA 
levels fall below 4.0 ng/mL [147, 149].  
Suffice it to say that PSA falls short of exhibiting the traits of an ideal cancer marker. 
More recent investigations have revealed alternative serum-level biomarkers that could 
offer greater specificity for PCa detection beyond PSA. These include early prostate 
cancer antigen (EPCA-2) [164], prostate stem-cell antigen (PSCA) [165, 166], α-
methylacl coenzyme-A racemase (AMACR) [167], methylated glutathione S-transferase 
π gene (GSTP-1) [168-170], prostate cancer antigen 3 (PCA3) [171, 172], human 
kallikrein 2 (HK2) [173, 174] and Hepsin [175, 176]. EPCA-2 has emerged as one of the 
more promising candidates [177], discovered by a proteomic screening of 385 serum 
samples at the Brady Urological Institute at Johns Hopkins Hospital by Leman, et al.  
The strength of any given biomarker is commonly assessed through receiver operator 
characteristic (ROC) curves. This measurement plots sensitivity vs (1 – specificity) in 
regards to the strength of the marker in diagnosing the condition in question. Sensitivity, 
in this case, describes the probability that the marker is a positive identifier of the 
pathology in question, or true positive. (1-specificity) refers to the probability that 
presence of the marker is not an identifier of an alternate condition, or a false positive. 
Another common metric used for comparing the strength of different markers is the 
calculation of the area under the curve (AUC) of the ROC curve. The ideal ROC curve 
would appear as a step function, indicating perfect specificity per level of detection 
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regardless of the acceptable false positive rate that comes with that concentration. The 
ideal ROC curve would yield an AUC of 1.0.  
Leman et al generated ROC curves for both EPCA-2 and total PSA in distinguishing 
individuals with either PCa or BPH (Figure 5.1.A) and in distinguishing individuals with 
organ-confined (OC) and non-organ-confined (NOC) disease (Figure 5.1.B). As can be 
seen, for nearly all levels of acceptable false positive rates, EPCA-2 offers greater 
sensitivity for PCa. Figure 2 further demonstrates the ability of this marker in 
distinguishing PCa from various alternative conditions. Overall, using the cut-off  
 
 
Figure 5.1. ROC curves for EPCA-2 and PSA in separating (A) healthy men with BPH from those 
with PCa and (B) distinguishing those with OC from those with NOC disease (80 patients 
with prostate cancer selected according to their OC or NOC disease status) [164]. 
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Figure 5.2. Serum analysis of EPCA-2 in study populations. Total of 330 serum samples screened for 
EPCA-2. Indirect ELISA’s showed that EPCA-2 has a cutoff of 30 ng/mL or greater at estimated 
concentration. Cutoff represented by red line across graph [164]. 
 
concentration of 30 ng/mL, EPCA-2 assays were found to demonstrate 92% specificity 
and 94% sensitivity for individuals with PCa (AUC = 0.89). PSA demonstrated an overall 
specificity among the same population of only 65% (AUC = 0.62) [164]. 
 
Sensor Preparation 
 
As mentioned in the introduction to this chapter, the goal is to assess both the 
sensitivity and specificity of the sensor design. A dose response curve is generated to 
assess the sensitivity of the sensor using varying concentrations of purified recombinant 
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mesothelin-Fc in buffer. To test device specificity, sensor testing was performed to 
identify the presence of PSA in LNCaP, a prostate cancer cell line, conditioned medium. 
Recognition elements for fluoroscein isothiocyanate (FITC) were used as the negative 
control, as no FITC is present in LNCaP conditioned medium (CM). As a secondary 
validation of the PSA results, a commercially available immunoassay kit was also 
employed to quantify the level of PSA in the LNCaP CM. 
Resonator arrays were fabricated as described in Chapter 3. Device operation and 
subsequent sensor testing was accomplished using a HP 8753 C Network Analyzer, 
equipped with a S-parameter test set and a Cascade Microtech 9000 Probe Station with a 
temperature control chuck. Devices were probed using Cascade Microtech ACP40 GSG-
150 probes. 
IgG antibodies were covalently attached to the surface of the ZnO piezoelectric film 
using the functionalization protocol described in Chapter 4 and summarized in Appendix 
D. In short, the protocol employs mercaptopropyl-trimethoxy silane (MTS) as a primary 
crosslinker to the ZnO surface, followed by N-γ-maleimido butyryloxy-succinimide ester 
(GMBS) as a secondary crosslinker to covalently bind IgG molecules at the Fc fragment 
to the device surface. The protocol is described by Figure 8. MB Anti-mesothelin mAb 
were obtained from Dr. Ira Pastan at the NCI and are described in [178]. All other mAb 
were obtained from Santa Cruz Biotechnology, Inc [anti-FITC (sc-69871) and anti-tPSA 
(sc-52170)]. Anti-tPSA, or total PSA, refers to an antibody specific to both complexed 
and free PSA. 
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Sensitivity Assessment 
 
Sensitivity testing was executed by preparing sensors to target mesothelin and 
applying them to varying concentrations of recombinant mesothelin-Fc protein in PBS. 
Purified recombinant mesothelin-Fc protein in buffer was obtained from Dr. Ira Pastan at 
the NCI.  Serial dilutions were prepared using PBS (pH 7.38) to create concentrations of 
1 ng/mL, 10 ng/mL, 100 ng/mL, 10 µg/mL, and 50 µg/mL. The functionalization 
protocol was performed with anti-mesothelin “MB” polyclonal IgG antibodies also 
supplied by Dr. Pastan on five separate 8-device arrays. 30 µL of each concentration of 
the purified protein solution was then deposited on the surface of each sensor array and 
allowed to incubate at room temperature for 20 minutes. After the incubation period, 
devices were rinsed with PBS buffer then DI water then dried with a N2 stream prior to 
measurement. S11 scattering responses for each device of each array were collected both 
prior to exposure to mesothelin solutions and again after the 20 minute incubation time. 
Individual devices are measured both before and after exposure to the liquid sample 
under test. Scattering responses are converted to impedance values using equation (3.15). 
The peak of the magnitude of the impedance response represents the condition of parallel 
resonance, as described in Chapter 3, which is an easily monitored condition. An example 
of the frequency shift observed after exposure to the sample is depicted in Figure 5.3. 
Figure 5.4 shows the device detection with increasing frequency shifts in response to 
increasing sample concentrations, returning a 195 kHz shift for the 50 mg/mL 
concentration and 29 kHz shift for the 1 ng/mL concentration. It is important to put the 
magnitude of these shifts in context. Prior investigations using QCMs (see Figure 5.5) as  
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Figure 5.3. Typical impedance response of single sensor device showing response before (∆) and after () 
exposure to the liquid sample under test. The peak of each curve represents the condition of parallel 
resonance. 
 
the sensor for detection of a known target (sonic hedgehog, SHH) in the same LNCaP 
CM yielded only an 80 Hz frequency shift due to ~3 ng/mL concentration [179].  
The actual concentration of SHH was determined by ELISA to be 0.2 ng for 70 µL of 
sample, or ~3 ng/mL [179]. At the lower concentrations, I observed frequency shifts 
almost 400 times greater in magnitude. This demonstrates an exceptional capability 
regarding potential limit of detection but cannot be directly compared due to the 
difference in targets and antibody affinities etc. Further device optimization will no doubt 
improve the sensitivity. Currently, however, the devices were clearly capable of broadly 
distinguishing increasing concentrations. Obviously the device response slows below 100 
ng/mL, which indicates that more work must be done to reconcile overall mass 
resolution. 
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Figure 5.4. Dose response curve due to varying concentrations of purified recombinant mesothelin-Fc in 
PBS buffer (pH = 7.38). n = 8 for each case above. [Error bars represent standard error (σ/√n)] 
 
 
Figure 5.5. QCM sensor detection yields 80 Hz shift due to 3 ng/mL concentration of mesothelin in 
sample.  While non-specific binding could compound the results, a control FITC antibody was used to 
subtract background binding [179]. 
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A control experiment was performed using buffer solution of 10 µg/mL of 
recombinant mesothelin-Fc with a sensor array coated with anti-mesothelin and a separate 
sensor array coated with anti-FITC. The results are summarized in Figure 5.6. While the 
anti-mesothelin coated devices clearly indicate positive detection of the target protein 
over the anti-FITC coated devices, using analysis of variance I found that there was 
statistically little difference between the frequency shift associated with exposure of the 
anti-mesothelin devices to the 1.0 ng/mL solution and the anti-FITC control sensor (p = 
0.409). As a result, no further testing was performed below 1 ng/mL because I 
determined this to be below the limit of detection for statistically significant 
differentiation from the reference. 
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Figure 5.6. Control experiment depicting average frequency shift observed by a reference sensor (coated 
with anti-FITC, n = 4) and a target sensor (coated with anti-mesothelin, n = 6) after exposure to a purified 
solution of 10 µg/mL of recombinant mesothelin-Fc in PBS buffer. [Error bars represent standard error 
(σ/√n)] 
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It must be noted that sensor sensitivity is often defined as the slope of the sensor 
response curve to varying loads [180]. A traditional approach to determining this with 
gravimetric sensors is to deposit a known amount of mass on the sensor surface and 
measure the frequency shift. This is not plausible with biological samples, however, so a 
more useful method is to describe the overall sensitivity trends displayed under the given 
test conditions. As can be seen from Figure 1, the active region makes up only a very 
small portion of the total area of the array, all of which is exposed to the LSUT. Note that 
the vast majority of the device footprint is inactive, which includes the electrodes 
themselves. Deposition of the 30 µL sample more than covers the entire array. Future 
investigations should involve the development of an appropriate micro-fluidic flow cell 
which can limit the exposure to only the active resonance area of the sensor array to the 
LSUT, thereby making a sensitivity determination more reasonable. For this reason, I 
made an attempt to describe the overall sensitivity trends displayed under the given test 
conditions. 
 
Specificity Assessment 
 
LNCaP CM was obtained from Dr. Milton Datta at the Winship Cancer Institute at 
Emory University. LNCaP CM was obtained from exponentially growing LNCaP cells in 
RPMI-1640 medium, which was supplemented with 10% fetal calf serum, 4500 mg/L 
glucose, 1mM sodium pyruvate, 10 mM HEPES, 2 mM glutamine, and 15 mg/L sodium 
bicarbonate. The CM is therefore considered a sufficiently “noisy” environment for 
preliminary testing of device selectivity because it contains many proteins and other 
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molecules from the cells. The functionalization protocol was performed with anti-FITC 
and anti-tPSA each on a separate 8-device array. Anti-FITC is employed as a negative 
control, targeting a molecule not to be found in CM. As a secondary control (marked 
‘Control’ during the experiment), the functionalization protocol was performed on a set 
of devices but the final step of incubation with some antibody solution was replaced with 
incubation with plain PBS. 30 µL of LNCaP CM was then deposited on the surface of 
each functionalized sensor array and allowed to incubate at room temperature for 20 
minutes. After the incubation period, devices were rinsed with aliquots of PBS buffer 
then a light stream of DI H2O then dried with a N2 stream for measurement. S11 scattering 
responses of each device of each array were collected both prior to exposure to LNCaP 
CM and again after the 20 minute incubation period. 
The results of testing multiple sensor arrays for our two targets are summarized in 
Figure 5.7. It is clear that the devices could distinguish the presence of PSA, though not 
as clearly as would be desired (p = 0.139). It is expected that due to the extensive 
molecular diversity of the LSUT, a significant degree of non-specific binding is likely 
occurring. This is demonstrated by the 70 kHz (on average) shift from the Control 
sensors, having the crosslinking molecules but no antibodies attached to the surface, as 
compared with the 49 kHz shift (on average) from the FITC-targeted negative control 
sensors exposed to CM. 
A commercially-obtained enzyme-linked immunoassay (EIA) kit for PSA (Biocheck, 
Inc: BS-1019) was used to independently determine the concentration of PSA in the 
LNCaP CM. The protocol was followed as described by the manufacturer using n=3 for 
control standards and blank wells and n=6 for the LNCaP CM wells. LNCaP CM was 
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Figure 5.7. Comparison of the average frequency shift observed by sensors coated without antibodies 
(Control) [n=48], with anti-FITC (negative control) [n=44], and anti-tPSA [n=45] after 20 minute 
incubation with LNCaP CM. 
 
diluted to 1:7 and 1:15 in PBS buffer. The results of the EIA are demonstrated in Figure 
5.8 below. A commercially available EIA kit for PSA (total) was used to determine the 
actual concentration of PSA in the LNCaP conditioned medium. The results indicated the 
concentration of PSA to be roughly 950 ng/mL.  
Given this very high concentration of our target, it is obvious that the sensor behaves 
differently given the “noise” of this testing environment. As stated at the beginning of 
this chapter, it was my goal to obtain preliminary results regarding the application of this 
sensor in a physiologically relevant medium. While the sensors are capable of 
distinguishing activity due to the appropriate target from control cases, they provide very 
little information regarding relative concentration. The testing protocol as it exists allows 
for many variables that must be controlled for, much of which can be solved with the 
development of an appropriate flow cell. Some of the variables I am referring to include 
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Figure 5.8. ELISA results for total PSA found in LNCaP conditioned medium using Biocheck, Inc BS-
1019. (n = 3 for all standards, n = 6 for test samples) 
   
varying distributed stress due to the application of the testing probes, drying of the 
surface environment, and uncontrolled exposure volumes are the most obvious. 
 
Preliminary Packaging 
 
I have taken steps towards developing a packaging system we are calling the 
AcµRayTM (Acoustic Micro-Array, pronounced – ak′ ū rā) that introduces controls for the 
variables I have listed above. The AcuRayTM system involves the development of two 
printed circuit boards (PCB), fabricated by Express PCB, which includes fixed electrical 
connections to each device, a fixed volume flow cell, and connectivity to an appropriate 
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network analyzer for monitoring. The package is shown in Figure 5.9 and is made up of a 
disposable array sensor board and a RF switch board. In order to achieve the fixed 
electrical connections, the electrode array needed to be redesigned in order to make 
connections with the disposable array sensor PCB board. Connections for each device 
were established by fusing electrodes from the fabricated sensor chip to the electrodes of 
the test board using conductive epoxy. A jig was developed (see Figure 5.10) to properly 
align the chip with the disposable PCB board and press the two pieces together while the 
conductive epoxy was allowed to set. Note that the test board also housed the liquid 
sample space that would expose the sensor surface to the liquid sample (Figure 5.9). It 
was envisioned that a flow cell could be attached to the sensor board here. Once set, the  
 
 
Figure 5.9. AcµRayTM System consisting of disposable array sensor card and RF switch card with 
appropriate connections. 
 
 135
 
Figure 5.10. AcµRayTM sensor system, including alignment jig for loading sensor chips onto disposable 
sensor array board. 
 
sensor board was connected via a PC card connector to the RF switch board. The RF 
switch board includes a SP8T RF rapid switching integrated circuit (IC) from Hittite 
Microwave Corporation (HMC253QS24). The switching IC was set up to be controlled 
by a computer via a National Instruments test controller (NI USB-6008). Once the 
network analyzer was connected the to the output of the sensor array via the SMA 
connector shown in Figure 5.9, the responses of each device could be obtained 
periodically as controlled by the RF switch. 
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CHAPTER 6 
CONCLUSION 
 
Over the course of this research, I have developed the fundamental components of a 
biosensor designed to meet the following specific aims: 
1. A bulk acoustic resonator device appropriate for application as a highly sensitive 
biosensor. 
2. An appropriate biosensor preparation procedure by immobilization of appropriate 
capture agents. 
3. Demonstration of the functionality of these biosensors towards known cancer 
biomarkers. 
The sensor was comprised of two fundamental components outlined in aims 1 and 2. The 
first is a transducer element capable of monitoring its environment for extremely small 
perturbations. The second is the functionalization of the transducer as a biosensor by 
preparing its surface for high specificity for a particular target. 
To implement the transducer, a solidly mounted resonator consisting of alternating 
layers of W and SiO2 were grown on a p-doped <1 0 0> Si substrates with ZnO as the 
active piezoelectric layer at the surface. More than a thousand successful devices have 
been fabricated and tested after an investigation that included the fabrications of several 
tens of thousands of test devices. The acoustic mirror was designed to have a reflection 
coefficient closest to unity near the frequency of operation. The acoustic mirror 
frequency response was simulated to provide assurance of the frequency range coverage 
given a fixed number of alternating pairs of W and SiO2. Finite element modeling was 
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also performed to predict the electric field of an electrode configuration consisting of two 
long electrodes positioned on the top of the ZnO with a gap between them. Simulations 
showed that the electric field within the gap between the electrodes was primarily 
laterally oriented while the electric field directly beneath the electrodes was shown to be 
reduced in magnitude with an orientation normal to the surface of the ZnO.  
To verify the thickness shear mode operation of the devices, I investigated the 
experimentally extracted acoustic velocity and the effects of water loading on the 
resonance. Without these tests it is difficult to adequately determine that a resonance is 
necessarily TSM. I have presented evidence of a TSM wave through exposure of the 
device to deionized water, comparison of extracted acoustic velocity with theoretical 
acoustic velocity, and varying the piezoelectric film thickness to yield respective changes 
in the frequency response.  
I have further provided an investigation of two antibody immobilization techniques 
on planar ZnO surfaces. Several hundred surfaces were analyzed using water contact 
angle measurements, atomic force microscopy, and fluorescence microscopy to 
determine the surface characteristics and antibody surface coverage. I found that 
protocols employing both GPS and MTS are effective in immobilizing antibodies to the 
ZnO surface, but that MTS offers greater surface coverage, on average. The protocols 
yielded uniform and repeatable surface coverage using both methods which are necessary 
requirements for biosensor functionalization. Functionalization of crystalline ZnO 
surfaces is becoming an increasingly important topic as new biosensor platforms are 
being developed with this material. It was concluded that the MTS protocol offered 
superior results for functionalizing ZnO-based sensors due to the fact that it is a 
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commercially available chemical and provides high antibody surface coverage with good 
uniformity.   
I have further demonstrated here results for a novel acoustic biosensor system that 
exhibits all the qualities required for advances in proteomics research. Specifically, this 
system offers the potential for extraordinary sensitivity due to its operation in the several 
GHz range. Given frequency shifts in the tens of kHz for a few ng/mL levels of detection, 
improvement in general noise levels offers the potential to achieve several orders of 
magnitude improvement on the limit of detection. Further, the system is a simple array 
design that can be mass produced with existing industrial microelectronic fabrication 
equipment to reduce manufacturing costs and allow for real-time multiplexed sensor 
reporting. This last point has obvious molecular micro-array implications which provide 
the capability of implementing testing redundancy (reducing false positives and false 
negatives) as well as rapid multi-target monitoring. 
Any sensor platform of high sensitivity must additionally consider that false positives 
and false negatives significantly hamper the ability to employ such devices for research 
much less for patient diagnosis. A sensor array technology allows for monitoring of 
multiple sensors simultaneously which offers both replications of each measurement as 
well as the capability to identify a multi-protein signature. This is the strongest approach 
for minimizing false positives and false negatives. The development of such a system 
could have an impact at multiple levels including proteomic research, post-therapeutic 
and eventually early detection screening.  
As mentioned at the beginning of this dissertation, the findings of this research have 
led to the following: 
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• 4 peer-reviewed professional publications  
o 2 first-authored 
• 3 conference presentations  
• 6 conference posters 
Beyond publication of this research in the aforementioned professional journals and 
conferences, aspects of this research have also been independently selected for circulation 
by mass media. The American Association for Cancer Research (AACR) independently 
selected my abstract for a press release to promote the September 2007 Conference on 
Molecular Diagnostics and Cancer Therapeutic Development, presented in Appendix F. 
This was picked up by various news organizations, including CNN’s Sanjay Gupta, US 
News & World Report, Forbes, WebMD, Medicine.net, CBC News, various NBC and 
CBS news affiliates, HealthCentral.com, ScienceDaily, PhysOrg.com, Dentalplans.com 
and Health Scout. Links for these are also copied in Appendix F. The work was also 
highlighted in the April 17, 2008, broadcast of CNN’s Next Big Thing, with Miles 
O’Brien. 
Beyond the outputs of this research, I have also acquired a great deal of practical 
knowledge peripheral to the field of study. This thesis work would not have been possible 
without gaining proficiency with the following equipment: 
• Scanning electron microscopy (Leo 1530, Leo 1550, Zeiss Ultra60, Hitachi S800) 
• Atomic force microscopy (DI 3000) 
• X-Ray Diffraction 
• Laser Scanning Microscopy (Zeiss LSM 510) 
• Wafer probing (Cascade Microtech 9000) 
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• Microfabrication 
o Photomask design (ADS) 
o Plasma vapor deposition (Unifilm PVD 300) 
o Electron beam evaporation (CVC) 
o Photolithography 
o Ion beam milling 
o Step Profilometer (Tencor Alpha-Step) 
o Wafer dicing 
• Immunoassay protocols (ELISA) 
and the following software programs: 
• Applied Wave Research – Microwave Office (SPICE-based circuit modeling 
program) 
• Advanced Design System (CAD program) 
• Cascade Microtech WinCal Software 
• MATLAB 
Not only was proficiency required for the use of much of the microfabrication equipment, 
but the Microelectronic Acoustics Group owns and maintains its own fabrication 
equipment. It would not be an exaggeration to say that at least 15% of all the time spent 
in the laboratory for this doctoral program was spent on maintaining, modifying and often 
repairing this equipment. The Unifilm PVD-300, in particular, is a relatively complicated 
piece of equipment, comprised of more than 15 constantly degrading units including the 
vacuum chamber itself. I was exclusively in charge of maintaining this instrument for the 
entirety of my dissertation program, which underwent constant maintenance and had a 
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massive breakdown at least once a year, on average. In addition to the Unifilm, I was 
similarly in charge of monitoring and repairing the CVC E-beam evaporator system, the 
Karl Suss MJB3 Mask Aligner system, and various other pieces of equipment. This is in 
addition to the ordinary complexities and intricacies associated with using core facilities 
such as the AFM and the Confocal LSM. 
Over the course of this thesis work, I have developed several novel contributions to 
the field of biosensor microarrays. As summarized in the introduction of this manuscript, 
they include the following: 
 
1. The development of a novel thickness shear mode bulk acoustic resonator 
utilizing ZnO; 
2. The novel application of an appropriate surface chemistry protocol for 
functionalization of planar ZnO with monoclonal antibodies; 
3. Implementation of these sensors toward detection of clinically relevant cancer 
biomarkers. 
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APPENDIX A: MATLAB CODE – MIRROR SIMULATION 
% mirror.m 
% written by Anthony Dickherber, January 2004 
  
%Set frequency range 
f = 0:12e4:6e9; 
w = 2*pi*f; 
  
NumLayers = 6; 
d = zeros(1:6); 
  
%as given by page 56...unknown calculation/derivation/source 
%Z0 is the substrate material (Si), Z(odd) is the high acoustic 
impedance 
 
%material and Z(even) is the low acoustic impedance material 
%NOTE: Impedances are normalized by the active area of the device 
Z0 = .5;   %Si Substrate Z=0.5 
%ZH = .7837;   %AlN is 1.0672 
%ZL = .4549;   %SiO2 is 0.4183 
  
CenterFreqofInterest = 2e9; 
  
%material parameters for high and low acoustic impedance materials 
rhoo = 2332;    %bulk Si density, from Auld 
rhoL = 2200;     %density SiO2 = 2200 (fused silica from Auld) 
  
%rhoH = 8200;    %Ta2O5, from Shawn's thesis 
%rhoH = 7450;    %for LiTaO3 
%rhoH = 4700;    %for LiNbO3 
%rhoH = 3986;    %for Al2O3 
rhoH = 19200;   %for W (from Auld) 
  
C44o = 7.956e10; %c44 for Si (from Auld) 
C44L = 3.12e10; %c44 for SiO2 (fused silica from Auld) 
  
%C44H = 5.69e10;  %c44 for Ta2O5 
%C44H = 9.4e10;    %c44 for LiTaO3 
%C44H = 6.0e10;   %c44 for LiNbO3 
%C44H = 14.5e10;  %c44 for Al2O3 
C44H = 13.4e10;   %c44 for W  (crystalline from Auld) 
  
%Calculate the normalization factor for impedance values 
Ro = sqrt(rhoo*C44o); 
NormFact = Ro/Z0; 
  
%normalize impedance values of low and high impedance materials 
ZH = sqrt(rhoH*C44H)/NormFact; 
ZL = sqrt(rhoL*C44L)/NormFact; 
  
%using the values for stiffness coeff. and density on page 62 
VH = sqrt(C44H/rhoH);      %[m/s] 
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VL = sqrt(C44L/rhoL);     %[m/s] 
  
%define thicknesses found on page 98 of thesis (lambda/4) 
dH = 1/4*(VH/CenterFreqofInterest) %[m] 
dL = 1/4*(VL/CenterFreqofInterest) %[m] 
 
%calculate wave number for both regions 
kH = w/VH; 
kL = w/VL; 
  
%Set up the Impedance matrix 
Zeq = zeros(NumLayers-1,length(f)); 
  
%calculate equivalent impedance of stack shown on page 56 figure 3.8 
%using equation 3.11 found on page 55 of Shawn's thesis 
  
%Calculate impedance for first layer due to Z0 
if mod(NumLayers,2)>0 
    Zeq(1,:) = ZL*((Z0 + i*ZL.*tan(kL*d(1)))./(ZL + 
i*Z0.*tan(kL*d(1)))); 
    disp('1 Low') 
else 
    Zeq(1,:) = ZH*((Z0 + i*ZH*tan(kH*d(1)))./(ZH + i*Z0*tan(kH*d(1)))); 
    disp('1 High') 
end 
  
%Calculate impedance for the rest of the layers 
for n = 2:(NumLayers-1) 
    if mod(n,2) > 0 
        Zeq(n,:) = ZH*((Zeq(n-1,:) + i*ZH*tan(kH.*dH))./(ZH + i.*Zeq(n-
1,:).*tan(kH.*dH))); 
        disp('High') 
    else 
        Zeq(n,:) = ZL*((Zeq(n-1,:)+i*ZL*tan(kL*dL))./(ZL+i.*Zeq(n-
1,:).*tan(kL*dL))); 
        disp('Low') 
    end 
end 
  
%Zeq(2,:) = 
ZL*((Zeq(1,:)+i*ZL*tan(kL*dL))./(ZL+i.*Zeq(1,:).*tan(kL*dL))); 
%Zeq(3,:) = 
ZH*((Zeq(2,:)+i*ZH*tan(kH*dH))./(ZH+i.*Zeq(2,:).*tan(kH*dH))); 
  
Zin = ZL*((Zeq(NumLayers-1,:) + i*ZL.*tan(kL*d(6)))./(ZL + 
i*Zeq(NumLayers-1,:).*tan(kL*d(6)))); 
  
S11 = (Zin-1)./(Zin+1); 
  
plot(f,abs(S11)) 
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APPENDIX B: ELECTRODE CONFIGURATIONS IMPLEMENTED 
 
Four mask designs were required to reach the electrode design implemented as a 
biosensor. These are referred to as LFE0, LFE1, LFE2 and LFE3. A final LFE4 mask has 
been implemented for use with the AcµRay SystemTM, though testing is still on-going 
regarding this configuration. Provided in this appendix is a full record of all electrode 
geometries tried. 
 
LFE0 
 
Figure 1. LFE 0 Die, measuring 4mm x 5mm and containing 13 electrode configurations for LFE. Mask 
designed to fit 204 dice per 3" wafer. 
 
 
 
 
 
Device 1 Device 2 Device 3 
Device 4 
Device 5 
Device 6 
Device 7 Device 8Device 9Device 10
Device 11 
Device 12 
Device 13 
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Device 1 
 
 
Outer Diameter: 325 µm 
Inner Diameter: 240 µm 
Center Diameter: 205 µm 
Outer Gap: 84 µm 
Lead width: 6 µm 
 
 
 
 
 
 
 
 
Device 2 
 
Outer Diameter: 82 µm 
Inner Diameter: 60 µm 
Center Diameter: 50 µm 
Outer Gap: 25 µm 
 
 
 
 
 
Device 3 
 
 
Outer Diameter: 325 µm 
Inner Diameter: 240 µm 
Square Width: 144 µm 
Outer Gap: 85 µm 
Lead Width: 6 µm 
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Device 4 
 
Outer Diameter: 112.5 µm 
Inner Diameter: 58.75 µm 
Center Diameter: 51 µm 
Outer Gap: 28.75 µm 
Lead Width: 6 µm 
 
 
 
 
Device 5 
 
Outer Diameter: 112.5 µm 
Inner Diameter: 78.75 µm 
Center Diameter: 52.5 µm 
Outer Gap: 28.75 µm 
Lead Width: 6 µm 
 
 
 
 
Device 6 
 
Outer Diameter: 112.5 µm 
Inner Diameter: 80 µm 
Center Diameter: 62 µm 
Outer Gap: 28.75 µm 
Lead Width: 6 µm 
 
 
 
 
Device 7 
 
4 Outer Diameter: 206 µm 
4 Inner Diameter: 180 µm 
3 Outer Diameter: 163 µm 
3 Inner Diameter: 120 µm 
2 Outer Diameter: 112 µm 
2 Inner Diameter: 58.75 µm 
1 Diameter: 52.5 µm 
Lead Gap: 7.5 µm 
End Gap: 6 µm 
Lead Width: 6 µm 
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Device 8 
6 Outer Diameter: 205 µm 
6 Inner Diameter: 180 µm 
5 Outer Diameter: 170 µm 
5 Inner Diameter: 150 µm 
4 Outer Diameter: 140 µm 
4 Inner Diameter: 120 µm 
3 Outer Diameter: 110 µm 
3 Inner Diameter: 90 µm 
2 Outer Diameter: 80 µm 
2 Inner Diameter: 60 µm 
1 Diameter: 50 µm 
Lead Gap: 10 µm 
End Gap: 10 µm 
        Lead Width: 6 µm 
 
Device 9 
 
4 Outer Diameter: 142 µm 
4 Inner Diameter: 120 µm 
3 Outer Diameter: 110 µm 
3 Inner Diameter: 90 µm 
2 Outer Diameter: 80 µm 
2 Inner Diameter: 60 µm 
1 Diameter: 50 µm 
Lead Gap: 10 µm 
End Gap: 8 µm 
Lead Width: 6 µm 
 
 
Device 10 
 
4 Outer Diameter: 230 µm 
4 Inner Diameter: 180 µm 
3 Outer Diameter: 172 µm 
3 Inner Diameter: 120 µm 
2 Outer Diameter: 112 µm 
2 Inner Diameter: 60 µm 
1 Diameter: 52 µm 
Lead Gap: 6 µm 
End Gap: 6 µm 
Lead Width: 12 µm 
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Device 11 
 
Outer Diameter: 82 µm 
Inner Diameter: 60 µm 
Center Diameter: 50 µm 
Outer Gap: 28 µm 
Lead Width: 10 µm 
 
 
 
 
 
Device 12 
 
Outer Diameter: 82 µm 
Inner Diameter: 60 µm 
Center Diameter: 50 µm 
Outer Gap: 20 µm 
Lead Width: 10 µm 
 
 
 
 
 
Device 13 
 
 
Outer Diameter: 104 µm 
Inner Diameter: 60 µm 
Center Diameter: 50 µm 
Outer Gap: 28 µm 
Lead Width: 10 µm 
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LFE1 
 
Figure 2. LFE I Die which includes 42 different electrode configurations that could be superimposed to 
form a 2-layer electrode configuration for more efficient LFE. Die measures 10 mm x 10 mm, arranged to 
fit 36 dice per photo-mask. 
 
 
Style 1 
 
 
 
Electrode width = 10, 15, 25 µm 
Electrode gap = 2, 3, 4, 5 µm 
Electrode length = 55, 110, 250 µm 
 
 
 
 
 
 
 
 
 
Style 1 
Style 2 Style 3 
Style 4 
Style 5 
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Style 2 
 
 
 
 
Outer electrode width (Signal) = 20, 30, 50 µm 
Outer electrode diameter = 150 µm 
Electrode Gap = 2, 3, 4, 5 µm 
 
 
 
 
 
 
 
 
Style 3 
 
 
 
Electrode Width = 15 µm 
Electrode Gap = 2, 3, 5 µm 
Electrode Length = 128 µm 
 
 
 
 
 
 
 
 
 
Style 4 
     
 
 
 
Electrode width = 15 µm 
Electrode gap = 2, 3, 5 µm 
Electrode length = 250 µm 
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Style 5 
    
 
 
Electrode width = 10, 15, 20, 25 µm 
Electrode gap = 2, 3, 4, 5 µm 
Electrode length = 50, 150 µm 
# of finger pairs = 3, 5 
 
 
 
 
 
 
LFE2 
 
 
Figure 3. LFE II Die which includes 45 individual electrode configurations and 5 arrayed electrode 
configurations accounting for an additional 64 devices. Die measures 10 mm x 10 mm, arranged to fit 36 
dice per photo-mask. 
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2-Finger 
 
 
 
 
Electrode width = 15 µm 
Electrode gap = 2, 3, 4, 5, 6 µm 
Electrode length = 150 µm 
 
 
 
 
 
 
 
 
3-Finger 
 
 
 
 
Electrode width = 15 µm 
Electrode gap = 2, 3, 4, 5, 6 µm 
Electrode length = 150 µm 
 
 
 
 
 
 
 
 
IDT Electrode 
 
 
 
 
Both 3- and 4-pair IDTs 
Electrode width = 15 µm 
Electrode gap = 2, 3, 4, 5, 6 µm 
Electrode length = 150 µm 
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Thin 2-Finger 
 
 
 
 
Electrode width = 2, 3, 4, 5 µm 
Electrode gap = 3, 10, 15, 20, 25, 35 µm 
Electrode length = 150 µm 
 
 
 
 
 
 
 
 
Slab Electrode 
 
 
 
 
Electrode width = 25 µm 
Electrode gap = 3, 5, 10, 21, 61, 94, 131, 171 µm 
Electrode length = 275 µm 
 
 
 
 
 
 
 
 
8-Device Array 
 
Both 2- and 3-Finger Design 
Electrode width = 15 µm 
Electrode gap = 3 µm 
Electrode length = 150 µm 
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LFE3 
 
 
Figure 4. LFE III Die comprising 26 individual devices and 11 8-device arrays. Die measures 10 mm x 10 
mm and is arranged to fit 36 die per 3-inch wafer on photo-mask. 
 
 
Style 1 
 
 
 
Electrode Width = 10, 20 µm 
Electrode Gap = 10, 20, 40 µm 
 
 
 
 
 
 
 
Style 2 
 
 
 
Electrode Width = 20, 35 µm 
Electrode Gap = 10, 20, 40, 50 µm 
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Style 3 
 
 
 
Electrode Width = 20 µm 
Electrode Gap = 10 µm 
 
 
 
 
 
 
 
 
Array Style 1 
 
 
 
 
Electrode Width = 35 µm 
Electrode Gap = 20 µm 
Large squares are surfaces for  
subsequent wire-bonding 
 
 
 
 
 
 
 
 
Array Style 2 
 
 
 
Electrode Width = 35 µm 
Electrode Gap = 20, 50 µm 
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Array Style 3 
 
 
 
Electrode Width = 20 µm 
Electrode Gap = 10, 40 µm 
 
 
 
 
 
 
 
 
LFE4 
 
4-Device Array 
 
 
 
 
 
3-Finger Design 
Electrode width = 35 µm 
Electrode gap = 20 µm 
Overall area = 10 mm x 10 mm 
 
 
 
 
 
8-Device Array 
 
 
 
 
3-Finger Design 
Electrode width = 35 µm 
Electrode gap = 20 µm  
Overall area = 10 mm x 10 mm 
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APPENDIX C: PHOTOLITHOGRAPHY PROCEDURE 
 
The following materials were used for the photolithography process outlined below: 
1. Laurell Technologies Corporation  Model WS-200-4NPP Spin Coater 
2. Karl Suss MJB3 Mask Aligner 
3. Thermolyne Type 1900 Hot Plate 
 
Photolithography Procedure: 
1. Rinse the wafer with the following: TCE (Trichloroethylene), Acetone, Methanol, 
Isopropanol, DI H2O. 
2. Blow both sides dry with N2 gas stream to remove moisture 
3. Warm wafer on a heater plate for ~ 1 minute over 100ºC to remove all moisture 
4. Load wafer on vacuum chuck of spin coater. Dispense enough 98% HMDS by 
pipette to cover entire wafer. Spin the wafer with 98% HMDS at 4000 rpm for 30 
seconds at maximum acceleration. 
5. Soft bake the wafer immediately on hot plate at ~ 180 C for 30 seconds. 
6. Cool wafer on cooling block for 1 minute. 
7. Load wafer back on vacuum chuck of spin coater. Dispense enough Shipley’s 
1805 (S1805) photoresist by pipette to cover entire wafer. Spin the wafer with 
S1805 at 4000 rpm for 30 seconds at maximum acceleration. This should yield a 
layer of photoresist ~0.5 µm thick uniformly across the wafer, which is adequate 
for feature sizes greater than 0.8 µm. 
8. Soft bake the wafer immediately on hot plate at ~ 180ºC for 60 seconds. 
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9. Cool wafer on cooling block for 1 minute. This is a critical step. 
10. Mount wafer on vacuum chuck of Karl Suss MJB3 mask aligner. Verify wafer is 
flat on chuck. Load relevant photomask into mask holder of mask aligner and 
align wafer beneath the mask appropriately. (Physical contact of the wafer with 
the photomask was essential for adequate yield with the system used) 
11. Expose wafer to ~60 mJ of 365 nm UV light. (The system used for these 
experiments was calibrated to 4 mW, which required 15 seconds exposure time) 
12. Remove wafer from the mask aligner and submerge in Chlorobenzene bath for 90 
seconds. 
13. Completely dry wafer using N2 gas stream to remove all chlorobenzene. DO NOT 
expose surface to DI H2O or any other liquids before next step. 
14. Prepare developer solution (5 parts DI H2O to 1 part Microposit 351 concentrated 
developer). Submerge wafer in developer solution and manually agitate for 35 – 
45 seconds, or until photoresist die begins to “burst out.” A practiced eye should 
be able to discern the point at which the appropriate features of the mask design 
have been fully resolved (i.e. all undesireable photoresist has been removed) but 
not over-developed. 
15. Immediately rinse the wafer in a stream of DI H2O. 
16. Completely dry wafer using N2 gas stream to remove water. 
17. Hard bake wafer for an additional 60 seconds on hot plate. This also ensures that 
all water is evaporated from the surface. 
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APPENDIX D: FUNCTIONALIZATION PROTOCOL 
 
The following equipment was used for the surface functionalization protocol outlined 
below: 
1. Branson Model 2510 Ultrasonic Bath 
2. Nitrogen glove box 
3. Unifilm PVD-300 Sputtering System – Ion mill tool 
4. VWR Scientific Products Standard Shaker 
5. VWR Scientific Products mini vortexer 
6. VWR 25 mL centrifuge tubes 
 
Crosslinker Immobilization 
 
1. Prepare the 4% MTS primary crosslinking solution by mixing 1 part MTS 
solution (Fluka) to 24 parts dry Toluene (99.5% A.C.S., Sigma Aldrich) in a 
sufficiently large centrifuge tube. Mix solution thoroughly using vortexer at 
greater than medium level for more than 30 seconds. 
2. Deposit enough of 4% MTS crosslinker solution into appropriate sealed 
containers to accommodate samples. (For the purposes of these experiments, 3-4 
mL was deposited in to 50 mL centrifuge tubes from VWR which accommodated 
1 cm × 1 cm wafer chips) 
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3. Rinse the ZnO coated surfaces with the following: TCE (Trichloroethylene), 
Acetone (VWR, BDH), Methanol (ultra, J.T. Baker), Isopropanol (VWR, BDH), 
DI H2O (Aristar Plus, VWR, BDH). 
4. Blow both sides dry with N2 gas stream to remove moisture 
5. Warm samples on a heater plate for ~ 1 minute over 100ºC to remove all moisture 
6. Load samples using carbon tape to secure them onto platform surface to be placed 
on planet 5 of the Unifilm PVD-300 sputtering system. 
7. Using loadlock, load platform onto planet 5 of the Unifilm system. 
8. Run program to ion mill surfaces using 9 mA beam current for 5 minutes. 
9. IMMEDIATELY submerge each ZnO coated sample individually into containers 
with 4% MTS crosslinker solution and immediately seal. It is EXTREMELY 
IMPORTANT to minimize exposure time of the samples to air after removing 
them from the vacuum environment of the ion mill before submerging them in 
MTS solution. 
10. Allow samples to incubate for 24 hours. 
11. Prepare 1 mM GMBS (Fluka) solution in ethanol (95%, Fisher) at least 2 hours 
prior to using. 1mM GMBS solution was allowed to mix for 2 hours on a shake 
table at medium speed, or until all granules of GMBS were no longer visible in 
the solution. Again prepare enough of 1 mM GMBS solution into appropriate 
sealed containers to accommodate samples. (3-4 mL in 50 mL centrifuge tubes) 
12. Remove samples from 4% MTS solution and rinse using stream of ethanol for 
several seconds. 
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13. Submerge samples in a small buoyant container with sufficient ethanol to cover 
the samples and place in ultrasonic bath for 5 minutes. 
14. Remove sample from sonication bath and deposit in 1 mM GMBS solution and 
seal. Allow samples to incubate for 24 hours. 
15. Remove samples from 1 mM GMBS solution and rinse using stream of  ethanol 
for several seconds. 
16. Submerge samples in a small buoyant container with sufficient ethanol to cover 
the samples and place in ultrasonic bath for 5 minutes. 
17. Samples are now prepared for IgG immobilization. 
 
Antibody Immobilization 
 
18. Immediately after ethanol sonication, dry samples with N2 gas stream and deposit 
200 µg/mL solution of IgG antibodies by pipette onto surface of sample. (For the 
experiments described in this thesis, 30 µL was sufficient) 
19. Allow Ab solution to incubate on surface for 4 hours. 
20. Rinse surface with PBS buffer stream. 
21. Samples are now functionalized and ready for exposure to liquid sample for 
detection. 
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APPENDIX E: MATLAB CODE – PIEZOELECTRIC TA2O5 
%Calculations defined for Z directed propagation li][0 0 1] 
%Assumed Class of 2mm for Ta2O5 
%Written by Christopher Corso 
  
% syms lx ly lz; 
% lLj = [0 0 0; 0 0 0; 0 0 1; 0 1 0; 1 0 0; 0 0 0]; %Set this according 
to direction of propagation 
% liJ= [0,0,0,0,1,0;0,0,0,1,0,0;0,0,1,0,0,0]; %Also set this according 
to direction of propagation 
 
syms c11 c12 c13 c23 c33 c44 c55 c66 e14 e25 e36 e15 e24 e33 e32 e31 
lex ley lez epsxx epsyy epszz; 
% stiffness= [c11,c12,c13,0,0,0; c12,c11,c23,0,0,0; c13,c23,c33,0,0,0; 
0,0,0,c44,0,0; 0,0,0,0,c55,0; 0,0,0,0,0,c66]; %Stiffness 
Tensor for Orthorhombic 
 
% lj=[0; 0; 1]; %Set this according to direction of propagation 
% li=[0 0 1]; %Set this according to direction of propagation 
% Efieldj=[lex; ley; 0]; %direction of electric field in x y plane 
% Efieldi=[lex ley 0]; %direction of electric field in x y plane 
 
piezoiL=[0,0,0,e14,0,0;0,0,0,0,e25,0;0,0,0,0,0,e36]; %defined for class 
222 
piezoKj=[0,0,0;0,0,0;0,0,0;e14,0,0;0,e25,0;0,0,e36]; %defined for class 
222 
 
% permittivity=[epsxx, 0, 0; 0, epsyy, 0; 0, 0, epszz]; %Perittivity 
% top=piezoKj*Efieldj*Efieldi*piezoiL; 
% bottom=Efieldi*permittivity*Efieldj; 
% piez=top/bottom; 
% stiffened=stiffness+piez; 
% christoffel=liJ*stiffened*lLj 
  
%Above Calculations Redone for Assumed class 2mm Ta2O5 
% 
  
%Declaration of euler angles for rotation of matrices 
rotation=1;  % 1 if rotation to be carried out, 0 if not  
phi=0;       % clockwise rotation around z axis  
theta=-275.216;   % clockwise rotation around new y axis 
psi=0;       % clockwise rotation around new z axis 
  
%Declaration of rest of variables 
syms lx ly lz; 
lLj = [0 0 0; 0 0 0; 0 0 1; 0 1 0; 1 0 0; 0 0 0]; %Set this according 
to direction of propagation 
liJ= [0,0,0,0,1,0;0,0,0,1,0,0;0,0,1,0,0,0]; %Also set this according to 
direction of propagation 
  
%lLj = [1 0 0; 0 0 0; 0 0 0; 0 0 0; 0 0 1; 0 1 0]; %Set this according 
to direction of propagation 
%liJ= lLj'; %Also set this according to direction of propagation 
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syms c11 c12 c13 c23 c33 c44 c55 c66 e14 e25 e36 e15 e24 e33 e32 e31 
lex ley lez epsxx epsyy epszz; 
 
stiffness= [c11,c12,c13,0,0,0; c12,c11,c23,0,0,0; c13,c23,c33,0,0,0; 
0,0,0,c44,0,0; 0,0,0,0,c55,0; 0,0,0,0,0,c66]; %Stiffness 
Tensor for Orthorhombic 
 
%lj=[0; 0; 1]; %Set this according to direction of propagation 
%li=[0 0 1]; %Set this according to direction of propagation 
 
Efieldj=[1; 0; 0]; %Arbitrary direction of electric field 
Efieldi=[1 0 0]; %Arbitrary direction of electric field 
 
%piezoiL=[0,0,0,0,e15,0;0,0,0,e24,0,0;e31,e32,e33,0,0,0]; %defined for 
class 222 
%piezoKj=[0,0,e31;0,0,e32;0,0,e33;0,e24,0;e15,0,0;0,0,0]; %defined for 
class 222 
permittivity=[epsxx, 0, 0; 0, epsyy, 0; 0, 0, epszz]; %Perittivity 
 
if rotation==1; 
    Mphi= [cosd(phi)^2 sind(phi)^2 0 0 0 sind(2*phi); sind(phi)^2 
cosd(phi)^2 0 0 0 -sind(2*phi); 0 0 1 0 0 0; 0 0 0 
cosd(phi) -sind(phi) 0; 0 0 0 sind(phi) cosd(phi) 0; -
sind(2*phi)/2 sind(2*phi)/2 0 0 0 cosd(2*phi)]; 
    Mtheta= [cosd(theta)^2 0 sind(theta)^2 0 -sind(2*theta) 0; 0 1 0 0 
0 0; sind(theta)^2 0 cosd(theta)^2 0 sind(2*theta) 0; 0 0 0 
cosd(theta) 0 sind(theta); sind(2*theta)/2 0 -
sind(2*theta)/2 0 cosd(2*theta) 0; 0 0 0 -sind(theta) 0 
cosd(theta)]; 
    Mpsi= [cosd(psi)^2 sind(psi)^2 0 0 0 sind(2*psi); sind(psi)^2 
cosd(psi)^2 0 0 0 -sind(2*psi); 0 0 1 0 0 0; 0 0 0 
cosd(psi) -sind(psi) 0; 0 0 0 sind(psi) cosd(psi) 0; -
sind(2*psi)/2 sind(2*psi)/2 0 0 0 cosd(2*psi)]; 
    MphiPrime=Mphi'; 
    MthetaPrime=Mtheta'; 
    MpsiPrime=Mpsi'; 
    aphi= [cosd(phi) sind(phi) 0; -sind(phi) cosd(phi) 0; 0 0 1]; 
    atheta= [cosd(theta) 0 -sind(theta); 0 1 0; sind(theta) 0 
cosd(theta)]; 
    apsi= [cosd(psi) sind(psi) 0; -sind(psi) cosd(psi) 0; 0 0 1]; 
    aphiPrime=aphi'; 
    athetaPrime=atheta'; 
    apsiPrime=apsi'; 
 
stiffnessrotated=Mpsi*Mtheta*Mphi*stiffness*MphiPrime*MthetaPrime*Mp
siPrime; 
 
piezoiLrotated=apsi*atheta*aphi*piezoiL*MphiPrime*MthetaPrime*MpsiPr
ime; 
 
permittivityrotated=apsi*atheta*aphi*permittivity*aphiPrime*athetaPr
ime*apsiPrime; 
 
piezoKjrotated=conj(piezoiLrotated'); 
top=piezoKjrotated*Efieldj*Efieldi*piezoiLrotated; 
bottom=Efieldi*permittivityrotated*Efieldj; 
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piez=top/bottom; 
stiffened=stiffnessrotated+piez; 
christoffel=liJ*stiffened*lLj 
else 
    top=piezoKj*Efieldj*Efieldi*piezoiL; 
    bottom=Efieldi*permittivity*Efieldj; 
    piez=top/bottom; 
    stiffened=stiffness+piez; 
    christoffel=liJ*stiffened*lLj 
end 
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APPENDIX F: AMERICAN ASSOCIATION OF CANCER 
RESEARCHERS PRESS RELEASE 
A New Technology for Cancer Screening Listens for the Signs of Cancer 
 
ATLANTA – Cancer-sensing 
devices built as cheaply and 
efficiently as wristwatches – 
using many of the same operating 
principles – could change the 
way clinicians detect, treat and 
monitor cancer in patients. 
Researchers from the Georgia 
Institute of Technology have 
created an acoustic sensor that 
can report the presence of small 
amounts of mesothelin, a 
molecule associated with a 
number of cancers including 
mesothelioma, as they attach to 
the sensor’s surface.  
 
According to the researchers, the study is a proof of principle, demonstrating a technique 
that might work for the detection of nearly any biomarker – a collective term for a 
molecular signal that denotes the presence of disease.  They present their findings today 
in Atlanta, Georgia at the American Association for Cancer Research’s 2nd Annual 
International Conference on Molecular Diagnostics in Cancer Therapeutic Development.   
“It is one thing to be able to identify biomarkers for a disease, but it is another to be able 
to find them in blood quickly and easily at very low concentrations,” said Anthony 
Dickherber, a graduate student in the School of Electrical and Computer Engineering at 
Georgia Tech. “We envision that, one day, doctors can use an array of our sensors as a 
sort of laboratory in their office, where they could use a quick blood sample to detect or 
monitor the signs of cancer.” 
 
According to Dickherber, such a device would be a boon to healthcare practice, allowing 
physicians to screen patients for signs of disease before opting for more expensive or 
invasive diagnostic techniques. Responding to the growing need for such sensors in both 
research and clinical practice, Dickherber, along with fellow Georgia Tech graduate 
student Christopher Corso and research adviser William D. Hunt, Ph.D., conceived of 
and developed  the ACµRay™ (pronounced ak´-u-rā) chip, standing for ACoustic micro-
arRAY – a device that shares more in common with an inexpensive wristwatch than the 
sort of cutting edge molecule-sorting apparatuses currently used by researchers and 
clinical laboratory technicians.   
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The array consists of a series of electrodes deposited on the surface of a thin film of zinc 
oxide, which allows the device to resonate, or vibrate, at a specific frequency when a 
current is applied, much like the quartz timing devices used in many clocks and watches.  
“The sensor itself is built on a base of silicon, like a computer chip, and could be mass-
produced using very well known and inexpensive microelectronic fabrication 
techniques,” Dickherber said.  
 
To turn this array into a sensor, the Georgia Tech researchers coated the zinc oxide 
surface with mesothelin-specific antibodies generated in the lab of Ira Pastan, M.D., at 
the National Cancer Institute.  These molecules are engineered versions of the antibodies 
the immune system creates to identify foreign intruders, such as microbial parasites. In 
this study, the researchers coated the sensor with antibodies for mesothelin, a cell-surface 
protein that is highly expressed in mesothelioma, ovarian cancer, pancreatic cancer and 
other malignancies.  
 
When the mesothelin binds to an antibody, the added mass changes the frequency at 
which the acoustic wave passes between the electrodes on the surface of the device. The 
device is able to “hear” the pitch change due to nanomolar concentrations of mesothelin 
(just a few molecules amid billions) binding to antibodies on the chip. The technology 
has the potential of detecting biomarkers in even lower concentrations than those tested, 
Dickeherber said.   
 
“It is really an elegant engineering solution to a very complicated problem,” said Hunt, a 
professor of electrical and computer at Georgia Tech and lead researcher on the project. 
“With refinement, this technology could readily lead to an inexpensive, ubiquitous 
technology for researchers, physicians and the clinical laboratory.” 
 
This research is supported by grants from the U.S. Army Medical Research & Materiel 
Command Prostate Cancer Research Program, the National Science Foundation, The V 
Foundation, the National Cancer Institute and the Georgia Cancer Coalition. 
 
>>>>> 
 
AACR 2007 Conference on Molecular Diagnostics in Cancer Therapeutic 
Development 
 
September 17-20th, Atlanta, Ga.  
 
Coverage for Tony Dickherber, Christopher Corso, and William Hunt “A New 
Technology for Cancer Screening Listens for the Signs of Cancer”* 
 
From our press release: 
RxPG News 
http://www.rxpgnews.com/research/A-new-technology-for-cancer-screening-listens-for-
the-signs-of-cancer_64056.shtml 
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Dentalplans.com 
http://www.dentalplans.com/articles/25102/ 
 
PhysOrg.com 
http://www.physorg.com/news109349930.html 
 
ScienceDaily 
http://www.sciencedaily.com/releases/2007/09/070918144313.htm 
 
 
Original Stories: 
 
WebMD (Dan DeNoon) 
“Sensor Hears Cancer's Call; Tiny Biosensors Detect ‘Song’ of Cancer Markers, Say 
Researchers” 
http://www.webmd.com/cancer/news/20070918/sensor-hears-cancers-call 
 
From the WebMD story above: 
Medicine.net 
http://www.medicinenet.com/script/main/art.asp?articlekey=83974 
 
 
From the Amanda Gardner HealthDay story “Tiny Sensor Could Spot Cancer 
Early”: 
 
CBC News 
http://www.cbc.ca/cp/HealthScout/070918/6091806AU.html 
 
Health Central.com 
http://www.healthcentral.com/newsdetail/408/608331.html 
 
WFIE 14 Indiana (NBC affiliate) 
http://www.14wfie.com/Global/story.asp?S=7094493&nav=3w6r 
 
LEX 18 Kentucky (NBC affiliate) 
http://www.lex18.com/Global/story.asp?S=7094493&nav=EQls 
 
Forbes 
http://www.forbes.com/forbeslife/health/feeds/hscout/2007/09/18/hscout608331.html 
 
US News & World Report 
http://health.usnews.com/usnews/health/healthday/070918/tiny-sensor-could-spot-cancer-
early.htm 
 
Dentalplans.com 
http://www.dentalplans.com/articles/25095/ 
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Health Scout 
http://www.healthscout.com/news/1/608331/main.html 
 
HealthCentral.com 
http://www.healthcentral.com/newsdetail/408/608331.html 
 
KOLD News Arizona (CBS Affiliate) 
http://www.kold.com/global/story.asp?s=7094493 
 
 
CNN News Room 
 
September 19, 2007 Wednesday 
SHOW: CNN NEWSROOM 3:00 PM EST 
Bail Set For O.J. Simpson; Ahmadinejad to Visit Ground Zero?; Al Sharpton's Planned 
Protest in Jena, Lousiana 
BYLINE: Joe Johns, Paul Vercammen, Deborah Feyerick, Susan Roesgen, Ed 
Lavandera, Don Lemon, Fredricka Whitfield, Jeffrey Toobin, Sanjay Gupta, Susan 
Lisovicz, Wolf Blitzer 
SECTION: NEWS; International 
 
 
WHITFIELD: Straight ahead, a high tech computer chip smaller than a penny that can 
detect cancer. Details on that straight ahead in "THE NEWSROOM". 
 
WHITFIELD: A computer chip could one day make diagnosing cancer as easy as telling 
time. 
 
Here's CNN's chief medical correspondent, Dr. Sanjay Gupta. 
 
DR. SANJAY GUPTA, CNN CORRESPONDENT: This is something that really 
fascinates me quite a bit. This is a little chip that I'm holding up here. I'm actually holding 
it in a pair of tweezers this thing is so small. It's called the ACuRay and it's not something 
that's going to be widely available quite yet. But researchers have been focusing on this 
particular chip as a way to detect cancer very, very early. 
 
Again, it's called the ACuRay. You can take at it there. What it is specifically is 140 
different electrodes actually bound together by zinc oxide. The theory a simple one -- 
basically, if you have cancer molecules in your blood and you wash your blood over the 
sensor, the way that those cancer molecules bind to this 
 
ACuRay gives off a certain resonance, a certain frequency that can be measured. If you 
have cancer molecules, it's going to sound different than if you don't have cancer 
molecules in your blood. The whole idea is that you want to detect cancer as early as 
possible. 
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Now what does this all mean? 
 
There could be a day when doctors have several different little devices like this in their 
office and you walk in, you give a drop of blood and they immediately screen to tell if 
you have any cancer molecules in your bloodstream. It could be used, perhaps, in the 
future for infectious diseases, as well. 
 
Again, as I mentioned, it's not something we may see in our lifetimes as a general way of 
practicing, but this whole idea you might be able to find cancer early, earlier than ever 
before, before it shows up on a C.T. scan or an MRI, when it's just a few still a few 
molecules in your blood is sort of the holy grail of cancer detection and screening. 
 
Could this be the answer? 
 
Possibly one day. It's something that we're certainly going to keep an eye on -- back to 
you. 
 
LEMON: All right, Sanjay. 
 
It's time now to check in with CNN's Wolf Blitzer. 
 
WHITFIELD: Yes, in "THE SITUATION ROOM" -- what do you have on tap? 
 
 WOLF BLITZER, HOST, "THE SITUATION ROOM": All right, guys, thanks very 
much. 
 
The Republican presidential candidate, Rudy Giuliani, has a message for MoveOn.org -- 
bring it on. He talks about his high profile spat with the liberal anti-war group in an 
exclusive one-on-one interview with our chief national correspondent, John King. That's 
coming up. 
 
Also, Reverend Jesse Jackson says Democratic presidential candidate Barack Obama -- 
and I'm quoting now -- "is acting like he's white." We'll show you what's behind that 
controversial comment. 
 
Also, carefree lives in the face of unimaginable suffering. There are some disturbing 
newly released images of the men and women who ran the Nazi Auschwitz death camp. 
All that and a lot more coming up right here in "THE SITUATION ROOM" -- back to 
you. 
 
LEMON: All right, Wolf, we'll be watching. 
 
Thank you. WHITFIELD: All right, the closing bell and a wrap of the action on Wall 
Street straight ahead. 
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